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Hypoglycaemia leads to cognitive impairment in humans. The literature relevant
to the effects of acute hypoglycaemia and the effects of recurrent hypoglycaemia in
normal human subjects and patients with diabetes is reviewed. The research
described in thesis includes studies involving experimentally induced
hypoglycaemia, and clinically based assessments of patients with insulin-dependent
diabetes.
The effect of acute insulin-induced hypoglycaemia on cognitive function in humans
was examined. The principal studies were performed: i) - to examine whether
cerebral adaptation to acute neuroglycopenia occurs in normal subjects, ii) - to
examine whether the degree of impairment of cognitive function during acute
neuroglycopenia is related to the level of cognitive ability of the subject and iii) -
to establish whether patients with insulin-treated diabetes, who have impaired
awareness of hypoglycaemia exhibit a more severe degree of cognitive impairment
during modest hypoglycaemia. In addition to cognitive function testing in patients
with impaired awareness, studies of cerebral blood flow during hypoglycaemia
were undertaken using Single Photon Emission Tomography (SPET). Mood
changes during acute hypoglycaemia were also examined in non-diabetic subjects.
During 60 minutes of exposure to moderate hypoglycaemia there was no evidence
of short term cerebral adaptation to neuroglycopenia in normal subjects.
Cognitive ability did appear to have some influence on cognitive dysfunction during
hypoglycaemia: those subjects of lower cognitive ability appeared to suffer a
smaller degree of cognitive dysfunction during hypoglycaemia. During acute
hypoglycaemia subjects were observed to have marked changes in mood: there was
a decrease in hedonic tone, an increase in tense arousal and a decrease in energetic
arousal.
Diabetic patients with impaired awareness of hypoglycaemia suffered greater and
more prolonged cognitive dysfunction during hypoglycaemia than patients with
normal awareness. Although hypoglycaemia did induce changes in cerebral blood
flow during hypoglycaemia, there were no differences between the patients with
impaired or normal awareness of hypoglycaemia.
A one year prospective study was undertaken to assess the frequency of severe
hypoglycaemia in two groups of patients with insulin-dependent diabetes. Patients
with impaired awareness of hypoglycaemia were shown to be at a sixfold increased
risk of severe hypoglycaemia compared with the patients with normal awareness of
hypoglycaemia.
A descriptive study examined the changes in personality, cognitive function and
lifestyle in a small self-selected group of patients who have a long history of
insulin-dependent diabetes and recurrent severe hypoglycaemia. These patients
were observed to have become less extraverted and more neurotic, had problems
with simple everyday activities and ability to interact socially had also declined.
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Aim of study:- Acute hypoglycemia causes cognitive dysfunction both in normal
subjects and patients with diabetes, and it has been suggested that cerebral
adaptation may occur in response to short-term hypoglycaemia. This was
examined in the present study by measuring serial changes in cognitive function
and in symptoms after 60 minutes of continuous hypoglycaemia.
Methods:- Hypoglycaemia was induced with a hyperinsulinaemic glucose clamp on
two separate occasions in 24 non-diabetic human subjects. Cognitive function was
assessed using the following cognitive test battery : Paced Auditory Serial Addition
Test (PASAT), Rapid Visual Information Processing (RVIP), Trail-Making B
(TMB), Digit Symbol Substitution Test (DSST) and Four Choice Reaction Time
(CRT). In Study A the blood glucose was maintained at 4.5mmol/l throughout.
On two separate occasions (Study B and Study C) the blood glucose was stabilised
at 4.5mmol/l for 30 minutes, lowered to 2.5mmol/l for 60 minutes and restored to
4.5mmol/l for 30 minutes. In each study the cognitive test battery was
performed immediately after stabilisation of blood glucose at 4.5 mmol/1 and the
subsequent battery was repeated at different time intervals: Study A - after a
further 40 minutes of euglycaemia; Study B - after 5 minutes of hypoglycaemia;
Study C - after 40 minutes of hypoglycaemia.
Results:- Acute hypoglycaemia induced a significant deterioration in cognitive
function which was manifest in all tests except TMB (p<0.05), but performance
ability did not differ between Studies B and C. Hypoglycaemic symptoms
assessed by a scaled questionnaire, increased significantly during hypoglycaemia
(p< 0.001) but no differences were detected between the scores at 30 minutes and
60 minutes.
Conclusion:- In non-diabetic humans, no improvement appears to occur, either in
cognitive function or in symptom scores after 40 to 60 minutes of hypoglycaemia




Aim of study:- There is a large inter-individual variation in the cognitive
dysfunction observed during hypoglycaemia, the reason for which is not apparent.
The present study examines whether IQ exerts a differential effect on cognitive
performance during acute hypoglycaemia.
Methods:- Hypoglycaemia was induced with a hyperinsulinaemic glucose clamp on
two separate occasions in 24 non-diabetic subjects (as described in study 1). The
subjects were divided into high and low IQ groups according to their results on the
Alice Heim Test and National Adult Reading Test. Cognitive function was
assessed as described in study 1.
Results: - Multivariate analysis of variance demonstrated a deterioration in
cognitive performance irrespective of IQ group (p < 0.005). Acute hypoglycaemia
induced a significant deterioration in cognitive function in all tests except TMB
(p < 0.05). There was no overall effect of IQ on deterioration in cognitive
performance; univariate analysis of variance revealed group differences in two of
the tests: the lower IQ group deteriorated significantly less than the higher IQ
group during hypoglycaemia in the 4 second PASAT (p=0.03) and tended to have
higher false alarm rates in the RVIP (p=0.06). There were no differences in
performance between Studies B and C, indicating that duration of hypoglycaemia
does not have a differential effect on performance in subjects of lower intelligence.
Symptoms assessed by a scaled symptom questionnaire changed significantly
during hypoglycaemia (p<0.001), but there were no identifiable differences
between the IQ groups.
Conclusion:- Intelligence level may play a minor role in the degree of cognitive




Aim of study:- Previous studies in patients with Type 1 diabetes and impaired
awareness have suggested that cognitive function differs both during euglycaemia
and hypoglycaemia compared with patients with normal awareness of
hypoglycaemia. Changes in cognitive function were examined in 20 patients with
Type 1 diabetes, 10 of whom had normal awareness of the onset of hypoglycaemia
(Group A) while 10 had impaired awareness of hypoglycaemia (Group B).
Methods:- A hyperinsulinaemic glucose clamp was used to produce the following
conditions: (a) euglycaemia (blood glucose concentration 4.5 mmol/1), (b)
hypoglycaemia (2.5mmol/l) and (c) restoration of euglycaemia (4.5mmol/l). On
a separate day a euglycaemic control study was performed (4.5mmol/l).
Cognitive function was assessed using Rapid Visual Information Processing
(RVIP), Trail Making B (TMB), Paced Auditory Serial Addition Test (PASAT)
and Digit Symbol Substitution Test (DSST).
Results:- Multivariate analysis of variance demonstrated a significant difference in
performance during the hypoglycaemic study compared with the euglycaemic
control study (p<0.01). A trend was observed towards an overall effect of
awareness on performance (p=0.08). Further analysis of the individual tests
demonstrated a significant effect of awareness on RVIP correct responses across
time (p=0.05), and an interaction of awareness by study by TMB (p=0.03).
Analysis of the simple effects revealed that during hypoglycaemia, subjects in
Group A were less accurate in their responses (RVIP misses p=0.03) and, on
recovery from hypoglycaemia, cognitive function remained impaired in Group B
compared to Group A (TMB p=0.04, RVIP correct responses p=0.02, RVIP
misses p=0.04).
Conclusion:- Patients with impaired awareness of hypoglycaemia appeared to
exhibit more profound cognitive dysfunction during acute hypoglycaemia in some
tests and the dysfunction persisted for longer following restoration of euglycaemia.
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STUDY 4 SUMMARY
Aim of study:- Changes in regional cerebral blood flow (rCBF) during acute
hypoglycaemia have been described previously. The significance of these changes
with regard to cognitive function and awareness of hypoglycaemia is not known.
Methods:- Regional cerebral blood flow was measured in 20 patients with Type 1
diabetes, 10 of whom had normal awareness of hypoglycaemia (Group A) while 10
had impaired awareness of hypoglycaemia (Group B). Blood glucose
concentrations were manipulated as described in study 3 using the
hyperinsulinaemic glucose clamp and rCBF was measured during i) euglcaemia
(4.5mmol/l) and ii) hypoglycaemia (2.5 mmol/1). The distribution of the isotope
99mTc-Exametazime was determined using a single slice multi-detector head
scanner. 250MBq of isotope were injected during euglycaemia and a further 250
MBq was injected during hypoglycaemia. The rCBF was estimated in 30 regions
of interest, derived from a standard neuroanatomical atlas, on two parallel slices at
40 and 60mm above the orbito-meatal line.
Results:- Analysis of variance did show a significant difference between the groups
in right occipital blood flow, irrespective of the scan conditions. Both groups also
exhibited increased rCBF to both superior pre-frontal cortices and the right
thalamus with concomitant reduced flow to the right putamen compared with the
baseline scans. When changes in cognitive function during hypoglycaemia were
correlated with changes in rCBF, greater prefrontal increments in tracer uptake
were associated with a smaller deterioration in performance in the Paced Auditory
Serial Addition Test (PASAT).
Conclusion :- These results suggest that the rCBF may have a protective role in
the prevention of cognitive dysfunction during acute hypoglycaemia.
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STUDY 5 SUMMARY
Aim of study:- Patients with diabetes frequently report changes in mood during
acute hypoglycaemia and patients exposed to recurrent hypoglycaemia have been
shown to be less 'happy' and more anxious. However few studies have addressed
acute changes in mood occurring during a single episode of hypoglycaemia.
Methods:- Hypoglycaemia was induced on two occasions using a
hyperinsulinaemic glucose clamp in 24 non-diabetic human subjects (see study 7);
on a third occasion a euglycaemic 'placebo' control study was performed. Serial
changes in mood were assessed using the UWIST Mood Adjective Checklist
before, during and after 60 minutes of controlled hypoglycaemia (2.5 mmol/1).
Results:- Analysis of variance demonstrated that hypoglycaemia induced a
significant reduction in hedonic tone (ie subjects became less happy; p=0.027), a
significant increase in tense arousal (ie subjects became more tense; p=0.001) and
a trend towards a decline in energetic arousal (ie became less energetic; p=0.056)
in comparison with the euglycaemia control study. The changes in tense arousal
persisted for 15 minutes after restoration of euglycaemia and the changes in
energetic arousal were still present after 30 minutes following the restoration of
euglycaemia. In comparison hedonic tone returned to baseline scores within 15
minutes of restoration of euglycaemia.
Conclusions:- In non-diabetic subjects, during acute hypoglycaemia, profound
changes in mood were observed, towards a state called 'tense-tiredness', which
persisted for at least 30 minutes after restoration of euglycaemia. Laboratory
induced hypoglycaemia may provide a means by which to investigate the biological
basis of mood. In addition, these findings may be of clinical relevance in patients
with diabetes who are exposed frequently to hypoglycaemia in daily life.
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STUDY 6 SUMMARY
Aims of study:- Diabetic patients with impaired awareness of hypoglycaemia are
recognised to be at an increased risk of developing severe hypoglycaemia but the
actual frequency is unknown.
Methods:- A prospective study was undertaken for 12 months in 60 patients with
Type 1 diabetes: 29 had impaired awareness of hypoglycaemia and 31 had normal
awareness of hypoglycaemia. The two groups of patients were matched for age,
age of onset of diabetes, duration of diabetes and glycaemic control. Episodes of
severe hypoglycaemia were recorded within 24 hours of the event and verified
where possible by witnesses.
Results:- During the 12 months, 19 (66%) of the patients with impaired awareness
had one or more episodes of severe hypoglycaemia in 12 months with an overall
incidence of 2.8 episodes per patient per year. Only 8 (26%) of the patients with
normal awareness experienced severe hypoglycaemia (p<0.01) with an annual
incidence of 0.5 episodes per patient per year (p<0.001). Severe hypoglycaemia
occurred at different times of the day in the two groups: patients with impaired
awareness experienced a greater proportion of episodes during the evening
(p=0.03) and patients with normal awareness experienced a greater proportion in
the early morning (p=0.05). Fear of hypoglycaemia was also assessed; patients
with impaired awareness of hypoglycaemia were observed to worry more about
hypoglycaemia than patients with normal awareness (p=0.008), but this did not
modify their behaviour.
Conclusion:- This prospective evaluation confirmed that impaired awareness of
hypoglycaemia predisposes to an increased (sixfold) frequency of severe
hypoglycaemia, much of which occurred at home during waking hours.
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STUDY 7 SUMMARY
Aim of study:- It has been proposed that recurrent severe hypoglycaemia may
cause permanent cognitive impairment in insulin-treated diabetic patients.
Changes in mood, personality and social function were examined in a group of five
Type 1 diabetic patients, all of whom had a history of recurrent hypoglycaemia.
Methods:- Five patients with Type 1 diabetes were studied, aged 50 to 66 years,
who had a duration of diabetes ranging from 24 to 47 years. Information on
medical history and frequency of severe hypoglycaemia was obtained from their
carers and hospital records. The patients' carers assessed the premorbid and
present behaviour and personality of the patients using standard questionnaires.
Results:- All patients had experienced multiple episodes of severe hypoglycaemia
and had impaired awareness of hypoglycaemia. Cerebral dysfunction pre-dated
the development of identifiable diabetic complications which were mild in nature
and had been apparent for between one and 17 years. Significant deteriorations
were demonstrated in cognitive (p=0.04) and social functions (p=0.04), compared
with assessment of premorbid function. Patients had tended to become more
neurotic (p=0.08) and less extravert (p=0.07). All of the patients and three of
the carers recorded scores suggestive of psychiatric morbidity on the General
Health Questionnaire. The patients had experienced loss of employment and the
carers described a reduction in the patients' social interactions.
Conclusion:- In the absence of other potential causes of cerebral dysfunction, these
major changes in cognitive abilities, personality and social behaviour may be in
part attributed to recurrent severe hypoglycaemia. The need for professional






Patients with diabetes are exposed to a variety of metabolic insults including hyper-
and hypoglycaemia, both of which affect cognitive function (Ryan 1988,
Richardson 1990, McCall 1992). Although the pathogenetic role of
hyperglycaemia in the development of various diabetic complications is well
established, the adverse effects of acute and recurrent hypoglycaemia on the brain
have received limited attention until recently, despite previous clinical
observations that severe hypoglycaemia can cause cerebral damage and overt
psychopathology (Moersch and Kernohan 1938, Sahs and Alexander 1939,
Lawrence 1942, Murphy and Purtell 1943, Fischer and Dolger 1946, Jones 1947).
The incidence and symptomatology of hypoglycaemia will be discussed before
reviewing the effects of hypoglycaemia on cerebral function.
Incidence of Hypoglycaemia
Since the advent of insulin therapy in 1922 for the treatment of patients with
diabetes mellitus, hypoglycaemia has been recognised to be a common and
potentially dangerous side-effect of such treatment (Paz-Guevera et al 1975,
Deckert et al 1978, Hepburn et al 1989) and is one of the most feared
complications of insulin treatment. The causes of acute hypoglycaemia are often
multifactorial and may result from the unphysiological methods presently available
for the administration of insulin in combination with varying degrees of patient
error. Hypoglycaemia of varying severity is a common side effect of insulin
therapy, although the frequency is difficult to estimate with accuracy unless
confined to severe episodes (Pramming et al 1991). When severe hypogly¬
caemia is defined as the need for external assistance to resuscitate the patient,
approximately 30% of insulin-treated diabetic patients experience severe
hypoglycaemia at some time with an incidence of about 1.4-1.6 episodes"1 patient"1
year"1, and an unfortunate minority experience recurrent severe hypoglycaemia
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(Goldstien et al 1981, Gale 1985, Pramming et al 1991). Comparisons of intensive
and conventional insulin therapy have revealed that the frequency of severe
hypoglycaemia is three times greater in patients exposed to intensive insulin
therapy than in patients on conventional insulin regimens (DCCT Research Group
1991).
Symptoms of hypoglycaemia
The symptoms which usually alert a patient to the onset of hypoglycaemia can be
subdivided into three groups: those attributable to neuroglycopenia, which
interferes with intellectual activity and impairs cognitive function, those resulting
from activation of the autonomic (principally of the sympatho-adrenal) system and
non-specific symptoms associated with malaise (Cooke 1934, Hepburn et al
1991a). Neuroglycopenic symptoms comprise confusion, drowsiness, odd
behaviour, speech difficulty and incoordination. The 'malaise' symptoms include
those such as headache and nausea. Stimulation of autonomic centres in the
hypothalamus triggers an autonomic discharge (or 'reaction') which increases
peripheral autonomic neural activity and is characterised by symptoms such as
sweating, tremor, pounding heart and hunger. The simultaneous secretion of
adrenaline probably augments some of these autonomic symptoms. Following the
triggering of putative glucose-sensitive receptors located within the brain and also
possibly in other peripheral organs (eg pancreatic / hepatic), various counter-
regulatory hormones are released, the most important of which are glucagon and
catecholamines in normal humans. In patients with Type 1 diabetes of over five
years duration glucagon secretion may be diminished or absent and catecholamines
are the principal counterregulatory hormones (Frier et al 1986). These hormones
stimulate the restoration of blood glucose via metabolic actions on hepatic
glycogenosis and gluconeogenesis.
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The symptoms of hypoglycaemia are idiosyncratic and may vary with
circumstances and time, but usually comprise a combination of autonomic,
neuroglycopenic and non-specific symptoms. A patient's ability to recognise the
onset of hypoglycaemia may be affected by numerous factors including long
duration of diabetes, strict glycaemic control, previous episodes of severe
hypoglycaemia, sleep, alcohol and drugs such as hypnotics and non-selective beta-
blockers. The interactions between hypoglycaemic warning symptoms, the integrity
of glucose counterregulation and the effects of neuroglycopenia on cognitive
function are important in determining the severity and morbidity of hypoglycaemia.
Impaired awareness of hypoglycaemia
Impaired awareness of hypoglycaemia is the inability of the patient to perceive the
onset of hypoglycaemia. It is important that a patient is able to detect
hypoglycaemia in sufficient time to allow ingestion of carbohydrate to restore the
blood glucose towards normal. However if there is a defect in warning symptoms
the blood glucose may have already fallen too low, resulting in severe
neuroglycopenia which will in turn impair the patients ability to seek help. There
are many early anecdotal reports of patients treated with insulin, in whom the
perception of the onset of warning symptoms of hypoglycaemia has altered since
the time of diagnosis (Maddock and Trimble 1928, Lawrence 1941, Balodimos and
Root 1959). More recent studies have shown that approximately 50% of patients
with Type 1 diabetes of over 20 years duration experience a change in their
symptoms of hypoglycaemia, which usually results in a switch from predominantly
autonomic symptoms to neuroglycopenic symptoms (Pramming et al 1991). The
term 'impaired awareness' is preferred to 'unawareness' of hypoglycaemia as the
degree of perception of the episode will also be dependent on the situation eg a
labourer will find it more difficult to perceive the onset of hypoglycaemia while
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working outside on a hot day if his warning symptoms are predominantly those of
sweating; in addition some patients can 're-educate' themselves to recognise new
warning symptoms such as dizziness or yawning in place of sweating and
trembling. However it has been shown that these patients with impaired
awareness are at greater risk of experiencing recurrent severe hypoglycaemia
(Hepburn et al 1990, Pramming et al 1991). In patients who have impaired
awareness of hypoglycaemia, reliance on observers such as relatives or colleagues
becomes paramount to detect the development of acute hypoglycaemia. The
patient may be observed to be exhibiting manifestations of overt neuroglycopenia
with impairment of cognitive function and increasing confusion which interferes
with perception of the manifestations of severe hypoglycaemia.
Impaired awareness of hypoglycaemia appears to consist of two separate clinical
entities at opposite ends of a spectrum, one of which is transient, reversible and
related to strict glycaemic control and the other is chronic, irreversible and related
to duration of diabetes (Amiel et al 1987, Hepburn and Frier 1991). Recurrent
hypoglycaemia has been shown to result in 'hypoglycaemia-associated autonomic
failure' (Cryer and Gerich 1990, Cryer 1992). This phenomenon comprises three
clinical syndromes: defective glucose counterregulation, hypoglycaemia
unawareness and elevated glycaemic threshold during effective insulin therapy
(Cryer 1992). These three syndromes tend to cosegregate ie they occur in
patients with a long duration of diabetes (Ryder et al 1990, Hepburn et al 1990)
and appear to be perpetuated by recurrent hypoglycaemia. A single episode of
hypoglycaemia results in elevated glycaemic thresholds for autonomic and
symptomatic responses and impaired physiological defence to subsequent
hypoglycaemia and may result in transient impaired awareness of hypoglycaemia.
It is possible that the chronic form of impaired awareness of hypoglycaemia lies at
the extreme end of the spectrum of 'hypoglycaemia associated autonomic failure',
occurring in patients with longer duration diabetes and a history of recurrent
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episodes of severe hypoglycaemia, and is irreversible, although various
alternative causes have also been proposed (Heller and Cryer 1991, Clarke et al
1991, Hepburn and Frier 1991, Gerich et al 1991, Heller and Macdonald 1991).
It is now clear that autonomic neuropathy per se does not cause impaired
awareness of hypoglycaemia although it may also be found in many patients with a
long duration of diabetes (Ryder et al 1990, Hepburn et al 1991b).
The pathophysiology of alterations in symptoms of hypoglycaemia is not known
and may result from a defective activation of a glucose sensor which when
exposed to hypoglycaemia triggers central neuronal activity which is eventually
manifest as the autonomic discharge already described. Cerebral glucose
metabolism has been reviewed previously (McCall 1992) and it appears that the
brain may provide the location of a glucose sensor. In one study in dogs (Biggers
et al 1989) peripheral hypoglycemia was maintained with concomitant cerebral
euglycaemia (obtained by infusing glucose into cerebral arterial blood supply) and
it was observed that the counterregulatory hormonal responses were significantly
impaired compared with the responses which occurred when cerebral
hypoglycaemia was allowed to occur. Although other studies have supported the
role of this putative cerebral glucose sensor (Skov and Pryds 1992) a recent study
again performed in dogs (Donovan et al 1993) proposed that hepatic glucose
sensors mediate the counterregulatory responses. Until the glucose sensor in
healthy subjects or patients with diabetes and normal awareness of hypoglycaemia
is identified, it is difficult to hypothesise on the mechanism which is defective in





HYPOGLYCAEMIA AND COGNITIVE FUNCTION
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The evidence for the detrimental effects of hypoglycaemia on the brain has been
documented for many years (Moersch and Kernohan 1938, Lawrence 1942,
Fischer and Dolger 1946, Jones 1947) although the precise mechanisms involved
and the resulting effects on behaviour, cognitive function and personality have only
recently been the topic of scientific research. One of the reasons for this is that
these areas of study are very difficult to quantify and were therefore previously
neglected. Advances in statistical knowledge and psychometric analysis have now
enabled the introduction of many standardised tests and questionnaires which allow
quantification and comparison between subjects of variables such as cognitive
function.
The results of such studies will be reviewed. Cognitive function will be
considered with respect to :
1) permanent changes occurring as a result of the cumulative effects of
recurrent exposure to severe hypoglycaemia.
2) transient changes in response to acute insulin-induced hypoglycaemia.
The methods required to study cognitive function during acute hypoglycaemia vary
considerably from those necessary to assess the potential effects of recurrent severe
hypoglycaemia.
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LONG TERM EFFECTS OF RECURRENT ACUTE HYPOGLYCAEMIA
ON COGNITIVE FUNCTION
Anecdotal reports of diabetic patients who have experienced repeated severe
hypoglycaemia have described the development of serious and often permanent
deterioration in cognitive function, intellectual capacity and personality (Moersch
and Kernohan 1938, Tyler and Ziskind 1940, Lawrence 1942, Murphy and
Purtell 1943, Wilder 1943). 'Insulin shock' therapy was introduced in the 1930's
as method of treatment for various psychoses; it was initially considered to be a
relatively safe form of treatment although early published reports did acknowledge
that this therapeutically induced hypoglycaemia was associated with a significant
morbidity (Frostig 1938, Meduna and Fiedman 1939).
More recently the cumulative effects of recurrent episodes of hypoglycaemia on
cognitive function have been studied in patients with Type 1 diabetes of various
ages. The importance of these findings is that if recurrent severe hypoglycaemia
is shown to impair cognitive function permanently, the therapeutic goals for
glycaemic control which are currently recommended for patients with insulin-
treated diabetes will need re-evaluation. It may be necessary to strive for
suboptimal glycaemic control in individual patients who are at increased risk of
severe hypoglycaemia, to avoid jeopardising intellectual function. Studies of
adults and children should be differentiated, because recurrent severe
hypoglycaemia is likely to impose different effects on the immature developing
brain of a child compared with the adult who has attained maximum cognitive
ability before being exposed to this metabolic insult.
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Recurrent Hypoglycaemia and Cognitive Function in Adults with Diabetes
A correlation between cognitive dysfunction and the estimated frequency of severe
hypoglycaemia was demonstrated by Bale (1973) using a measure of global
intelligence (the Walton Black New Word Learning Test) to examine cognitive
performance in 100 Type 1 diabetic patients. In another study, cognitive function
was measured with an extensive battery of cognitive tests, including the Wechsler
Adult Intelligence Scale, and an association was reported between the number of
episodes of severe hypoglycaemia and cognitive dysfunction in Type 1 diabetic
patients (Skenazy and Bigler 1984). Patients with Type 1 diabetes who had a
history of recurrent severe hypoglycaemia (Wredling et al 1990) were observed to
exhibit impairment ofmotor ability, problem solving and visuo-spatial skills, and
abnormalities of frontal lobe function (as assessed by finger-tapping, Necker cube
reversal and maze tests). These patients were also observed to be more cautious at
the expense of speed in deriving their answers, which is similar to observations of
performance during acute hypoglycaemia (Holmes et al 1983).
Langan et al (1991) used the National Adult Reading Test (NART) (Nelson 1982)
and Wechsler Adult Intelligence Scale - Revised (WAIS-R) (Wechsler1981) to
determine whether changes in IQ had occurred in 100 Type 1 diabetic patients who
had no history or evidence of other organic brain disease. The NART (see Part
II) is an assessment of the 'best' global cognitive function ever attained,
irrespective of time, and is resistant to progressive brain disease. The comparison
of pre-morbid assessment of IQ, using the NART, with measurements of the
patient's present IQ (WAIS-R) can identify any significant deterioration which has
occurred over a period of years. The diabetic patients who had previously
experienced five or more episodes of severe hypoglycaemia had a definite
deterioration in IQ and also had poorer reaction times. It was also possible to
refute the suggestion that a lower premorbid IQ predisposes the patient to severe
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hypoglycaemia, which could not be excluded in previous studies (Wredling et al
1990). Comparison of the same diabetic patients (Langan et al 1991) with a
matched control group of 100 non-diabetic subjects demonstrated that the diabetic
patients had lower WAIS-R performance and verbal IQ scores (Deary et al 1993a).
However, after controlling for the frequency of severe hypoglycaemia, the
performance IQ was similar both in the diabetic and the control groups although a
significant difference in verbal IQ persisted. These findings suggest previous
exposure to hypoglycaemia is associated with poorer performance IQ; factors such
as the social impact of the diabetes may explain the lower verbal IQ which was
apparent in the diabetic patients.
In order to determine which modalities of cognitive function were affected by
previous exposure to severe hypoglycaemia the patients from Langan's study
(1991) were also studied using Four Choice Reaction Time (CRT), Rapid Visual
Information Processing (RVIP) and a memory task (Sternberg Memory
Scanning)(Deary et al 1992). CRT measures the time taken for a subject to
respond to one of a choice of lights, which is flashed on at random; both the time
taken to decide an appropriate response (decision time) and the time taken to
perform the response (movement time) are recorded. In the RVIP test the subject
observes a screen, on which numbers are displayed individually, and is asked to
press a button each time a sequence of three odd or three even numbers occurs; the
number of correct responses, incorrect responses and the time taken to respond are
obtained. In the diabetic patients the decision time for the CRT and the number of
RVIP correct responses correlated significantly with the frequency of previous
severe hypoglycaemia (Deary et al 1993a), and factor analysis suggested that
decision and response initiation processes, were affected by a history of
hypoglycaemia rather than processes such as encoding and storage.
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These studies have all depended on retrospective estimation of the frequencies of
severe hypoglycaemia which may be inaccurate. In a prospective study, the
Stockholm Diabetes Intervention Study (SDIS), comparing intensive and
conventional insulin regimens in a group of Type 1 diabetic patients (Reichard et al
1991), the frequency of severe hypoglycaemia increased during five years of strict
glycaemic control, but no impairment of cognitive function was demonstrated over
this period. However, a clear discrimination in the frequency of severe
hypoglycaemia was not made between the intensively-treated and conventionally-
treated patient groups, so diminishing the power of the study and increasing the
susceptibility to a type II statistical error. In addition, five years may be too short
a period for overt cognitive deterioration to emerge, and the limited battery of
cognitive function tests which were used may not be of sufficient sensitivity to
demonstrate subtle changes of cognitive ability (Deary and Frier 1992, Gold et al
1993).
The advent of sophisticated cerebral scanning techniques such as single photon
emission tomography (SPET) have facilitated the demonstration that acute
hypoglycaemia alters regional cerebral blood flow, in particular to the frontal lobes
where blood flow was increased (Thllroth et al 1992). These changes were also
present (and were more prominent) during normoglycaemia in diabetic patients
who had a history of recurrent severe hypoglycaemia (MacLeod et al in press).
Similarly changes in the frontal lobes have been identified in patients dying from
hypoglycaemia (Terplan 1932).
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Recurrent Hypoglycemia and Cognitive Function in Children with Diabetes
Premature infants are at risk of spontaneous hypoglycaemia and a prospective
controlled study of non-diabetic children has demonstrated that infants exposed to
hypoglycaemia subsequently had a lower IQ and had evidence of retarded
development (Pildes et al 1974). In a study of children with Type 1 diabetes it
was observed that IQ was significantly lower than that of age-matched, non-
diabetic children with a similar educational background and the IQ deficit in the
diabetic children was associated with the number of preceding episodes of severe
hypoglycaemia (Ack et al 1961). Fallstrom (1974) showed that diabetic children
had more perceptual disturbance, anxiety and behavioural problems compared with
healthy non-diabetic children of the same age; the severity of these abnormalities
correlated with the frequency of previous hypoglycaemic convulsions. Studies of
children with Type 1 diabetes have also shown that up to 80% of children who had
experienced five or more episodes of severe hypoglycaemia had permanent EEG
abnormalities (Eeg-Olofsson and Petersen 1966, Eeg-Olofsson 1977, Haumont et al
1979, Soltesz and Acsadi 1989). Visual evoked potential abnormalities have been
shown to be more frequent in diabetic children compared with normal subjects
(Cirillo et al 1984).
Adolescent diabetic patients have been demonstrated to have poorer cognitive
function compared with normal controls and the poorest performance occurred in
those diabetic children who had developed diabetes before the age of five years
(Ryan et al 1984, 1985). Multiple regression analysis revealed that long duration
of diabetes was associated with poorer verbal and learned skills, and that early
age of onset principally appeared to affect the tests which measured the ability to
process new information. Subsequent studies have attempted to correlate the
frequency of hypoglycaemic episodes with changes in cognitive function (Rovet et
al 1987, Golden et al 1989) and have shown that the diabetic children who
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performed poorly on cognitive function testing had previously experienced more
hypoglycaemic convulsions and had been exposed to frequent asymptomatic
biochemical hypoglycaemia.
In a three year prospective study of 63 children with Type 1 diabetes no major
deficits in cognitive function occurred during the study period (Rovet et al 1991).
However those patients with onset of diabetes before five years of age had evidence
of frequent biochemical (asymptomatic) hypoglycaemia and exhibited a poorer
spatial ability, whereas those children with diabetes of later onset had more
frequent symptomatic episodes of hypoglycaemia and had poorer verbal skills.
One study has shown that relative youth may not necessarily indicate better
cognitive and coping skills (Connis et al 1989). It has been suggested that diabetic
children with early onset of diabetes should be considered for neuropsychological
testing if they have a history of recurrent hypoglycaemia (Puczynski et al 1992).
The effects of recurrent severe hypoglycaemia on cognitive function are
summarised in the Thble 1.2.1.
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TABLE 1.2.1
EFFECTS OF RECURRENT SEVERE HYPOGLYCAEMIA
ON COGNITIVE FUNCTION IN INSULIN-DEPENDENT
DIABETIC PATIENTS
• moderate reduction in IQ occur over a period of several years
• early onset of diabetes may affect ability to process new information
• accuracy of performance is maintained at the cost of speed
• decision but not encoding processes are affected by previous severe
hypoglycaemia
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Other factors affecting cognitive function in patients with diabetes
Many other factors may potentially influence cognitive function which include age
at onset of diabetes, duration of diabetes, quality of glycaemic control, the
presence of other conditions which may potentially affect cognitive function and
limited educational attainment through loss of schooling. The effect of recent poor
metabolic control on cognitive function has been examined in patients with either
Type 1 or Type 2 diabetes; while some studies have failed to demonstrate any such
effect (Prescott et al 1990, Donald et al 1984, Lawson et al 1984) other studies
have shown an association between poor metabolic control (predominantly
hyperglycaemia) and impaired cognitive function (Holmes et al 1986, Reaven et al
1990). Holmes et al (1988) examined a group of Type 1 diabetic patients who had
near-normal glycaemic control and observed that they appeared to perform more
poorly both on auditory and visual reaction time tasks than a group of matched
diabetic patients with moderate glycaemic control. In some studies, duration of
diabetes and age at onset have been associated with poorer cognitive function
(Holmes et al 1988, Reaven et al 1990) whereas others have been unable to
demonstrate this relationship (Donald et al 1984, Prescott et al 1990). The
problems of investigating changes in cognitive function after recurrent episodes of
hypoglycaemia are exemplified by these conflicting and disparate results. Several
other independent and confounding factors such as premature cerebrovascular
disease, hypertension, alcoholism or previous head injury may interfere with
cognitive function, and have to be excluded when investigating the putative effects
of severe hypoglycaemia in diabetic patients.
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EFFECT OF ACUTE HYPOGLYCAEMIA ON COGNITIVE FUNCTION
Early anecdotal reports described the effects of neuroglycopenia resulting from
hypoglycaemia either from the therapeutic administration of exogenous insulin or
from the autonomous hyperinsulinaemia associated with insulin-secreting tumours
(Dashiell 1930, Wilder 1943, Fineberg and Altschul 1951). However, before the
1970's very few formal studies of the effects of acute hypoglycaemia on cognitive
function had been reported. Subsequent studies have addressed the following
questions and these will be reviewed:
1 Which modalities of cognitive function are impaired by hypoglycaemia ?
2 Is there a blood glucose 'threshold' at which cognitive impairment
commences and how does that relate to the physiological and
neuroendocrine responses to hypoglycaemia, including the perception of
symptoms and the activation of counterregulatory mechanisms ?
3 In what way are the symptoms of hypoglycaemia related to cognitive
impairment ?
4 Are there adaptive mechanisms in the brain which limit the degree of
cognitive impairment ?
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Limitations of experimental models in the study of the effects of acute
hypoglycemia on cognitive function
Before it is possible to compare and contrast studies it important to appreciate that
there are many limitations in experimental models used in the study of acute
hypoglycaemia on cognitive function. Analysis of the literature of such studies
demonstrates many disparate results and it is important to consider certain
methodological differences between studies before attempting to interpret and
compare results.
Subjects
Studies on diabetic subjects should not be compared with studies on non-diabetic
subjects as the effect of diabetes per se and hyperglycaemia may confound results.
In addition the type of diabetes must be considered ie Type 1 (insulin-dependent) or
Type 2 (non-insulin-dependent), and the duration and age of onset of diabetes of
the subjects differs between studies as well as the degree of glycaemic control.
Method of induction ofhypoglycaemia
Hypoglycaemia induced in the laboratory setting must be reproducible and safe and
two principal methods of induction of hypoglycaemia have been utilised in the
study of changes in cognitive function: 1) - insulin infusion, 2) - hyperinsulinaemic
glucose clamp. In the former method insulin is infused at a steady rate until the
threshold for the onset of hypoglycaemia is reached. The hyperinsulinaemic
glucose clamp consists of a fixed rate insulin infusion and a variable rate glucose
infusion which allows stabilisation of the blood glucose at predetermined
concentrations. The merits of each of these techniques have been reviewed
previously (Heine 1993), but in brief, while the insulin infusion technique is
probably more physiological it does not allow prolonged cognitive testing at fixed
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blood glucose concentrations or accurate determination of glycaemic thresholds for
changes in symptoms, counterregulatory hormones or cognitive function. The
hyperinsulinaemic glucose clamp is more reproducible and is the only method
presently available to safely allow prolonged cognitive testing, although some
responses to hypoglycaemia may be modified by hyperinsulinaemia. Comparison
of studies using different methods of induction of hypoglycaemia are not therefore
possible.
Blood glucose sampling
Blood glucose measurements vary depending on the site and method of sampling.
Values have sometimes been cited as 'plasma' concentrations or as 'whole blood'
concentrations and are not therefore directly comparable. Glucose concentrations
also vary depending on whether sampling was 'venous' or 'arterialised'; in the
fasted state there is little arterio-venous difference in glucose concentrations
(Hampton et al 1986) but post-prandially or after an intravenous glucose load (as in
the glucose clamp) this difference increases (Liu et al 1992).
Cognitive test batteries
Several different methods for assessment of cognitive function are available
probably because there is no single test which can assess all aspects of cognitive
function and in addition many studies have tried to analyse whether certain aspects
of cognitive function are more affected by hypoglycaemia and therefore use more
specific tests. The sensitivity of these tests to detecting subtle changes in cerebral
function varies considerably. Improved performance in some tests arises as a
result of repeated attempts at the tests and should be accounted for in the
interpretation of results. These practice effects can be minimalised by allowing
subjects to have trial runs at the tests, although in many studies in the literature it is
not made clear whether this has been done.
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With these limitations in mind the results of the studies of acute hypoglycaemia on
cognitive function will be reviewed.
Modalities of cognitive function affected by acute hypoglycaemia
The initial studies of the effects of acute hypoglycaemia on cognitive function
aimed to identify which modalities of cognitive function were affected.
Frequently in these studies large cognitive test batteries were employed principally
as an exploratory exercise. The main findings from these studies are shown in
Thble 1.2.2 and although it is not possible to describe all the studies performed in
this area, a few of the principal results be described below, in chronological order.
Flenders and Lifshitz (1976) demonstrated impairment of fine motor coordination
during acute hypoglycaemia in a group of Type 1 (insulin-dependent) adolescent
diabetic patients. Holmes et al (1983), investigated insulin-treated diabetic
patients using a hyperinsulinaemic glucose clamp method to induce controlled
hypoglycaemia. Changes in memory tasks (using digit span and Rey Auditory
Verbal Learning Test), general attention and psychomotor tasks (using matching
tasks and visual reaction time), visuospatial-memory tasks (using Benton Visual
Retention Tests) and academic ability tasks (using mathematical tests) were
examined. They found that reaction time was slower during hypoglycaemia and
fewer mathematical tasks could be performed in a given time although accuracy
was maintained. Memory was not impaired, nor was visual perception affected.
Herold et al (1985) similarly demonstrated slowing of reaction times during
hypoglycaemia both in non-diabetic subjects and in insulin-treated diabetic adults.
Considerable variability in response between subjects was noted which suggested
differing degrees of individual susceptibility to acute hypoglycaemia. In a further
study, Holmes et al (1984), observed that verbal fluency and Stroop test
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performance were impaired in patients with Type 1 diabetes during acute
hypoglycaemia.
Pramming et al (1986), used a variable rate insulin infusion to induce
hypoglycaemia in a group of insulin-treated diabetic patients and showed changes
in cognitive function using a battery of tests including subtraction tasks, trail-
making tests, digit span, Bourdon-Story recall, categorisation and finger-tapping.
Deterioration in the performance in all of these tests was observed, and differed
from the results of Holmes et al (1983) by demonstrating that tests of immediate
memory were also impaired. In an anecdotal case report, changes in the temporal
lobe (which is involved in memory function) have been identified by magnetic
resonance imaging in a diabetic patient who experienced severe but transient
amnesia after hypoglycaemic coma (Chalmers et al 1991). However the degree of
hypoglycaemia experienced by this patient was obviously far greater than that
which is usually induced experimentally.
Hoffman et al (1989) described a deterioration in trail-making and pursuit-rotor
tasks in patients with Type 1 diabetes, associated with prolongation of reaction
times and also observed a marked variability between subjects as described
previously (Herold et al 1985). Stevens & al (1989) demonstrated impairment of
the digit-symbol substitution test (a subtest of the Wechsler Adult Intelligence test)
in normal (non-diabetic) subjects but did not observe any effect on choice reaction
times, although the degree of hypoglycaemia which was induced using a stepped
hyperinsulinaemic glucose clamp technique was relatively modest (arterialised
blood glucose 3.4 mmol/1). The variable results of these studies might be related
to the differing techniques used to induce hypoglycaemia. In addition, variable
degrees of severity and times of exposure to hypoglycaemia were induced before
cognitive testing was applied and a wide range of cognitive test batteries of varying
34
sensitivity have been utilised by different workers.
The identity of the study population is important as previously mentioned and may
provide variable results as patients with Type 1 diabetes have been shown to be
more severely affected than normal subjects at arterialised blood glucose levels of
2.0mmol/l (Wirsen et al 1992).
In summarising the above studies it appears that there is a large inter-individual
variation in performance but on the whole tests of complex cognitive function
which require information to be perceived, processed and a response given appear
to be most affected eg Stroop test, Trail-making tests, Digit Symbol Substitution
and matching tasks. Driesen et al (1991) have also shown that during moderate
hypoglycaemia (blood glucose 2.8-3.3 mmol/1) only choice reaction times were
prolonged (which involve complex information processing) in patients with Type 1
diabetes, while at lower blood glucose concentrations (1.9-2.5 mmol/1) both simple
and choice reaction times were impaired. This suggests that the degree of
hypoglycaemia experienced is also important in determining which cognitive
processes are impaired.
In general, during acute hypoglycaemia, skills which require more complex
decision making and discrimination appear more likely to be impaired significantly
than simple motor tasks (eg. simple reaction time). Trail-making B and pursuit
rotor tests were impaired more significantly than trail-making A and visual reaction
times (Hoffman et al 1989). This suggests that it is not primarily the motor
component of these tasks which is compromised (Hoffman et al 1989), otherwise
all of the tasks should be impaired to a similar degree. Further evidence in favour
of this theory will be discussed later.
The results from the afore mentioned studies would lead one to expect that driving
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skills would be impaired by hypoglycaemia as they involve complex decision
making, but Hoffman et al (1989) did not observe abnormalities in insulin-treated
diabetic patients using a driving simulator. However only a small number of
subjects were tested and the type of simulator employed was thought unlikely to
provide a very good comparison with actual driving conditions. The driving
simulator may have awakened the subjects interest as an 'entertainment' rather
than simulating the monotony of true driving conditions. However Cox et al
(1991) have demonstrated significant impairment of driving skills during controlled
hypoglycaemia using a more sophisticated driving simulator in a similar group of
diabetic patients. In this study it was also observed that there was a compensatory
slowing of driving in attempt to maintain accuracy of performance.
In conclusion, complex information processing is most profoundly affected by
acute hypoglycaemia, although simple processes will be affected at more severe
degrees of hypoglycaemia. There is also a marked variability between subjects,
particularly between those with diabetes and those without diabetes.
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Neurophysiological changes during acute hypoglycaemia
Neurophysiological measurements are not dependent on patient cooperation and
may therefore add important additional information about cerebral function during
acute hypoglycaemia, although the clinical significance of some of the tests may be
difficult to interpret. Cerebral dysfunction during acute hypoglycaemia has been
demonstrated during acute hypoglycaemia using neurophysiological tests.
Electroencephalographs (EEG) changes occur during acute hypoglycaemia with
decrements and slowing of alpha activity, and an increased occurrence of theta and
delta waves, particularly in the frontal areas of the brain (Hoagland et al 1937,
Harrad et al 1985, Pramming et al 1988, Thmburrano et al 1988, Bendtson et al
1991). Delays in visual evoked and brain stem potentials which record the
cortical changes in electrical activity resulting from an aural or visual stimulus,
have also been demonstrated during acute hypoglycaemia (Koh et al 1988, Jones et
al 1990).
Another evoked potential, the p300 wave, which reflects the cortical activity of
cognitive processes and so combines a measure of cognition and
electrophysiology, is recorded by administering a varying visual or aural stimulus
such as a combination of soft clicks and loud clicks. With the latter the subject is
asked to count the number of soft clicks (which are less frequent than the loud
clicks) while the cortical neurophysiological event (the p300 evoked potential) is
recorded. This measurement appears to be associated with attention and short
term memory but not with general intelligence and reasoning (Polich et al 1983).
During acute hypoglycaemia, delayed transmission and reduction in amplitude of
p300 evoked potentials have been documented (Jones et al 1990, Tallroth et al
1990). Changes in the p300 wave may be temperature-dependent (Durrant et al
1991), and as core body temperature may fall in response to acute hypoglycaemia
38
(Molnar and Read 1974), this variable should be measured when interpreting data.
Delays in brain-stem sensory evoked potentials have been observed during
hypoglycaemia in Type 1 diabetic patients, with no concomitant alterations in the
auditory nerve potentials; the changes observed could be rapidly reversed by the
restoration of normoglycaemia (Ziegler et al 1991). This suggests that central
rather than peripheral nerve function is most affected. In summary, these
variations in EEG, brain-stem, visual evoked potentials and p300 evoked potentials
suggest that neuroglycopenia causes widespread cerebral dysfunction during
insulin-induced hypoglycaemia.
Studies combining cognitive function tests and neurophysiological tests
The relevance of the alterations in neurophysiological parameters and how they
relate to changes in cognitive processes observed during hypoglycaemia is unclear.
In an attempt to correlate cognitive dysfunction with neurophysiological changes
which occur during acute hypoglycaemia, p300 evoked potentials and reaction
times have been studied simultaneously (Blackman et al 1990). Changes in p300
evoked potentials and reaction times occurred in parallel, but the pl40 wave, which
measures sensory processes, was not affected by hypoglycaemia. Accuracy of
choice by the subjects was preserved but a marked variability was noted between
subjects with respect to all of the neurophysiological and cognitive function tests.
These results suggest that sensory processes are not affected by hypoglycaemia.
The p300 wave and reaction time changes occurred in parallel, indicating that some
common component of these tests must be affected to cause delayed transmission.
As the p300 wave is not a measure of motor activity, presumably some other
component of reaction time is affected such as the decision-making process and the
central integration of information within the brain. Following the restoration of
39
blood glucose to normal, a lag phase of a minimum of 30 minutes, and possibly as
much as 90 minutes, has been observed before cognitive function (measured by
reaction times and p300 changes) returns to normal (Herold et al 1985, Wirsen et
al 1992,Blackman et al 1992, Eckert et al 1992). This observation has obvious
clinical relevance, in that diabetic patients should allow sufficient time for recovery
of cognitive function after an acute episode of hypoglycaemia before attempting to
resume tasks which involve decision-making and cognitive skills such as driving or
operating machinery .
Is there a glycaemic 'threshold' for changes in cognitive function during acute
hypoglycaemia ?
The sequence of neurophysiological and cognitive events which occur during acute
hypoglycaemia has been studied in normal subjects and in patients with insulin-
dependent diabetes. Variable and disparate results have been obtained which may
reflect the different techniques used to induce hypoglycaemia. The temporal
sequence of responses which occurs as blood glucose declines is of obvious clinical
importance as it may determine whether diabetic patients can detect the onset of
hypoglycaemia, enabling appropriate action to be taken before their cognitive
function becomes impaired by neuroglycopenia.
Holmes et al (1983, 1984) (using a hyperinsulinaemic glucose clamp), found that
cognitive changes were evident in insulin-dependent diabetic patients at a venous
blood glucose of 3.3 mmol/1 while another study (Pramming et al 1986) (using an
intravenous insulin infusion) showed that changes in cognitive functioning occurred
when venous blood glucose had declined to between 3.0 and 2.0 mmol/1. By
contrast, changes in p300 evoked potentials have been reported to occur at
arterialised blood glucose concentrations of 4.0 mmol/1 in non-diabetic volunteers,
which most clinicians would consider to be normoglycaemia (De Feo et al 1988).
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These findings have not been replicated by others who have demonstrated changes
in p300 waves in healthy individuals at arterialised blood glucose concentrations of
3.0 (Jones et al 1990) and 2.6 mmol/1 (Blackman et al 1990). Another study,
using a comprehensive battery of cognitive function tests and a 'stepped' glucose
clamp technique demonstrated that the initial changes of cognitive function
occurred at an arterialised blood glucose threshold of 2.7 mmol/1 (Mitrakou et al
1991). In a group of diabetic adolescents cognitive function was observed to
deteriorate when arterialised blood glucose declined to between 3.3 and 3.6
mmol/1, which is above the glycaemic thresholds reported in many adult studies.
This suggests that cognitive function in children with diabetes may be more
sensitive to the effects of hypoglycaemia (Ryan et al 1990).
Thus it appears that glycaemic thresholds for cognitive dysfunction do occur but
the blood glucose concentrations at which changes become apparent is highly
variable depending on study techniques and the type and age of subjects studied.
How are hypoglycaemic symptoms related to deterioration of cognitive
function during acute hypoglycaemia ?
An important question is how the perception of the onset of hypoglycaemic
symptoms relates to cognitive dysfunction and the neuroendocrine and
neurophysiological responses. A hierarchy of responses has been described as
blood glucose declines, commencing with counterregulatory hormonal release
(Schwartz et al 1987), and followed by simultaneous changes in cognitive function
and the perception of neuroglycopenic symptoms (Mitrakou et al 1991) (Fig.
1.2.1). Some studies in non-diabetic subjects have demonstrated a rise in plasma
concentrations of counterregulatory hormones before any demonstrable changes in
cognitive function (Ipp and Forster 1987, Stevens et al 1989). De Feo and his
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colleagues (1988) reported the converse in non-diabetic subjects; they observed that
the p300 evoked potential, as a correlate of cognitive function, developed an
increased latency before counterregulatory hormonal secretion had commenced
and before hypoglycaemic symptoms had appeared, suggesting that moderate
neuroglycopenia precedes perception of symptoms. However the p300 event was
the only measure of cognitive function which was examined and this conclusion has
been challenged.
FIGURE 1.1.1
HIERARCHY OF EVENTS DURING ACUTE HYPOGLYCAEMIA
IN NON-DIABETIC PATIENTS

























This relation between perception of the onset of hypoglycaemia and the
development of cognitive dysfunction has been investigated in other studies and
some diabetic subjects were observed to be unable to perceive the development of
hypoglycaemia before their cognitive function became impaired (Pramming et al
1986). In Cox's study utilising a driving simulator it was observed that many of
the subjects demonstrated a deterioration in driving skills at a blood glucose
concentration of 2.6 mmol/1, before they were aware of the onset of hypoglycaemia
(Cox et al 1991). Similar abnormalities have been demonstrated in studies of
patients with insulin-dependent diabetes in whom subjective inability to detect the
onset of symptoms of hypoglycaemia was evident during experimental
hypoglycaemia so that the patients exhibited overt neuroglycopenia and cognitive
impairment (Sussman et al 1963, Heller et al 1987, Hepburn et al 1991b).
The characterisation of diabetic patients with respect to their clinical history of
impaired awareness of hypoglycaemia has varied considerably between studies,
but definite evidence exists for an alteration in the glycaemic thresholds for
autonomic (sympatho-adrenal) activation in affected patients. Diabetic patients
with chronic impaired awareness of hypoglycaemia (unrelated to glycaemic
control) were noted to have a poorer performance in trail making tests during
normoglycaemia (Hepburn et al 1991b). This may reflect the effect of previous
exposure to severe recurrent hypoglycaemia, the frequency of which is increased in
patients with established loss of awareness of hypoglycaemia (Hepburn et al 1990).
Only one patient with loss of awareness was able to complete the trail-making test
at an arterialised blood glucose of 1.4 mmol/1 while all of the patients with normal
awareness of hypoglycaemia were able to complete the task (Hepburn et al 1991b).
Patients with apparent impaired awareness of hypoglycaemia, during experimental
hypoglycaemia also exhibit cognitive dysfunction (four choice reaction times) at a
lower blood glucose than 'aware' control subjects with diabetes (Maran et al
1992), although this shift in glycaemic threshold may be mediated in part by strict
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glycaemic control.
When cognitive function and hypoglycaemia symptom scores were assessed in a
group of 24 diabetic children immediately after the resolution of symptomatic mild
hypoglycaemia (capillary blood glucose less than 3.3mmol/l), cognitive function
remained impaired even though the symptom score returned to normal (Puczynski
et al 1990). This indicated a dissociation between the more rapid resolution of
physical symptoms and the slower recovery of cognitive function following mild
hypoglycaemia. In children with diabetes this may be of particular relevance to
learning ability and to school examination performance following mild
hypoglycaemia.
In summary, although there are few studies in this area it appears that the relation
between the threshold for the onset of cognitive dysfunction and symptomatic
awareness of the onset of hypoglycemia is variable and may depend on the patients
previous history of impaired perception of hypoglycaemia.
The effect of glycaemic control on cognitive dysfunction during acute
hypoglycaemia
The results of studies which have examined non-diabetic human subjects
(Mitrakou et al 1991) may not be extrapolated directly to patients with diabetes
treated with insulin, in whom several factors can influence these putative glycaemic
thresholds for the perception of symptoms, autonomic activation and the magnitude
of the neuroendocrine responses. These include the quality of glycaemic control,
the frequency of previous exposure to hypoglycaemia and the duration of diabetes
(Severinghaus 1926, Maddock and Krall 1953, Simonson et al 1985, Lager et al
1986, Amiel et al 1987, Amiel et al 1988, Boyle et al 1988, Heller et al 1991,
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Hepburn et al 1991b). In general it is more difficult to assess a change in the
glycaemic threshold at which cognitive dysfunction commences as most cognitive
tests take some time to administer, during which the blood glucose may have fallen
further or cerebral adaptation may have occurred.
Widom and Simonson (1990) compared groups of Type 1 diabetic patients who had
either good or poor glycaemic control. A hyperinsulinaemic 'stepped' glucose
clamp was used to lower blood glucose and symptoms were subdivided into
autonomic and neuroglycopenic groups. The glycaemic thresholds for
neuroglycopenic symptoms and for impairment of cognitive function were
unaffected by the antecedent glycaemic control, but more profound hypoglycaemia
was required to activate counterregulatory hormonal release and autonomic
symptoms in the diabetic patients with good glycaemic control. Similarly, in a
mixed group of insulin-dependent diabetic patients with strict glycaemic control
and non-diabetic patients who had chronic hypoglycaemia caused by an
insulinoma, the thresholds for autonomic activation and counterregulatory
hormonal secretion were higher ie a lower blood glucose was required for the
initiation of these responses, while the threshold for neuroglycopenic symptoms
was unchanged compared to a control group (Amiel et al 1991). EEG changes
provoked by hypoglycaemia were most pronounced in the diabetic patients who had
good glycaemic control, suggesting a greater cerebral vulnerability to neurogly-
copenia and indicating a dissociation of the impairment of cognitive function from
activation of the autonomic nervous system.
Blackman et al (1990) extended their studies in normal subjects to examine subjects
with Type 1 diabetes with poor glycaemic control (Blackman et al 1992), and ob¬
served a wide range of thresholds of arterialised blood glucose (3.5-2.5 mmol/1)
for increased p300 latency which did not differ significantly from those of a
nondiabetic group. By contrast, Jones et al (1991), using a glucose clamp
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technique, have demonstrated that the thresholds for p300 latency, the secretion of
adrenaline and the onset of symptoms of hypoglycaemia all occurred at lower
blood glucose concentrations in strictly controlled patients with Type 1 diabetes
compared with non-diabetic control subjects, suggesting that susceptibility to
cerebral dysfunction was diminished in the patients with diabetes. They postulated
that patients with diabetes who are treated intensively with insulin develop a
resistance to neuroglycopenia and do not release counterregulatory hormones or
experience symptoms of hypoglycaemia until the blood glucose reaches a much
lower level than in non-diabetic subjects.
The effect of glycaemic control on the latency and amplitude of p300 evoked
potentials in patients with Type 1 diabetes has been examined during
hypoglycaemia induced by a intravenous insulin infusion (Ziegler et al 1992).
Those patients with strict glycaemic control developed cognitive dysfunction at
significantly lower venous blood glucose values (1.6mmol/l) than the patients with
poor glycaemic control (3.5mmol/l), ie the threshold for inducing cognitive
impairment was higher. Although the authors acknowledge that the absolute
thresholds cannot be determined using this technique the sequence of events
demonstrated that the group with poor control often exhibited cognitive dysfunction
before the counterregulatory hormonal responses had commenced and before they
had reported subjective awareness of hypoglycaemia, suggesting that strict
glycaemic control may induce a degree of cerebral 'adaptation' to modest
neuroglycopenia. Similarly, patients with functional hypoglycaemia (as opposed
to insulin-induced hypoglycaemia) have been shown to have a deterioration in
cognitive function and onset of counterregulatory hormonal secretion at higher
blood glucose concentrations than control subjects (Snorgaard et al 1991).
In conclusion the effect of glycaemic control on cognitive function remains
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controversial, with some studies reporting a deterioration in cerebral function at the
same blood glucose concentrations (Amiel et al 1991) while some report no effect
on cerebral function (Widom and Simonson 1990, Blackman et al 1992) and yet
others reporting a degree of cerebral adaptation to hypoglycaemia in patients with
strict glycaemic control (Jones et al 1991 , Ziegler et al 1992). These disparate
results probably reflect the variable techniques and protocols for inducing
hypoglycaemia and the tests used to measure cerebral function. In addition
glycated haemoglobin which was used as measure of glycaemic control only gives
information about average control two months prior to the study and does not
necessarily reflect the frequency of episodes of mild or asymptomatic
hypoglycaemia which may have occurred during that period.
Cerebral adaptation to acute hypoglycaemia
The few studies which have examined how the symptoms of hypoglycaemia are
modified in association with alterations in cognitive function suggest that some
degree of cerebral adaptation to prolonged hypoglycaemia can occur. The total
symptom score of hypoglycaemia has been found to parallel changes in reaction
time in non-diabetic and in insulin-dependent diabetic patients. After exposure to
constant mild hypoglycaemia for 40 minutes (arterialised blood glucose 3.0
mmol/1) induced by a glucose clamp, both the reaction times and the symptom
scores improved in parallel (Kerr et al 1989, Kerr et al 1991a). This evidence
may represent an important cerebral adaptive mechanism in insulin-dependent
diabetic patients, which preserves and protects intellectual function even when
exposed to moderate neuroglycopenia.
In rats subjected to chronic hypoglycaemia the uptake of glucose in the brain was
increased (Cremer et al 1983, McCall et al 1986) as was the brain glucose
transport capacity (Pelligrino et al 1990). During hypoglycaemia in non-diabetic
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human subjects there appears to be facilitated transport of glucose from blood to
brain during moderate hypoglycaemia (arterialised blood glucose 2.7mmol/l) which
is accompanied by a reduction in brain glucose consumption (Blomqvist et al
1991). It is possible that further adaptation of glucose transporter mechanisms
may occur in humans with insulin-dependent diabetes in a manner similar to that
demonstrated in the animal studies.
While it is plausible that neuroglycopenic symptoms and cognitive function will
change simultaneously and in parallel in response to acute hypoglycaemia, more
investigation is required to confirm this premise. In addition, care must be taken
with study design and with the methodology used to induce hypoglycaemia as high
plasma insulin concentrations have been shown to modify the intensity of
hypoglycaemic symptoms but do not appear to affect cognitive function (Kerr et al
1991b). It is not known whether neuroglycopenic symptoms and autonomic
activation are dissociated during episodes of accidental insulin-induced
hypoglycaemia in daily life or whether these changes are artefactual as a product of
the artificial (and unphysiological) glucose clamp techniques used in the laboratory
to induce hypoglycaemia.




CHANGES IN COGNITIVE FUNCTION OBSERVED
DURING ACUTE HYPOGLYCAEMIA
• complex cognitive function tests such as choice reaction times, digit symbol
substitution and trail-making B are affected
• accuracy is generally preserved at the expense of a slower response
• considerable inter-subject variability is often present
• diabetic patients may be more affected than normal controls
• effects on memory are less well defined but do not appear to be of major
significance; in particular there are few demonstrable effects
on immediate memory
• changes in neurophysiological function occur such as EEG changes
and latency of evoked potentials occur
• recovery of cognitive function is delayed following hypoglycaemia
(but not EEG changes).
• glycaemic thresholds at which cognitive dysfunction occurs vary depending
on mode of investigation
• cognitive dysfunction may precede perception of symptoms and hormonal
counterregulatory responses in some patients during acute hypoglycaemia,
especially patients with hypoglycaemia unawareness or strict glycaemic
control
• during prolonged acute hypoglycaemia initial cognitive dysfunction may
resolve despite persisting hypoglycaemia, suggesting cerebral adaptation
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CLINICAL RELEVANCE OF CHANGES IN COGNITIVE
FUNCTION CAUSED BY HYPOGLYCAEMIA
Changes in cognitive function of a variable degree may occur and in some cases
may be sufficiently profound as to significantly affect a patient's ability to function
in everyday life. In clinical practice it is uncommon for individual patients to
develop significant cerebral damage or cognitive deficits after an isolated episode
of severe hypoglycaemia, but more likely that recurrent severe hypoglycaemia has
a cumulative effect producing a subtle and insidious decline in cognitive function
and IQ over a number of years. As this occurs slowly, it may be erroneously
ascribed to the degenerative changes associated with the progression of
macrovascular complications, such as cerebrovascular disease, in patients with
Type 1 diabetes of long duration.
The degree to which an average decline in IQ of 5.8 points (Langan et al 1991)
will affect performance in daily tasks is not possible to predict, but it is likely that
any decline in cognitive function is clearly of major importance to patients with
Type 1 diabetes in occupations which are intellectually demanding and require the
rapid handling of data and information. It is important to appreciate that the
estimated decline in IQ of 5.8 points is an average measure, and that some patients
exhibited a greater decrement, which may have a more significant effect on
intellectual ability. Multiple episodes of severe hypoglycaemia may occur in a
few unfortunate patients and they are therefore probably most at risk of a greater
decline in IQ which might interfere with performance at work. Aspects of quality
of life other than potential changes in cognitive function may also be affected by
recurrent hypoglycaemia; patients who have experienced recurrent episodes of
severe hypoglycaemia have been reported to be more anxious and to score lower in
'happiness' rating scales compared with diabetic patients without severe
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hypoglycemia (Wredling et al 1992).
The aetiology of cognitive dysfunction in diabetic patients is probably
multifactorial, and may be associated with both peripheral and 'central' forms of
neuropathy (Khardori et al 1986, Pozzessere et al 1988, Pozzessere et al 1991,
Ryan et al 1992, Dejgaard et al 1991) resulting from a combination of chronic
hyperglycaemia, and exposure to recurrent severe hypoglycaemia.
Not all patients exposed to hypoglycaemia develop problems with impaired
awareness of hypoglycaemia and irreversible cognitive dysfunction which suggests
that patients are not equally susceptible to the pathological effects of
neuroglycopenia, and may not therefore develop cognitive dysfunction despite
recurrent hypoglycaemia. Until vulnerable patients can be identified, one of the
most important therapeutic dilemmas in the modern management of diabetes is
whether diabetic patients should have to risk sacrificing intellectual capacity
through an increased exposure to severe hypoglycaemia in order to prevent the
complications of microangiopathy. This is of particular relevance to the
management of diabetic children, especially those who are very young at the time
of diagnosis. In these patients, recurrent severe hypoglycaemia may have such a
profound effect on their cerebral and intellectual development as to seriously limit






Acute Hypoglycemia and Cognitive Function - Hypoglycaemic Clamp Studies
There is a large inter-individual variability in the effects of acute hypoglycaemia
and it is important to try and identify any factors that may make an individual more
prone to developing cognitive dysfunction as a result of recurrent hypoglycaemia so
that targets of glycaemic control can be modified in these patients. This would
permit the majority of patients with Type 1 diabetes to aim for optimal glycaemic
control to avoid or delay the development of the long term microvascular
complications of diabetes. In addition little is known about the cerebral response
to protracted acute hypoglycaemia ie the phenomenon of 'cerebral adaptation'
remains poorly defined. Kerr and colleagues (Kerr et al 1989, 1991a) suggested
that during hypoglycaemia of 40- 60 minutes the brain adapts to the effects of
neuroglycopenia and the cognitive dysfunction which initially occurs, becomes less
profound as the duration of hypoglycaemia increases. Further studies in this area
are required to try an identify the presence of such adaptation and to define the
possible mechanisms operating. The hypothesis that 'cerebral adaptation to
hypoglycaemia occurs' was therefore postulated and a Study 1 was designed to
investigate this further.
In view of the large inter-individual variation in the degree of cerebral dysfunction
experienced during hypoglycaemia, two important factors were investigated as
possible causes of this variability; firstly the effect of IQ on cognitive dysfunction
during hypoglycaemia and secondly the effect of subjective awareness of
hypoglycaemia on cognitive dysfunction during acute hypoglycaemia. The effect
of other cerebral insults, such as alcohol, on cognitive function have been
investigated previously and it was shown that subjects of greater IQ were more
susceptible to cognitive dysfunction after alcohol consumption than those of a lower
IQ (Maylor et al 1990). Using hypoglycaemia as the metabolic insult further
information on cognitive processes as well as the nature of the effect of
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hypoglycaemia could be investigated. Study 2 was therefore designed to assess
the effect of IQ on the cognitive response to acute hypoglycaemia.
A previous study suggested that patients with impaired awareness of
hypoglycaemia appeared to be more susceptible to the effects of acute
hypoglycaemia (Hepburn et al 1991b). However this study had not been designed
to address this question and the patient groups were not matched. Study 3 was
designed to establish whether patients with insulin-treated diabetes, who have
acquired impaired awareness of hypoglycaemia exhibit a more severe degree of
cognitive impairment during moderate hypoglycaemia. The mechanism for
altered perception of the symptoms of hypoglycaemia and the delayed initiation of
counterregulatory responses may result from a defective glucose sensor. However
no discrete glucose sensor has been located and if it was present within the brain it
might be expected that the alteration in its function may result from defective
delivery of blood glucose to the receptor ie an alteration in regional blood flow.
Therefore as an adjunct to study 3, regional cerebral blood flow was measured
during hypoglycaemia in patients with impaired awareness of hypoglycaemia (study
4).
Although patients frequently describe mood changes during and after episodes of
hypoglycaemia occurring in daily life there have been no formal assessments of
this. The subjects in studies 1 and 2 were therefore questioned about mood
changes during acute hypoglycaemia, using a standardised questionnaire (study 5).
54
Clinical Studies of Patients with Type 1 Diabetes
The actual frequency of severe hypoglycaemia in patients with impaired awareness
has only been documented retrospectively and as this potentially fatal complication
is more common in such patients it is important to know its true prevalence. A
year long prospective study (study 6) was designed to assess and compare the
frequency and morbidity of severe hypoglycaemia in patients with Type 1 diabetes
with and without normal awareness of hypoglycaemia.
Although there are now reports of the long term effects of hypoglycaemia on
cognitive function as tested by formal psychological tests already described, there
are few reports of the actual impact of recurrent severe hypoglycaemia on
personality, social function or everyday life. A carers' group identified five
patients with a long duration of diabetes, all of whom had suffered problems with
work, home life and relationships. A predominantly descriptive account (study 7)
is provided of these problems and possible causes identified.
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METHODS FOR IIYPOGLYCAEMIC CLAMP STUDIES
56
Ethical Permission
Permission was granted for each of the studies by the Lothian Health Board Ethics
of Medical Research Subcommittee for Medicine and Clinical Oncology (reference
numbers: MCO/71/91, MCO/134/91, MCO/78/91, MCO/77/91, MCO/76/91).
Written consent was obtained from all subjects following detailed explanation of
the nature of the studies (see Appendix for 'Subject Explanation Sheets').
Subjects
The details of criteria for selection of subjects for each study are explained in the
individual study chapters.
The Hyperinsulinaemic Glucose Clamp Technique
All of the hypoglycaemia studies were performed using a modified manual
hyperinsulinaemic glucose clamp technique to manipulate blood glucose (DeFronzo
et al 1979). In this method insulin was infused at a fixed rate, and a variable rate
of infusion of 20% dextrose was used to manipulate the blood glucose
concentrations. Insulin was initially infused at a rate of 150 mU/m2/min and
reduced to and then maintained 60 mU/m2/min over a period of 10 minutes (see
Appendix). This loading dose saturated the insulin receptors to facilitate
subsequent manipulation of the blood glucose. The 20% dextrose infusion was
commenced after about 5 minutes in the non-diabetic subjects, initially at a rate of
about 1 ml/kg/hour. In the diabetic subjects the dextrose infusion was only
commenced after the blood glucose concentration had reached less than 5 mmol/1.
The subsequent infusion rate of the dextrose was determined by the arterialised
blood glucose concentrations measured at the bedside. In order to induce
hypoglycaemia the dextrose infusion was stopped for about five minutes and then
recommenced at about half of the rate used during stable normoglycaemia.
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Although the glucose clamp technique is unphysiological, it is the only method
available for reliably maintaining the blood glucose at predetermined
concentrations for prolonged periods of time, sufficient to allow administration of
the cognitive test batteries.
Experimental Procedure for Clamp Studies
Subjects were fasted for at least four hours prior to study. A teflon cannula was
inserted into an antecubital vein in the non-dominant arm under local anaesthesia
(lignocaine 1%) for the infusion of human soluble insulin ( Actrapid; Novo
Nordisk Laboratories, Copenhagen, Denmark) and the variable rate infusion of
20% dextrose. Arterialised venous blood samples were obtained at three minute
intervals from a retrograde cannula in a dorsal hand vein of the same arm; the
hand was warmed in a heated box (55°C) and the cannulae were kept patent with
0.9% sodium chloride. Dextrose was infused using an I\AC Site Saver pump and
insulin was infused (60mU/m2/min) using an IMED Gemini PCI pump. The rate
of dextrose infusion was adjusted every 3 minutes according to the blood glucose
concentration measured at the bedside using a glucose oxidase method (Yellow
Springs Instrument 2300 Stat, Yellow Springs, Ohio, USA). Warming the hand
allows shunting of blood from the arterial to venous system and "arterialised"
venous blood glucose concentrations have been shown to approximate very closely
with true arterial blood glucose concentrations and are necessary as venous blood
glucose concentrations are highly variable, particularly in combination with the
glucose clamp technique (Liu et al 1992).
The subjects were not informed of their blood glucose concentrations during the
experiments. The blood glucose concentration was initially stabilised and
maintained at 4.5 mmol/1 in all the studies and the subsequent manipulations of the
concentrations are explained in the individual study chapters.
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Choice of Degree of Hypoglycemia
In all of the studies, the degree of hypoglycaemia used was 2.5 mmol/1. The
reason for the choice of this value was that although there is considerable variation
in the glycaemic thresholds for changes in cognitive function, most of the recent
studies have documented a change at blood glucose concentrations above this level
(as discussed in Part I, Chapter 2). In order to be sure that the glycaemic
threshold for cognitive dysfunction had been reached and in an attempt to produce
as greater change in cognitive function as possible , the lowest glucose
concentration which could be tolerated safely by the subjects, for the duration of at
least one hour, was used.
Catecholamine and Physiological Measurements
Blood was withdrawn at certain time points (indicated in the relevant chapters),
before being separated and stored at -40°C. Plasma catecholamines were assayed
using an HPLC method with an electrochemical detector (Goldstein et al 1981).
Continuous heart-rate measurements were recorded from precordial electrodes
using an ECG monitor, and blood pressure was recorded with a Copal
sphygmomanometer at the times indicated in the individual studies.
Assessment of Symptoms of Hypoglycaemia
A standard symptom questionnaire was devised (see Appendix) on the basis of
previous studies assessing symptoms of hypoglycaemia (Hepburn et al 1991a,
Deary et al 1993b). Each subject was required to complete the questionnaire at
appropriate time points described in each study. As far as possible the subjects
were allowed to complete the questionnaire in their own time without the
interference of the experimenters in order to obtain accurate answers. The
symptoms were divided into three groups according to the classification established
in a previous study (Hepburn et al 1991a, Deary et al 1993b) a) - autonomic
(anxiety, pounding heart, sweating, tremor, hunger, warmness and shivering), b) -
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neuroglycopenic (difficulty speaking, confusion, drowsiness, dizziness, inability to
concentrate, double vision and blurred vision) and c) - non-specific (tingling lips,
nausea, headache, weakness). Each symptom was graded on a 1 to 7 scale, 1
indicating that the symptom was 'not present at all' and 7 indicating that the
symptom was present 'a great deal'; the minimum total score was therefore 18 and
the maximum possible score was 126.
Assessment of Changes in Mood during Hypoglycaemia
The UWIST Mood Adjective Checklist (UMACL) (Matthews et al 1990) was used
to assess mood at the same time points that symptoms were assessed (see
Appendix). The UWIST questionnaire has previously been validated and
measures the three factors of mood about which there is most agreement (Matthews
et al 1990). The subjects completed the questionnaire on their own to avoid
attribution bias. Mood-relevant adjectives were graded by intensity on a scale of 1
to 4 and were classified into three groups : hedonic tone, tense arousal and
energetic arousal. Higher scores indicated a high 'happiness' rating for hedonic
tone, a high 'anxiety' rating for tense arousal and a high 'energy' rating for
energetic arousal. The maximum score which could be attained for each of the
three mood components was 32 and the minimum score was four.
Cognitive Measurements
Tests of complex cognitive processes were utilised as they have been shown to be
more profoundly affected by acute hypoglycaemia than tests of simple processes.
All of the tests have been well validated and many have also been used in other
studies of cognitive function in patients with diabetes. In addition two of the tests,
the Trail-Making B (TMB) and Digit Symbol Substitution Test are the most
frequently used subtests (in psychopharmacological and neuropsychological studies)
from the two best known neuropsychological batteries: the Holstead-Reitan and
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Wechsler Adult Intelligence Scale respectively. Both of these subtests are known
to be sensitive to mild cerebral insults and it was important to include such tests as
these as deterioration in these tests provided confirmation that the degree of
cerebral dysfunction induced was satisfactory. The other three tests the Paced
Auditory Serial Addition Test (PASAT), Rapid Visual Information Processing
(RVIP) and Four Choice Reaction Time (CRT) are also known to be sensitive to
mild cerebral insults and were used because they are tests of complex information
processing. In each of the studies a combination of these five tests, detailed
below, was utilised, and the details of the order and duration of each test battery
are given in the relevant study chapters. In each of the studies the tests were
administered in a fixed order on each occasion.
1 - Paced Auditory Serial Addition Test (PASAT) (Deary et al 1991a)(see
Appendix): the subject listens to a fixed random sequence of the numbers 1 to 9
read aloud at 4 second intervals and is required to add the first number to the
second number and give the answer, the second number to the third number and
give the answer and so on for a total of 61 numbers. The process is then repeated
with the numbers being read at 2 second intervals. The score is the total number
of correct answers on each run (ie maximum score of 60). The PASAT is said to
be a measure of attention and concentration (Gronwall and Wrightson 1977, Deary
et al 1991a); the 4 second PASAT has been shown to be associated with short
term memory and whereas the 2 second test is more closely related to perceptual
processing speed (Deary et al 1991a).
2 - Digit Symbol Substitution test (DSST) (Wechsler 1981)(see Appendix):
in this subtest of the Wechsler Adult Intelligence Scale - Revised, a symbol must be
substituted for each digit (using a key provided) and the score is the total number
of correct symbols drawn in 90 seconds. This test provides a test of discretionary
and decision-making skills.
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3 - Trail-Making B (TMB1 (Reitan et al 1974)(see Appendix): this is a
subtest of the Halstead-Reitan Neuropsychological Test Battery. Nine alternative
versions were produced and validated for equal degrees of difficulty to avoid
potential practice effects which might have occurred if the same trail had been used
repeatedly. They were administered in random order to each of the subjects in
each study so that no subject performed the same trail more than once and all the
tests were utilised equally and in different orders. The subject joins numbers to
letters in sequence (eg 1 to A, A to 2, 2 to B, B to 3, 3 to C etc.) and the time
required to complete the task is measured. This test provides a measure of visual
searching, mental set shifting and psychomotor speed.
4 - Rapid Visual Information Processing (RVIP1 (Wesnes and Warburton
1984, Deary et al 1992): a random sequence of digits (1-9) is shown individually
on a monitor over a period of 5 minutes and the subject is asked to press a button
each time a series of 3 consecutive even or odd numbers occurs. Three measures
are taken from the test a) the total number of correct answers ie targets detected
('hits'), an estimate of ability to encode, store and classify digits,and make
comparisons at speed; b) the number of false alarms ie responses to non-target
sequences ('misses'), an indication of the response threshold or caution of the
subject and c) the time taken to respond to each sequence ('reaction time' - RT) is
recorded, an indication of the motor aspects of the decision making process. The
subjects are not instructed to respond quickly in this test and so the significance of
the 'reaction time' is doubtful. This test was run on a BBC microcomputer.
The total number of hits over five minutes, the total number of misses and the
mean reaction time were used in analyses.
5 - Four Choice Reaction Time (CRT) (Hick 1952, Jensen 1987, Deary et
al 1992): a device is used which measures both decision time and movement time;
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this consists of a black box with a sloped top on which lies a 'home' button and
four equidistant response buttons. The subject is asked to press the home button
with the preferred finger of the dominant hand; when one of the response buttons is
lit, a timer begins and is stopped when the subject's finger leaves the 'home*
button, recording the decision time (DT). When the finger is lifted from the home
button this also starts a second timer which is stopped when the appropriate
response button is pressed by the subject, using the same finger, giving a measure
of movement time (MT). The subject completed 30 responses in three batches of
ten, separated by a few seconds rest. The test was controlled by a BBC Master
microcomputer. The mean scores for DT and MT for all 30 responses were used
for analysis.
Before commencing the study each subject was required to perform all of the
cognitive tests to minimise any practice effect during the experimental procedures.
Similar instructions were given to each subject but as the patients were of different
cognitive abilities, some required longer practice times in order to become familiar
with the tests.
Tests of Intelligence
Prior to enrolment into the studies, the level of cognitive ability in each subject was
assessed using a combination of the Alice Heim 4 test (AH4, Heim 1968) and the
National Adult Reading Test (NART, Nelson 1982). In the AH4 test, which is
divided into two parts, the subject completes as many questions as possible in ten
minutes in each part. A choice of answers is provided for each question; the first
part of the test provides an assessment of verbal and numerical skills were as the
second part provides an assessment of visuo-spatial skills. The test does not
provide an actual IQ but merely an indication of global cognitive ability. The
maximum score in each part is 65. The NART assesses premorbid IQ, that is the
peak level of mental ability attained by a subject prior to any cognitive
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deterioration; the subject is asked to pronounce 50 irregular English words (eg
ache, depot) and the number pronounced correctly is the score obtained. The
NART has been validated against the Wechsler Adult Intelligence Scale and has
been shown to correlate closely with this test in subjects without reason for
cognitive decline (Crawford 1989).
Statistical Methods
The individual tests utilised are detailed in the relevant study chapters. All
statistical procedures were performed using an IBM computer with software
package SPSS-PC or SPSS-X. Cognitive function scores in the general
population are normally distributed and in each of the studies the scores were also
demonstrated to approximate to a normal distribution and therefore the use of





SHORT TERM CEREBRAL ADAPTATION TO ACUTE INSULIN-INDUCED
HYPOGLYCAEMIA IN NON-DIABETIC SUBJECTS
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INTRODUCTION
The capacity of the brain to adapt to neuroglycopenia would represent an
important adaptive mechanism to reduce the cognitive dysfunction which occurs
during insulin-induced hypoglycaemia. Studies in rats have suggested that
chronic hypoglycaemia results in adaptation of glucose transporters in order to
increase brain glucose uptake (Cremer et al 1983, McCall et al 1986, Pelligrino et
al 1990). In humans subjects a degree of cerebral adaptation has been
demonstrated after prolonged hypoglycaemia of 56 hours duration (Nagy et al
1993). Previous studies in normal humans and in patients with Type 1 diabetes
have suggested that tolerance to asymptomatic hypoglycaemia may develop within
60 minutes of hypoglycaemia, as a result of rapid cerebral adaptation to
neuroglycopenia (Kerr et al 1989, Kerr et al 1991a). However in these studies
only a single measure of cognitive function was used to assess cerebral changes
during neuroglycopenia, and the method used to estimate symptom scores was
primitive and of limited value. The aim of the present study was to use an
extensive battery of cognitive tests and a validated symptom scoring system to
assess the nature and degree of deterioration in cognitive function during
hypoglycaemia and to examine whether any improvement in cognitive function and
symptom scores could be detected after a period of continuous exposure to




24 healthy non-diabetic subjects were recruited (13 male, 11 female) with a mean
age of 29.5 ± 4.3 years (±SD) and a mean body mass index of 23.9 ± 2.7 kg m"
2(±SD). Eleven of the subjects were medical or paramedical staff and the
remaining subjects had a variety of different educational backgrounds. Seventeen
of the subjects were right handed and seven were left handed. None of the
subjects had any relevant medical history of note and none was taking any regular
medication other than the oral contraceptive pill. None of the subjects had a
family history of diabetes.
Experimental Procedure
All subjects were studied on three separate occasions, each at least two weeks
apart. After a light breakfast the subjects fasted until conclusion of the study.
The blood glucose concentrations were controlled using a hyperinsulinaemic
glucose clamp as described in Part II.
The study design is shown in figure 3.1.1. On one occasion (Study A) the blood
glucose concentration was stabilised and maintained at 4.5 mmol/1 while the first
battery of cognitive tests (Tl) was administered; after completion of the tests the
blood glucose was stabilised at 4.5mmol/1 for a further 40 minutes, following
which a second cognitive test battery was performed (T2). Twenty minutes after
the second test battery was completed a further abbreviated test battery was
presented (T3) while the blood glucose was maintained at 4.5 mmol/1, and this
was repeated after a further 15 minutes (T4). This euglycaemic study (A) served
as a control study for Studies B and C, both of which involved the induction of
hypoglycaemia (2.5mmol/1). Induction of hypoglycaemia took about 10 minutes,
after completion of the first cognitive test battery (Tl). In Study B the second
67
cognitive test battery (T2) was administered immediately after induction of
hypoglycaemia (2.5 mmol/1). In Study C the blood glucose concentration was
maintained at 2.5 mmol/1 for 40 minutes before the administration of the second
cognitive test battery (T2), and was then returned to euglycaemia (4.5 mmo/1). In
Studies B and C the blood glucose was maintained at 2.5 mmol/1 for a total of 60
minutes before returning to euglycaemia (4.5 mmol/1). Abbreviated test batteries
(T3 and T4) were administered 15 and 30 minutes after stable euglycaemia had
been re-established in Studies B and C, corresponding to T3 and T4 in Study A
(figure 3.1.1). As the order of the studies could be arranged in six possible
sequences, four subjects were randomly allocated to each sequence to
counterbalance the order of the study conditions. The subjects were not informed
of their blood glucose concentrations during the experiments.
At each of the seven time points indicated in figure 3.1.1 by (S), the symptom
questionnaire described in Part II was completed by each subject. In Studies B
and C the symptom scores were given at identical times irrespective of difference
in timing of the cognitive test batteries. Continuous heart-rate measurements were
recorded at the times indicated (figure 3.1.1).
Cognitive Test Battery
The cognitive test battery utilised in this study comprised five tests (described in Part
II) and took approximately 20 minutes to administer in the following order:
1 - Paced Auditory Serial Addition Test (PASAT) (Deary et al 1991a)
2 - Four Choice Reaction Time (CRT) (Hick 1952, Deary et al 1992)
3 - Digit Symbol Substitution test (DSST) (Wechsler 1981)
4 - Trail-Making B (TMB) (Reitan 1974)
5 - Rapid Visual Information Processing (RVIP) (Deary et al 1992)
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These five cognitive tests were administered at each of the times T1 and T2 in each
of the studies. A shortened test battery comprising the Four Choice Reaction
Time and the Digit Symbol Substitution Test, and lasting approximately 6 minutes,
was administered at times T3 and T4 in order to assess recovery of cognitive
function after hypoglycaemia.
On a separate day before commencing the study, each subject was required to
perform all of the cognitive tests in the above order, to minimise practice effects
during the experimental procedures.
Statistical Analysis
Multivariate analysis of variance (MANOVA) was used to assess the effects of
hypoglycaemia on cognitive function. The main independent variable was Study, a
within subjects factor with three levels, "euglycaemia" (Study A), "early
hypoglycaemia" (Study B) and "late hypoglycaemia" (Study C). The effect of
Study, therefore, incorporates any effect of hypoglycaemia on performance, and
differences between the two hypoglycaemia conditions.
There was a large inter-individual difference in baseline cognitive test scores for
the subjects, as there were subjects of relatively low and relatively high IQ levels
(see Part III Chapter 2). For this reason therefore the absolute change from the
baseline cognitive score (Tl) to the score obtained in the experimental condition
(T2) was the measure used for each cognitive test. In all studies the first test
period represents a baseline score assessed during euglycaemia (Tl). The second
test period (T2) represents the score during early hypoglycaemia in Study B, late
hypoglycaemia in Study C, and a second test at euglycaemia in Study A. The
dependent variables, comprising the within subjects factor Test, were the nine
scores derived from the cognitive function tests : four and two second PASAT,
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DSST, TMB, RVIP hits, RVIP misses RVIP reaction times, Four Choice decision
time (DT) and movement time (MT).
The overall significance in the multivariate tests was calculated from the Wilks'
Lamda test statistic. Separate univariate analyses of variance (ANOVA) were
used to assess the effects of the differential study conditions on the individual
cognitive tests, symptoms, blood glucose, blood pressure and heart rate.
Significant results were further analysed using t-tests to determine specific
differences between the study conditions. In order to minimise the Type 1 error
rate, the following planned comparisons were made in the assessment of cognitive
function scores:
i) Study B scores vs Study C scores - this test compares the effect of
immediate hypoglycaemia (Study B) with prolonged hypoglycaemia (Study C).
ii) Study A scores vs mean of (Study B + Study C) scores - this test
compares the effect of euglycaemia with hypoglycaemia per se.
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RESULTS
Blood glucose
The blood glucose profiles of all three studies are shown in figure 3.1.2. In the
hypoglycaemia Studies (B and C) the profiles appeared very similar throughout
which was confirmed by testing with analysis of variance. At the times of
cognitive testing during hypoglycaemia, ie between 5 and 25 minutes of
hypoglycaemia in Study B and between 40 to 60 minutes of hypoglycaemia in
Study C, no differences in blood glucose concentrations could be discerned
between the Studies B and C.
Blood pressure and heart rate
The blood pressure and heart rate profiles are shown in figures 3.1.3a, b and c.
The systolic blood pressure did not change substantially in any of the studies,
although the expected fall in diastolic blood pressure and rise in heart rate were
observed during both hypoglycaemia studies. Analysis of variance confirmed a
significant difference among the studies across time (Study by Time interaction
p=0.03) for the diastolic blood pressure ie that the diastolic blood pressure fell
significantly during the hypoglycaemia studies compared with the euglycaemia
control study.
Cognitive function
The results of the cognitive function testing are shown in figure 3.1.4. and the
raw scores are shown in table 3.1.1. For all test variables a positive deflection
indicates an improvement in function, whereas a negative deflection indicates a
deterioration in function. At baseline, no significant differences were present
among the three studies for any cognitive test variable.
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Multivariate analysis
Multivariate analysis of variance revealed a significant effect of Study on overall
cognitive performance (p=0.01), and also a significant effect of Test (p=0.01),
with a significant interaction between Study and Test (p=0.001). This indicates
that there were significantly different effects on cognitive performance among the
three study conditions, and also that hypoglycaemia had a differential effect on the
individual tests, necessitating further analysis of each test separately.
Univariate analysis
The results of univariate analysis of variance for each test are shown in table 3.1.2.
For the Four Choice reaction time and the DSST there is an additional "time"
factor, because each of these tests was also performed twice during recovery from
hypoglycaemia (T3 and T4).
PASAT - (Figure 3.1.4a). In Study A there was an improvement from
baseline score, whereas in both Studies B and C there was a significant
deterioration during hypoglycaemia. This applies to both the 4 second test and the
2 second test (table 1: Study effect). Further analysis with t-tests showed that
although there was a significant effect of hypoglycaemia per se on performance (A
v mean [B+C], p=0.006 for 4 second and p<0.001 for 2 second), no significant
difference in performance occurred between Studies B and C, ie PASAT
performance showed no improvement with persisting hypoglycaemia.
Four Choice Reaction Time - (Figures 3.1.4b and c). Performance
remained stable during the euglycaemia control Study A, whereas slowing was
observed both in DT and MT during hypoglycaemia (Studies B and C). DT and
MT in Studies B and C returned towards baseline values during the recovery
period. Analysis with t-tests confirmed a significant deleterious effect of
hypoglycaemia on performance (A v mean [B+C], p=0.05 for DT and p=0.002
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for MT). The time of testing after onset of hypoglycaemia (Study B vs Study C)
did not affect DT performance. After prolonged hypoglycaemia (Study C), the
MT was significantly slower than in Study B (p=0.018), ie movement time
deteriorated increasingly with prolonged hypoglycaemia. Performance during
recovery did not differ significantly from baseline.
DSST - (Figure 3.1.4d). In Study A performance improved throughout the
study, but in Studies B and C performance deteriorated during hypoglycaemia,
returning towards normal in the recovery periods. Further analysis with t-tests
confirmed the effect of hypoglycaemia on performance (A v mean [B+C],
p=0.004), and the absence of a significant difference between Studies B and C
indicated that no adaptation had occurred. During the recovery periods the
subjects' performances were not significantly different from the euglycaemia study
(A vs [B+C]).
TMB - (Figure 3.1.4e). A trend towards an improvement in performance
in Study A was observed with deteriorations in performance in Studies B and C.
Analysis with t-testing confirmed a significant effect of hypoglycaemia (A v mean
[B+C] p=0.007). No difference in performance was observed between Studies B
and C indicating that there was no adaptation in TMB performance as
hypoglycaemia persisted.
RVIP hits - (Figure 3.1.4f). Performance did not change during Study A
and deteriorated during hypoglycaemia (Studies B and C). Further analysis with
t-tests confirmed the effect of hypoglycaemia (A v Mean [B+C] p= 0.001) but
revealed no difference in performance between the hypoglycaemia Studies B and
C, suggesting that RVIP hits performance did not adapt after persisting
hypoglycaemia.
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RVIP false alarms (misses') - (Figure 3.1.4g). No significant difference in
RVIP misses was observed among any of the studies, suggesting that
hypoglycaemia did not have an effect on performance on this variable.
RVIP reaction time - (Figure 3.1.4h). In Study A there appeared to be a
slight improvement in performance during the study, with a slight deterioration in
performance in Study C and no change in Study B. However, testing with
ANOVA did not identify a significant difference among the studies, and t-tests did
not reveal any effect of hypoglycaemia or any difference between Studies B and C.
Symptom Scores
Results of the symptom scores at the 7 time points are shown in figures 3.1.5.
The baseline for the y axis on each graph is taken as the minimum score possible.
The symptom profiles across time were similar for autonomic and neuroglycopenic
scores. During Study A total, autonomic or neuroglycopenic scores did not
change across time. However, in both hypoglycaemia studies (symptom
questionnaires were completed at similar times during the studies, irrespective of
the times of cognitive testing) significant increments in symptoms were recorded
(ANOVA Study effect p< 0.001, Study by Time interaction p=0.004) ie during
hypoglycaemia symptoms scores increased compared with baseline and compared
with the euglycaemia study indicating that the change in symptoms was attributable
to the effect of hypoglycaemia and not simply the effect of time. There was no
evidence to suggest that symptoms became less intense as hypoglycaemia
persisted. The scores actually increased as hypoglycaemia progressed from 30 to
60 minutes, although the difference did not achieve significance.
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TABLE 3.1.1
SCORES FROM COGNITIVE FUNCTION TESTS IN CLAMPS A, B AND C
Cognitive Test
Clamp A Clamp B Clamp C
PASAT - 4-second T1 56.8+5.9 56.8+4.1 57.1+3.5
T2 58.3+2.9 56.3+4.1 55.9+3.5
PASAT - 2-second T1 45.0+9.8 45.4+ 10.5 45.8 + 10.9
T2 50.1+7.1 41.6+12.2 38.7+12.2
CRT - DT / ms T1 325+44 332+45 334+47
T2 329+46 352+46 351+53
T3 325+45 332+48 339+44
T4 320+45 328+45 326+37
CRT - RT / ms T1 162+44 168+41 171+48
T2 164±46 207+73 188+57
T3 159+40 178+53 175+43
T4 158 ±41 168+46 170+42
TMB / s T1 31.5 + 11.3 32.5 + 11.1 29.1 + 10.4
T2 28.6+9.3 35.0+11.9 31.1 + 14.1
DSST T1 71.6+11.7 70.7+12.6 69.8+ 11.4
T2 74.9+12.1 67.4+11.8 68.5+ 11.6
T3 75.9+ 12.7 72.3 + 13.3 73.4+ 13.5
T4 78.7+13.8 76.5+ 17.1 76.1 + 15.9
RVTP 'hits' T1 25.4+8.5 26.1+7.8 26.5+7.5
T2 26.4+8.7 22.1+6.4 22.7+7.1
RVIP 'misses' T1 4.0+8.3 3.3+7.8 4.7+14.8
T2 3.7+9.5 4.4+12.5 5.7+15.5
RVIP 'reaction time' / ms T1 470+74 461+53 473+79




UNIVARIATE ANALYSIS OF VARIANCE OF THE
INDIVIDUAL COGNITIVE TESTS
SIGNIFICANCE
Cognitive Test Study effect Time Study by Time
PASAT 4 second 0.04
PASAT 2 second 0.001
Four Choice Reaction -
decision time NS 0.001 0.06
movement time 0.018 0.001 0.016
DSST 0.06 <0.001 0.039
TMB 0.08
RVIP - hits 0.001
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FIGURE 3.1.3
a - SYSTOLIC BLOOD PRESSURE DURING STUDIES A, B and C.
b - DIASTOLIC BLOOD PRESSURE DURING STUDIES A, B and C.
c - HEART RATE DURING STUDIES A,B and C.
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HYPO (T2) REC 1 (T3) REC 2 (T4)FIGURE 3.1.4
COGNITIVE FUNCTION TEST RESULTS DURING STUDIES A, B and C,
MEASURED AS CHANGES FROM BASELINE SCORES DURING INITIAL
EUGLYCAEMIA. Solid area - Study A; close hatched are - Study B; wide
hatched area - Study C.
a - PASAT 4 and 2 second scores
b - 4 Choice reaction time decision time (DT)










-<•■<2G3-J nj a^3CO, re- rêre3re- c/irec/i -►re ■—•r^io re



































Baseline Hypo H+30 H+60 END
FIGURE 3.1.5
SYMPTOMS EXPERIENCED DURING HYPOGLYCAEMIA. Solid area -
Study A; close hatched area - Study B; wide hatched area - Study C.
a - Total symptom score (autonomic + neuroglycopenic + non-specific)
b - Autonomic symptoms
c - Neuroglycopenic symptoms
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DISCUSSION
The cognitive function test battery which was employed in the present study
examined complex cognitive processes such as have typically been shown to be
more affected by acute hypoglycaemia (Holmes et al 1983, Herold et al 1985,
Pramming et al 1986, Hoffman et al 1989, Stevens et al 1989). In the present
study, in which a relatively large number of subjects was examined, the
multivariate analysis confirmed that the overall performance in the test battery
deteriorated significantly during hypoglycaemia. Further analyses determined
which tests were most affected by hypoglycaemia, and the extent of any differences
between early and more prolonged exposure to hypoglycaemia.
All of the tests in the present study were significantly affected by hypoglycaemia
with the exception of the TMB test, although the latter has previously been shown
to be affected by hypoglycaemia in patients with Type 1 diabetes (Hoffman et al
1989, see also Part III Chapter 3). In a study which compared healthy non-
diabetic subjects with patients who had Type 1 diabetes, the Trail Making B was
used as part of the cognitive test battery and the patients with diabetes were
observed to perform more poorly during hypoglycaemia (Wirsen et al 1992). This
observation may explain why the performance in TMB in the non-diabetic subjects
in the present study did not deteriorate significantly during hypoglycaemia.
The RVIP task is a signal detection task and not all of the variables derived from
this task were affected by hypoglycaemia. The RVIP hits variable assesses the
efficiency of signal detection and was affected by hypoglycaemia. The RVIP false
alarms (misses) variable is a measure of response threshold or caution and did not
deteriorate significantly during hypoglycaemia in the present study which is in
agreement with the results of previous studies which have demonstrated that,
during this stress, accuracy tends to be preserved at the expense of speed of
performance (Holmes et al 1983, Herold et al 1985, Cox et al 1993a). The RVIP
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reaction time is not as accurate a measure of reaction time as the Four Choice
Reaction Time : in the former test the subjects are not instructed to complete the
task as quickly as possible.
In the present study no relative improvement in cognitive performance was
demonstrated after 40 to 60 minutes of hypoglycaemia when compared with
performance after 5 to 25 minutes of hypoglycaemia. One test, the movement
time (MT) of the Four Choice Reaction Time, was significantly worse after
prolonged hypoglycaemia, but this test reflects predominantly motor function rather
than decision-making processes and might indicate the development of fatigue
associated with prolonged ^exposure to the prolonged hypoglycaemia. A previous
study of healthy non-diabetic subjects (Kerr at al 1989) demonstrated that simple
reaction times initially deteriorated when the arterialised blood glucose was
lowered to 3.0 mmol/1, but subsequently improved after 60 minutes at the same
blood glucose concentration, although they remained slower than the original
baseline values. In that study (Kerr et al 1989), the data from any changes in the
euglycaemia study were not presented, and it is not possible to ascertain whether
this improvement could be attributed to a learning effect. In the present study the
method of analysis corrects for any potential learning effect which may be
occurring. The same authors repeated a similar study in patients who had Type
1 diabetes (Kerr et al 1991a); on that occasion the arterialised blood glucose was
lowered to 2.8 mmol/1, at which the simple reaction times were noted to
deteriorate. However, after 90 minutes of persisting hypoglycaemia, the reaction
time was returning towards normal, although it still remained prolonged. Simple
reaction time is not a good measure of changes in central cognitive processes
during hypoglycaemia because it involves little cognitive processing, and motor
function is emphasised. A recent study has confirmed that pure "cognitive " tasks
are more sensitive to neuroglycopenia than motor tasks (Cox et al 1993b). These
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studies (Kerr e al 1989, Kerr et al 1991a) cannot therefore be used to conclude that
any changes observed were the result of "cerebral adaptation" to neuroglycopenia.
The degree of hypoglycaemia induced in the present study was more profound than
that used by Kerr et al (1989). If cerebral adaptation to neuroglycopenia does
occur it is possible that this process depends upon the degree of hypoglycaemia ,
and it may take longer than 60 minutes of exposure to a low blood glucose.
However, a period of 60 minutes of continuous hypoglycaemia was considered to
be similar to some episodes of biochemical hypoglycaemia (which are often
asymptomatic) which occur in clinical practice when the diabetic patient is awake.
More protracted hypoglycaemia may occur in diabetic patients during sleep and
may promote cerebral adaptation, as no cognitive impairment has been
demonstrated on the morning after severe nocturnal hypoglycaemia (Bendtson et al
1992). A recent study in non-diabetic subjects (Nagy et al 1993), demonstrated
that cognitive function (measured with S troop test and finger-tapping) initially
deteriorated at an arterialised blood glucose of 3.6mmol/l but, after chronic
hypoglycaemia (2.8 mmol/1) had been maintained for 56 hours, cognitive function
did not deteriorate until the blood glucose was lowered to 2.5 mmol/1. The
results of this study suggest that, although a degree of adaptation to prolonged
hypoglycaemia appeared to have occurred, the threshold for cognitive dysfunction
was shifted to a more profound level of hypoglycaemia. One potentially
confounding factor in this study (Nagy et al 1993) was that there was no control
limb of the study to assess the effect of hyperinsulinaemia per se on cerebral
function, which was required to maintain that degree of hypoglycaemia (Kerr et al
1991b). A more recent study of non-diabetic patients with insulinomas, using a
hyperinsulinaemic glucose clamp technique, has suggested that when those patients
were exposed to recurrent episodes of hypoglycaemia, pre-operatively, they
appeared to be protected from cognitive dysfunction during acute hypoglycaemia;
although following operative removal of the insulinoma they became as susceptible
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to cognitive dysfunction as a control group (Mitrakou et al 1993). However it is
important to remember that these patients did not have diabetes and therefore may
be susceptible to different mechanisms of possible adaptation. Previous studies in
rats have shown that, during chronic hypoglycaemia, uptake of glucose by the
brain and the brain glucose transport capacity are increased (Cremer et al 1983,
McCall et al 1986, Pelligrino et al 1990) and it is possible that a similar mechanism
operates in human subjects exposed to chronic hypoglycaemia such as those with
an insulinoma.
Symptoms of hypoglycaemia increased to a maximum after 60 minutes of
hypoglycaemia in the present study. In a study of non-diabetic subjects reported
by Kerr and colleagues (1989), symptoms of hypoglycaemia were beginning to
resolve after 60 minutes at a blood glucose of 3.0 mmol/1. However, in the
present study a more comprehensive symptom scoring system was used, and the
greater degree of hypoglycaemia used in the present study compared with that used
by Kerr et al 1989, may have influenced any potential cerebral adaptation to
hypoglycaemia. In the study by Kerr et al (1989), although a reduction in
symptom scores and improvement in reaction time were demonstrated, the rise in
plasma catecholamine concentrations continued, suggesting that some dissociation
was occurring between the hormonal responses, cerebral function and awareness of
hypoglycaemia. The cognitive test battery used in the present study was more
stressful, and previous studies have shown that such tests per se may promote a
rise in catecholamines (Frankenhaeuser, 1971). However, in the present study,
the symptom profiles did not differ between Study B and Study C despite the tests
of cognitive function being administered at different times; if anxiety induced by
the tests was a major contributing factor to the total autonomic symptom scores
then the symptom profiles would have been expected to differ between Studies B
and C.
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Many previous studies have observed a delay in recovery of cognitive function
following hypoglycaemia (Ryan et al 1990, Eckert et al 1992, Blackman et al
1992). This was not a significant finding of the present study, and may be a
function of the different cognitive tests which were used and the different levels of
hypoglycaemia induced even though the present study examined a larger number of
subjects and utilised a very comprehensive cognitive test battery.
The aetiology of cognitive dysfunction during hypoglycaemia is probably
multifactorial, resulting from a direct cerebral effect of neuroglycopenia combined
with non-specific influences such as fatigue and headache. However, in clinical
practice the important issue is the degree of dysfunction experienced by the diabetic
patient treated with insulin. In the present study neither an improvement in
cognitive function nor a diminution of symptoms of hypoglycaemia could be
observed after 60 minutes of moderate hypoglycaemia, which suggests that cerebral
adaptation does not occur at this degree and duration of hypoglycaemia.
In summary
Normal subjects do not exhibit short term cerebral adaptation to hypoglycaemia






THE EFFECT OF INTELLIGENCE LEVEL ON




In humans intelligence is a manifestation of cerebral functioning which can be
quantitated in individuals. The brain is uniquely dependent upon and very
sensitive to the availability of glucose, fluctuations in which will induce changes in
cerebral function and may therefore be used as a tool to investigate cognitive
ability. The development of acute hypoglycaemia in the daily life of patients with
diabetes, as a result of insulin treatment is not reproducible and varying degrees of
hypoglycaemia are unsuitable for accurate evaluation of cognitive function. The
hyperinsulinaemic glucose clamp provides the facility for accurate manipulations of
blood glucose and can be used experimentally to study the effects of changes in
blood glucose on various physiological processes.
Studies examining the effect of acute hypoglycaemia on cognitive function have
revealed that there is a large inter-individual variation in the cognitive dysfunction
observed during acute hypoglycaemia (Herold et al 1985, Hoffman et al 1989); the
reason for these differences is not apparent. It has been suggested that patients
with diabetes perform more poorly than non-diabetic control subjects during
hypoglycaemia (Wirsen et al 1991), although in many previous studies, the non-
diabetic control groups have often comprised doctors and other professional groups
in whom IQ would be expected to be much higher than the general population.
These control groups would therefore be atypical and might confound interpretation
of the results.
The notion that high IQ might offer some protection against a metabolic form of
cerebral 'insult' is often discussed but has seldom been submitted to experimental
evaluation. The most common area of study is 'aging', but there is no clear
evidence to support the supposition that high IQ individuals have greater 'reserve
capacity' and thereby deteriorate less as they grow older (Raykov 1989, Baltes et al
1986, Christensen and Henderson 1991). Age is a notoriously difficult variable to
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study, and much of the difficulty in deciding on the reserve capacity issue arises
from the problems inherent in cross-sectional and longitudinal studies of aging.
A more convenient test of whether individuals with a high IQ have a greater
reserve capacity is to subject high and low IQ groups to an acute cerebral insult in
a controlled experiment. This was attempted by Maylor et al (1990) who stated
that, "we might expect that bright subjects, having greater processing resources or
reserve capacity, would be less adversely affected by alcohol than dull subjects".
Maylor et al examined the effect of alcohol intoxication on performance in a recall
test in high and low IQ groups (identified using the Alice Heim 4 test). Their
results indicated that alcohol had a greater effect on the high IQ group, though
they could not rule out 'floor' effects for the low IQ group. In other words the
low IQ group were already performing so poorly that the tests may not have been
sufficiently sensitive to identify any further deterioration.
The aim of the present study was to try and identify whether subjects with a high
IQ suffer more or less cognitive deterioration than those subjects with a lower IQ
during acute hypoglycaemia. Hypoglycaemia was utilised as a cerebral insult
(because it is directly associated with brain metabolism and more highly
controllable than other insults such as alcohol). In addition the present study
examines whether IQ may play a role in any putative cerebral adaptation to
hypoglycaemia (see Part III Chapter 1).
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METHOD
This study was performed in conjunction with Study 1 ( see Part III Chapter 1)
where the methods of study have already been described in detail, and will not be
repeated here. After the initial analysis of the data from the 72 hyperinsulinaemic
glucose clamps examining the presence of short term adaptation to hypoglycaemia,
the data was reanalysed to examine the effect of IQ on deterioration of cognitive
function during hypoglycaemia.
Subjects
The same 24 healthy subjects studied in Part III Chapter 1 divided into two groups:
one with higher cognitive ability (Group 1) and one with lower cognitive ability
(Group 2) (Table 3.2.1). Cognitive ability was assessed using Alice Heim 4 test
(AH4, Heim 1968) and the National Adult Reading Test (NART, Nelson 1982).
Experimental Procedure and Study Design
The study design was identical to that described in Part III Chapter 1. Figure
3.1.1.
Symptom scores and Physiological Measurements
These have been described previously in Part in Chapter 1.
Cognitive Test Battery
The five cognitive tests comprising the principal cognitive test battery have been
described previously (Part II):
1 - Paced Auditory Serial Addition Test (PASAT) (Deary et al 1991a)
2 - Four Choice Reaction Time (CRT) (Hick 1952, Deary et al 1992)
3 - Digit Symbol Substitution test (DSST) (Wechsler 1981)
4 - Trail-Making B (TMB) (Reitan 1974)
5 - Rapid Visual Information Processing (RVIP) (Deary et al 1992)
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A shortened test battery comprising the Four Choice Reaction Time and the Digit
Symbol Substitution Test was administered at times T3 and T4 in order to assess
recovery of cognitive function after hypoglycaemia (Figure 3.1.1).
Statistical Analysis
Multivariate analysis of variance (MANOVA) was used to assess the effects of
hypoglycaemia on cognitive function. There were two independent variables:
i) IQ with two levels, "high" (Group 1) and "low" (Group 2) ;
ii) Study , with three levels, "euglycaemic placebo" (Study A), "immediate
hypoglycaemia" (Study B) and "delayed hypoglycaemia" (Study C).
The key variable in all the analyses is IQ, and the most important statistical results are
the interactions representing the effect of IQ on performance under different study
studies (IQ by Study interaction). The effect of Study incorporates any effect of
hypoglycaemia on performance, and differences between the two hypoglycaemia
studies.
The absolute change from the baseline cognitive score (Tl) to the score obtained
in the experimental study (T2) was the measure used for each cognitive test.
Percentage change from baseline was also assessed and the results obtained were
very similar to the present method of analysis and so only the absolute change from
baseline is presented. In all the studies the first test period represents a baseline
score assessed during euglycaemia (Tl); the second test period (T2) represents the
score during early hypoglycaemia in Study B, late hypoglycaemia in Study C, and
a second test at euglycaemia in Study A. The dependent variables comprising the
within subjects factor "Test", were derived from the nine indices extracted from
cognitive function tests : four and two second PASAT, DSST, TMB, RVIP hits,
RVIP misses RVIP reaction times, Four Choice decision time (DT) and Four
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Choice movement time (MT).
Separate univariate analyses of variance (ANOVA) were used to assess the effects
of IQ and hypoglycaemia on the individual cognitive tests, symptoms, blood
glucose, blood pressure and heart-rate.
The overall significance in the multivariate tests was calculated from the Wilks'
Lamda test statistic. Significant results were further analysed using t-tests to
determine specific differences between the study studies. The assumptions for
parametric tests were satisfied for all variables unless otherwise stated. In order
to minimise the possibility of a Type 1 error, the following planned comparisons
were performed to assess the cognitive scores:
i) the mean of [Study B scores + Study C scores] in Group 1 vs Group 2
to reveal any effect of IQ on performance during hypoglycaemia.
ii) Study B scores v Study C scores - to compare the effect of immediate
hypoglycaemia (Study B) with prolonged hypoglycaemia (Study C) in each group.
iii) Study A scores v mean of [Study B scores -I- Study C scores) - to
compare the effect of euglycaemia with hypoglycaemia per se in each group.
It would be anticipated that with the addition of the TQ' factor into the analyses of
variance, the actual cells comprising the analysis would differ from the analyses of
variance described in Part HI Chapter 1. This may result in small differences in
the degree of significance of the main effects eg 'Study', 'Test'.
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TABLE 3.2.1
DEMOGRAPHIC DETAILS OF NON-DIABETIC SUBJECTS
Group 1 Group 2
'High IQ' 'Low IQ'
Age (years) 30.1 ±4.1 28.9±4.6 NS
Male / Female 5/7 8/4 NS
Right / Left handed 9/3 8/4 NS
NART errors 6.6+1.7 13.7±4.1 p<0.001




The blood glucose profiles of Studies A, B and C are shown in figure 3.2.1.
There was little variation in blood glucose concentrations during each phase of the
studies ie the standard errors during the euglycaemic and hypoglycaemic periods
were all small. In the hypoglycaemia studies (B and C) the profiles appear very
similar in both groups throughout which was confirmed by testing with analysis of
variance. At the times of cognitive testing during hypoglycaemia, ie between 5
and 25 minutes of hypoglycaemia in Study B and between 35 to 55 minutes of
hypoglycaemia in Study C, no differences in blood glucose concentrations between
the Studies B and C or between groups could be discerned. In other words both
groups were exposed to virtually identical degrees of hypoglycaemia and
euglycaemia throughout all the studies.
Blood pressure and heart rate
There were no significant differences in resting blood pressure or heart rate
between the groups. Analysis of variance across time revealed no significant
effect of hypoglycaemia on systolic blood pressure or heart rate in either group
(IQ, Study, Study by Time, IQ by Study, and IQ by Study by Time were all non¬
significant). There was, however a significant fall in diastolic blood pressure in
both groups during the hypoglycaemia study (Study by Time p=0.043), but there
was no difference between the groups.
Cognitive function
The raw scores for the cognitive data are shown in Table 3.2.2. In all the tests,
with the exception of the Four Choice reaction decision and movement times,
significant baseline differences between the groups were observed: as expected
Group 1 (high IQ) performed better than Group 2 (low IQ) (ie mean scores at T1
[Study A + Study B + Study C]; RVIP hits p=0.005, 4 second PASAT p=0.03,
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2 second PASAT p=0.03, TMB p=0.008, DSST p=0.036). The change from
baseline scores during hypoglycaemia is shown in figures 3.2.2 to 3.2.6. For all
test variables a positive (upward) deflection indicates an improvement in function,
whereas a negative (downward) deflection indicates a deterioration in function.
In the 4 second PASAT (fig 3.3.2a) there appeared to be a deterioration in the high
IQ group during hypoglycaemia (Studies B and C) although the low IQ group
improved considerably in performance in the euglycaemia placebo study (A) and
did not deteriorate during hypoglycaemia. In the 2 second PASAT (fig 3.2.2b)
both groups performed more poorly during hypoglycaemia and also appeared to
improve in the euglycaemia control study. Performance in the Four Choice
Reaction Time (fig 3.2.3a and 3.2.3d) and DSST (fig 3.2.4a) during
hypoglycaemia (Studies B and C), deteriorated during hypoglycaemia in both
groups. In the DSST, there was also an improvement in scores during the
euglycaemia study A. In the high IQ group performance deteriorated in the TMB
test during hypoglycaemia but did not appear to change greatly in the low IQ
group. During the recovery periods the performance in most subjects had
returned to baseline in the Four Choice Reaction Time and had improved in the
DSST to better than baseline scores in both groups.
Multivariate analysis
Multivariate analysis of variance of changes from baseline scores during each of
the studies revealed a significant effect of study conditions on performance
(p = 0.048) and also a significant effect of Test (p = 0.01) with a significant
interaction between Study and Test (p=0.005). This indicates that there were
significantly different effects of the study conditions on cognitive performance ie
that hypoglycaemia generally lowered cognitive scores, and also that
hypoglycaemia had a differential effect on the individual tests, necessitating further
analysis of each test separately. There was no overall significant effect of IQ on
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performance (the IQ, the effect of IQ by Study interaction and the IQ by Test by
Study interactions were non significant), although IQ tended to have a differential
effect on performance in the different tests irrespective of the study conditions (IQ
by Test interaction p=0.068).
Univariate analysis
The results of univariate analyses of variance for each test are shown in table
3.2.3. For the Four Choice reaction time and the DSST there is an additional
"time" factor as each of these tests was also performed twice during recovery from
hypoglycaemia (T3 and T4). It is possible that Type 1 errors might have
occurred but it was considered that the univariate analyses were necessary because
there are few other detailed studies of this type and the planned comparisons were
used to minimise these errors. In addition a significant Study by Test interaction
was noted which required further investigation.
PASAT - Figure 3.2.2a and b. In the 4 second PASAT, in Study A an
improvement from baseline score was observed in both groups, particularly in
those with a lower IQ. In both Studies B and C a significant difference between
the groups emerged : in Group 1 (high IQ) there was a significant deterioration
during hypoglycaemia which did not occur in Group 2 (Low IQ) (ANOVA effect
of Study p=0.033). Further analysis by comparing the scores from Study A at T2
with the mean of the scores from Studies B and C at T2, revealed that although a
significant effect of hypoglycaemia compared with euglycaemia could be observed
on the performance of Group 1 (high IQ; p=0.037) this was not found in Group 2
(low IQ; p=ns). Group comparisons then revealed that the low IQ group had
significantly better scores during hypoglycaemia in comparison with the baseline
scores than did the high IQ group (p=0.04). In the 2 second PASAT a significant
effect of hypoglycaemia on performance in both groups (Study effect p< 0.001)
was found but no differences between the groups could be distinguished. No
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significant difference within groups was demonstrated in the performance between
Study B and C, ie PASAT performance showed no adaptation to hypoglycaemia.
It can be seen from table 3.2.2 that the standard deviations for the 4-second
PASAT were considerably larger in the low IQ group than the high IQ group.
For this reason, a non-parametric comparison between the groups (using Mann-
Whitney U test) of the average change from baseline during hypoglycaemia for
Studies B and C was performed, which still showed a trend towards a difference in
performance between the groups (p=0.06).
Four Choice Reaction Time - Figure 3.2.3a-f. Performance did not change
during the euglycaemia placebo Study A in either group, but both DT and MT
deteriorated in both groups during hypoglycaemia (Studies B and C). However
this only reached significance for MT (ANOVA study by Time p=0.02), and
returned towards baseline values during the recovery period. IQ did not have an
effect on performance. Analysis with t-tests confirmed a significant deleterious
effect of hypoglycaemia on performance on MT in both groups (A v mean [B+C],
p=0.009 for Group 1 and p=0.05 for Group 2). The time of testing after onset
of hypoglycaemia (study B vs study C) did not affect performance in either group.
Performance during recovery was not significantly different from baseline in either
group.
DSST - Figure 3.2.4a, b, c. Changes in performance were similar in both
groups: in Study A there was an improvement in performance throughout, but in
Studies B and C performance deteriorated during hypoglycaemia ( Study by Time
p=0.043), returning towards normal in the recovery periods. Further analysis
with t-tests confirmed the effect of hypoglycaemia on performance in Group 1
(High IQ)(A v mean [B+C], p=0.01), although this failed to reach significance
98
for Group 2. However no significant differences in performance were observed
during hypoglycaemia between the groups (Mean [B+C]); in addition there was
no significant difference between Studies B and C in either group, indicating the
absence of a significant adaptation effect.
TMB - Figure 3.2.5. There was a trend towards an improvement in
performance in Study A in both groups, with deteriorations in performance in
Study B in both groups and Study C in Group 1 but not Group 2. However analysis
of variance did not reveal a significant difference between the groups or a
significant effect of hypoglycaemia overall.
RVIP hits - Figure 3.2.6a. Changes in scores were similar in both groups:
performance did not change during Study A but deteriorated during hypoglycaemia
(ANOVA Study effect p=0.002). Further analysis with t-tests confirmed the
effect of hypoglycaemia (A v Mean [B+C] p=0.02 for Group 1 and p=0.03 for
group 2) but revealed no difference in performance between the groups in either
Studies B or C.
RVIP misses - Figure 3.2.6b. IQ tended to have an effect on performance
during hypoglycaemia (ANOVA, IQ effect p=0.06): subjects in Group 2 made
significantly more false positive responses during hypoglycaemia in both studies
(A v mean [B+C] p=0.03) unlike group 1 (p=NS); comparison of the groups
demonstrated a trend towards and increased number of flase alarms in the low IQ
group compared with the high IQ group (mean [B +C] of Group 1 v Group 2
p=0.07).
From table 3.2.2 it can be seen that the standard deviations for the RVIP misses
were considerably larger in the low IQ group compared with the high IQ group.
Therefore the average change from baseline during hypoglycaemia was compared
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between the groups using a non-parametric analysis (Mann-Whitney U test); this
confirmed a significant difference in performance between the groups during
hypoglycaemia (p=0.025).
RVIP reaction time - Figure 3.2.6c. Testing with ANOVA showed no
significant effect of hypoglycaemia on performance and no difference between the
groups.
Symptom Scores
The symptom profiles did not differ between the groups for autonomic,
neuroglycopenic and non-specific scores (see Part III chapter 1).
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TABLE3.2.2
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FIGURE 3.2.1
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CL4M3 A V//M COAM=> B \//\ CLAM3 C
FIGURE 3.2.3
4 CHOICE REACTION TIME DECISION TIME (DT) CHANGES FROM
BASELINE DURING a) hypoglycaemia, b) 15 minutes after recovery of
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CLAM3 B \//\ CLAM3 C
FIGURE 3.2.3 (CONTINUED)
4 CHOICE REACTION TIME MOVEMENT TIME (MT) CHANGES FROM
BASELINE DURING d) hypoglycaemia, e) 15 minutes after recovery of
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CLAM3 B EZZ3 CLAM3 C
FIGURE 3.2.4
DSST CHANGE FROM BASELINE DURING a) hypoglycaemia,
b) 15 minutes after recovery of euglycaemia
c) 30 minutes after recovery of euglycaemia.
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FIGURE 3.2.5
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FIGURE 3.2.6
RVIP CHANGE FROM BASELINE DURING HYPOGLYCAEMIA
a) "hits', b) "false alarms' (misses) c) reaction time (RT).
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DISCUSSION
There is a large interindividual variation in the response of cognitive function to
various metabolic insults, including acute hypoglycaemia (Herold et al 1985,
Hoffman et al 1989, Maylor et al 1990). The much-posited but little-tested
question arises as to whether those subjects of higher IQ have a reserve capacity
enabling them to cope better under such studies as hypoglycaemia.
The hyperinsulinaemic glucose clamp provides a reproducible tool with which to
study the effects of IQ on cognitive reserve. The cognitive test battery was
carefully selected to examine complex cognitive processes which have been shown
previously to be more affected by acute hypoglycaemia (Holmes et al 1983, Herold
et al 1985, Pramming et al 1986, Hoffman et al 1989, Stevens et al 1989). All of
the tests in the present study were significantly affected by hypoglycaemia with the
exception of the TMB test although it has been shown previously by Hoffman et al
(1989) that this test is affected by hypoglycaemia in patients with Type 1 diabetes.
However, in a study comparing healthy subjects with patients who had Type 1
diabetes in which Trail Making B was used as part of the cognitive test battery, it
was found that the patients with diabetes performed worse during hypoglycaemia
(Wirsen et al 1991); this may explain why the performance in our healthy subjects
did not deteriorate significantly in this test during hypoglycaemia.
The low IQ group had a significantly poorer performance at baseline performance
which might be anticipated. Irrespective of whether absolute declines in scores or
percentage changes in scores were examined, the results were very similar.
Overall, during acute hypoglycaemia there were few differences in deterioration in
performance between the high and low IQ groups. In the present study no
relative improvements in cognitive performance were observed after 40 to 60
minutes of hypoglycaemia when compared with performance after 5 to 25 minutes
of hypoglycaemia in either group. This suggests that if adaptation to
110
hypoglycaemia does occur as suggested in some previous studies (Kerr et al
1989,1991a, Nagy et al 1993) although not confirmed in the studies in our
laboratory (Part III, Chapter 1), it does not appear to be an IQ-dependent process.
Many previous studies have observed a delay in recovery of cognitive function
following hypoglycaemia (Eckert et al 1992, Blackman et al 1992, Ryan et al
1990), although we have not been able to replicate these findings using an
extensive cognitive test battery and if a lag in recovery does occur it does not
appear to be IQ- dependent.
Further analysis of the individual tests determined which tests were most affected
by hypoglycaemia. In the 4 second PASAT, performance by the low IQ group
did not deteriorate as much as the high IQ group. It is possible that this difference
may be attributable to a Type 1 error, but it is also consistent with the findings of
Maylor et al 1990. It is also of interest that the 4 second PASAT is a test with an
empirical association to memory (Deary et al 1991a). During hypoglycaemia
there is an increase in cerebral blood flow to region of the brain involved in higher
cortical function, in particular to the frontal lobes (Thllroth et al 1992, see Part III
Chapter 4). It is possible that the supply of glucose to the brain is already
maximal in subjects with a high IQ and that there is little additional capacity to
increase transport of glucose across the blood brain barrier, for example by the
recruitment of additional glucose transporters. Very little is known about the
behaviour of the brain glucose transporters during acute hypoglycaemia and such a
mechanism may underlie the poorer performance which was observed in the high
IQ subjects in the 4-second PASAT in the present study. An alternative
explanation may be that subjects of higher IQ utilise different neuronal pathways
than those of lower IQ even when performing the same tasks. For example, in the
PASAT the higher IQ subjects may devise a method of adding up and remembering
the numbers presented, resulting in more correct responses, whereas the lower IQ
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subjects may treat each number as a new task and will therefore complete fewer
tasks overall but will also be less susceptible to the effects of neuroglycopenia as
they are utilising more simple pathways.
The subjects with a lower IQ performed more poorly during hypoglycaemia in the
RVIP false alarms, which is a measure of caution. This is similar to findings from
another study (see Part III Chapter 3) in which patients with Type 1 diabetes
who had impaired perception of the onset of hypoglycaemia (hypoglycaemia
unawareness), were observed to perform more poorly in the RVIP misses during
hypoglycaemia than diabetic subjects who had normal awareness of
hypoglycaemia, even though the groups were matched for IQ. Other studies,
which have not examined the effects of IQ, did not show a significant deterioration
in caution or accuracy during hypoglycaemia and that these functions appear to be
preserved at the expense of speed of performance (Holmes et al 1883, Herold et al
1985, Cox et al 1993a). A study by Deary et al (1992) demonstrated that previous
repeated severe hypoglycaemia also resulted in more false positive responses in the
RVIP, even when tested during euglycaemia. These pathways are also more
susceptible to the effects of repeated metabolic insults such as recurrent severe
hypoglycaemia (Deary et al 1992). The poorer performance in the subjects with
low IQ in the RVIP false alarms during hypoglycaemia may suggest that there may
be common neuronal pathways which are more susceptible to neuroglycopenia in
diabetic subjects with impaired awareness of hypoglycaemia (see Part III Chapter
3) and in all subjects who have a lower intelligence.
A larger number of subjects for the study may have been beneficial and would
have minimalised the risk of a Type 1 statistical error although in the present study
at least twice the number of subjects were examined compared with other
hypoglycaemic clamp studies previously described (Kerr et al 1989, Wirsen et al
1991, Stevens et al 1989). The study was very labour-intensive and it would have
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been very difficult to study more subjects without more extensive staffing and
resources. Many cognitive tests were applied which also predisposes to a Type 1
error; however as the study was concerned with an area in which there was little
previous experimental data, a large test battery was utilised predominantly as an
exploratory tool. The greater deterioration in performance in the 4-second
PASAT could be explained by 'floor' effects ie. this particular test was not
sufficiently sensitive to demonstrate a deterioration in the subjects with a lower IQ
as their performance was already poor. The degree of hypoglycaemia induced
was not severe; prolonged acute hypoglycaemia is uncomfortable for the subjects
and most would not be able or willing to tolerate, nor would it have been ethical to
have induced a lower blood glucose for a duration of greater than 60 minutes as
was used in the present study.
The aetiology of cognitive dysfunction during hypoglycaemia is probably
multifactorial, resulting from a direct effect of neuroglycopenia combined with
non-specific influences such as fatigue and headache which are also induced by
hypoglycaemia. However, clinically the important issue is the degree of
dysfunction experienced by the patient which will determine the patients' ability to
perform satisfactorily at work or in other tasks such as driving. People with
higher IQ's may be pursuing more demanding careers and any change in
performance caused by intermittent hypoglycaemia may influence the ability of the
patient to complete essential tasks. We have not been able to show that non-
diabetic with higher IQ have a greater cognitive reserve when exposed to acute
hypoglycaemia. Presumably this finding can be extrapolated to diabetic individual
and emphasises the importance of correcting hypoglycaemia as quickly as possible
in order to avoid protracted interference with daily activities.
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In summary: -
- subjects with a higher IQ are more susceptible to the deleterious effects of
acute hypoglycaemia on cognitive function than subjects of a lower IQ
- subjects with a lower IQ appear to be less cautious during acute





COGNITIVE DYSFUNCTION DURING ACUTE HYPOGLYCAEMIA
IN PATIENTS WITH TYPE 1 DIABETES AND
IMPAIRED AWARENESS OF HYPOGLYCAEMIA
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INTRODUCTION
The degree of cognitive dysfunction experienced during hypoglycaemia is highly
variable between subjects (Herold et al 1985, Hoffman et al 1989) and appears to
be greater in diabetic than non-diabetic subjects (Wirsen et al 1992), suggesting
that individuals with diabetes have an increased susceptibility to neuroglycopenia.
Impairment of subjective awareness of hypoglycaemia is an acquired complication
of insulin-treated diabetes of long duration and affects almost 50% of patients who
have had diabetes for 20 years or more (Pramming et al 1991). Diabetic patients
who have a history of impaired awareness of hypoglycaemia have been reported to
perform more poorly on cognitive function testing (Trail-Making B) than those
with normal awareness of hypoglycaemia, both at euglycaemia and during
hypoglycaemia (Hepburn et al 1991b), suggesting that patients with impaired
awareness of hypoglycaemia have an acquired cognitive impairment with a
heightened susceptibility to neuroglycopenia. The principal aim of this study was
to compare the effect of moderate hypoglycaemia (2.5mmol/l) on cognitive
function in Type 1 diabetic patients who had normal awareness of hypoglycaemia




20 patients with Type 1 diabetes, 10 with normal awareness of hypoglycaemia
(Group A) and 10 with a history of persistent impaired awareness of
hypoglycaemia (Group B), were recruited from the Diabetic Clinic of the
Edinburgh Royal Infirmary. The patients were allocated to each group a)
according to their individual responses to a visual analogue scale which assessed
awareness of hypoglycaemia (1 = always aware, 7 = never aware) and b) if they
had noticed any change in symptomatology since diagnosis. Patients were
assigned to Group A if they scored 1 on the scale and had experienced no changes
in the nature or intensity of symptoms of hypoglycaemia since commencing insulin
therapy. Group B patients scored 4 or more on the scale, reported predominantly
neuroglycopenic symptoms during hypoglycaemia and frequently recorded blood
glucose values below 2.5 mmol/1 without experiencing symptoms.
The demographic details of the patients are shown in table 3.3.1. The median
score on the visual analogue scale of awareness was 1.5 in Group A and 4 in
Group B. The age of the patients, age of onset and duration of diabetes and
frequency of previous severe hypoglycaemia did not differ significantly between
the groups. One subject in each group was left-handed. Exclusion criteria for
the study included a history of cerebrovascular, cardiovascular or peripheral
vascular disease, previous head injury, psychiatric illness, epilepsy (including
hypoglycaemia-induced convulsions), chronic alcoholism or any other systemic
disease. Patients were excluded if they had diabetic retinopathy, other than early
background changes, or visual impairment; none had evidence of peripheral or
autonomic neuropathy. Two patients (one in each group) had recently been
commenced on angiotensin converting enzyme inhibitors for hypertension. All
patients were using human insulin with the exception of one patient in Group A
117
who was using porcine insulin. As insulin species has been shown not to have a
differential effect on cognitive performance during acute hypoglycaemia (Maran et
al 1993), the insulin species used was discounted in the recruitment of the
subjects. Tests of intelligence level were performed on all the subjects prior to the
study and the groups were matched on the basis of a measure of "general cognitive
ability", assessed using the Alice Heim 4 Test (Heim 1968) and premorbid IQ,
estimated using the National Adult Reading Test (Nelson 1982).
Experimental Procedure
Studies were performed on two occasions, separated by at least two weeks. After
a light breakfast patients were fasted until the end of the study. Administration of
intermediate-acting insulin was omitted on the day of study and the morning dose
of short acting insulin was reduced by 25 % to reduce the risk of intercurrent
hypoglycaemia. Patients were asked to perform frequent capillary blood glucose
concentrations for 24 hours before the study. The study was postponed if a patient
either experienced symptoms of hypoglycaemia or documented a blood glucose of
less than 3.0 mmol/1.
The blood glucose concentrations were controlled using a hyperinsulinaemic
glucose clamp as described in Part II.
The subjects were not informed of their blood glucose concentrations during the
experiments. On one occasion (Study 1) the arterialised blood glucose
concentration was stabilised and maintained at 4.5 mmol/1 during the first battery
of cognitive tests (Tl), was then lowered to 2.5mmol/l and maintained at this level
for 30 minutes during the second cognitive test battery (T2), before being restored
to 4.5 mmol/1 at which it was maintained for 10 minutes before and during the final
cognitive test battery (T3)(fig. 3.3.1). On a separate occasion (Study 2) the blood
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glucose concentration was maintained at 4.5 mmol/1 throughout all three cognitive
testing periods. The study conditions were counterbalanced. One of the female
patients with impaired awareness was unable to participate in the euglycaemic
study as she developed an exacerbation of her irritable bowel syndrome and
required medication which may have affected cognitive function.
Cognitive and Physiological Measurements
Blood was withdrawn for estimation of plasma catecholamines at the time points
indicated in figure 3.3.1. Continuous heart-rate measurements and blood pressure
were recorded as shown in figure 3.3.1.
The cognitive test battery took approximately 20 minutes to administer and
consisted of four tests (as described previously in Part II) in the following order:
1 - Paced Auditory Serial Addition Test (PASAT) (Deary et al 1991a)
2 - Digit Symbol Substitution test (DSST) (Wechsler 1981)
3 - Trail-Making B (TMB) (Reitan et al 1974)
4 - Rapid Visual Information Processing (RVIP) (Deary et al 1992)
Statistical Analysis
Multivariate analysis of variance (MANOVA) was used to assess the effects of
hypoglycaemia on cognitive function. There were three independent variables :
i) Awareness of hypoglycaemia, with two levels, "normal" (Group A) and
"impaired" (Group B) ;
ii) Study, with two levels, "hypoglycaemic" (Study 1) and "euglycaemic"
(Study 2);
nilTime, with three levels, "first test period", "second test period" and "third
test period" (Tl, T2 and T3).
"Awareness" was a between subjects factor while "Study" and "Time" were within
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subjects factors.
In Study 1 and Study 2 the first test period represents a baseline score assessed
during euglycaemia (Tl); the second test period (T2) represents the score during
hypoglycaemia in Study 1 and a second test at euglycaemia in Study 2, and the
third test (T3) period represents recovery from hypoglycaemia in Study 1 and a
third test at euglycaemia in Study 2. The dependent variables were the scores
derived on seven cognitive function tests : four and two second PASAT, DSST,
TMB, RVIP hits, RVIP misses and RVIP reaction times.
The key variable in all the analyses is "Awareness", and the most important
statistical results are the interactions representing the effect of awareness on
performance under different study conditions (Awareness by Study interaction),
and in particular the effect of awareness on performance at certain time epochs
such as during hypoglycaemia and recovery (Awareness by Study by Time
interaction).
Separate univariate analyses of variance (ANOVA) were used to assess the effects
of Awareness, Study and Time on blood glucose, blood pressure and heart-rate.
Only nine patients of Group B were included in the overall MANOVA because of
missing data, although further analysis of variance of the individual test scores,
was performed in all 20 patients. The overall significance in the multivariate tests
was calculated from the Wilks' Lamda test statistic. Significant interactions were
further analysed using non-paired t-tests to determine specific differences between
the groups. Non-parametric tests (Mann Whitney) were used for hormonal data




DEMOGRAPHIC DATA OF DIABETIC SUBJECTS
Group A Group B Significance
Normal awareness Impaired awareness




























































The blood glucose profiles of both groups are shown in figure 3.3.2. Once stable
euglycaemic control had been established, the profiles were almost identical in both
groups throughout the study. Testing with ANOVA revealed no significant main
effect of Awareness, and the Awareness by Study and Awareness by Study by
Time interactions were not significant. In effect, no overall difference between
the two groups could be discerned, no differential effect of study type on blood
glucose was identified between the groups, and no time epochs within studies were
observed in which the blood glucose differed between groups.
Plasma Catecholamines
The results of the plasma catecholamine measurements are shown in table 3.3.2.
A marked variation was observed in the plasma concentrations of adrenaline and
noradrenaline between subjects. Many of the measurements for noradrenaline
were at the lower limit of detection of the assay, which may therefore lead to
inaccuracies. During the euglycaemia study the plasma concentrations of
noradrenaline and adrenaline did not differ significantly from baseline. Non-
parametric analysis did not demonstrate any difference between the two groups in
either study. However the increase in the levels of noradrenaline and adrenaline at
their peak during hypoglycaemia, compared with basal levels was significant in
both groups (p<0.01).
Blood pressure and heart rate
The blood pressure and heart rate results are shown in figure 3.3.3. Throughout
Study 1, Group A tended to have slightly higher systolic and diastolic blood
pressures, although both groups demonstrated a rise in systolic blood pressure
during hypoglycaemia. ANOVA showed no overall effect of Awareness, and the
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Awareness by Study interactions were not significant for the changes in systolic and
diastolic pressures. However, a significant difference in systolic blood pressure
(but not diastolic blood pressure) was observed between the two groups at certain
time epochs (Awareness by Study by Time interaction, p=0.02). This suggests
that the "aware" patients tended to have a slightly higher systolic blood pressure
than the patients with impaired awareness, although further analysis at individual
time points failed to identify any significant differences. Both groups also
demonstrated a rise in heart rate during hypoglycaemia and the "aware" patients
tended to have a slightly higher heart rate throughout the hypoglycaemia study.
However, on ANOVA there was no overall effect of Awareness, and the
Awareness by Study and Awareness by Study By Time interactions were not
significant, which indicates that the heart rates of both groups were similar
throughout the studies.
Cognitive tests
The results of the individual tests for both Study 1 and Study 2 are shown in
figures 3.3.4. The raw data for the scores is shown in table 3.3.3 a and b. To
standardise the format of all figures, a deterioration in performance is represented
by a downward deflection and an improvement as an upward deflection. It is
evident that performance deteriorated during hypoglycaemia in all tests, with only
minor changes in performance being observed in the euglycaemia control study.
Multivariate analysis:
Results of the MANOVA of the effects Awareness, Study, Time and their
interactions, on overall cognitive performance are shown in table 3.3.4.
Irrespective of awareness, the cognitive test battery demonstrated a significant
difference in performance between Study 1 and Study 2 during hypoglycaemia and
on recovery from hypoglycaemia (Study effect p= 0.001, Study by Time
interaction p=0.008), confirming a detrimental effect of hypoglycaemia on overall
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cognitive performance. A significant difference in performance in the different
cognitive tests was also observed across time in the two different studies (Test by
Study by Time interaction, p = 0.009), suggesting that not all of the tests were
equally affected by the changes in blood glucose at all time points. For example,
the pattern of change in caution in performance (RVIP misses, fig 3.3.4e) during
hypoglycaemia and on recovery from hypoglycaemia was quite different from the
change in performance observed with the PASAT or the DSST (Figs 3.3.4b and c).
The overall MANOVA results indicate that there was an overall trend for
awareness to affect performance (p=0.08 ).
Univariate analysis:
The effect of Awareness and its interactions with Study and Time were performed
using individual test scores to determine which tests were affected more than others
(Thble 3.3.5).
TMB (fig 3.3.4a) - A significant change in performance was noted across
time when comparing Study 1 (hypoglycaemia) and Study 2 (euglycaemia) in all
subjects (Study by Time interaction p< 0.001). Moreover a significant difference
was observed between the groups at certain time epochs, in particular on recovery
from hypoglycaemia (Awareness by Study by Time interaction p=0.03). Further
comparisons with t-tests confirmed that the patients with impaired awareness were
significantly impaired following recovery from hypoglycaemia compared with the
patients with normal awareness of hypoglycaemia (p=0.04), although there were
no differences in performance at baseline or during hypoglycaemia.
PASAT (4 and 2 second) (fig 3.3.4b) - Hypoglycaemia significantly
affected performance in these tests, with a deterioration in scores during
hypoglycaemia, followed by recovery in performance after the restoration of
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euglycaemia (Table 3.3.3 - Study and Study by Time interactions p<0.001).
However, ANOVA did not demonstrate any differences in performance between
the patients with normal or impaired awareness at any time of measurement.
DSSX (fig 3.3.4c) - This test was also significantly affected by
hypoglycaemia, with a recovery in performance observed following restoration of
euglycaemia (Thble 3.3.3 - Study effect p=0.005; Study by Time effect p<0.001).
No differences were found between the two groups at any time point.
RVIP hits (fig 3.3.4d) - Hypoglycaemia significantly affected performance
in this test in both groups (Study effect p = 0.04; Study by Time interaction
p=0.002). A significant difference in performance was observed between the two
groups at certain time epochs, in particular on recovery from hypoglycaemia
(Awareness by Time interaction p=0.05). However, overall there did not appear
to be a difference between groups (Awareness by Study by Time interaction non¬
significant). Comparison of test scores at each time point in Study 1 using
unpaired t-tests, demonstrated that, although no differences in performance were
evident between the groups during euglycaemia, during hypoglycaemia the
patients with impaired awareness tended to perform more poorly (p=0.08). On
recovery from hypoglycaemia the scores in the patients with normal awareness
returned to the baseline score whereas those patients with impaired awareness of
hypoglycaemia remained significantly impaired (p=0.02).
RVIP misses (fig 3.3.4e) - The patients with impaired awareness of
hypoglycaemia tended to be less cautious than the patients with normal awareness
throughout both studies (Awareness effect p=0.08). Analysis with t-tests at
individual time points demonstrated that during hypoglycaemia the patients with
impaired awareness became significantly less accurate than the patients with
normal awareness (p=0.03) and they remained less accurate even following
126
recovery from hypoglycaemia (p=0.04).
RYIP reaction times (fig 3.3.4f) - The patients in both groups became
significantly slower during hypoglycaemia (Study effect and Study by Time
interaction p< 0.001) and the patients with impaired awareness tended to be slower
overall. Analysis with t-testing demonstrated that the patients with impaired
awareness of hypoglycaemia also tended to become slower during hypoglycaemia
(p = 0.09) and remained significantly slower following recovery from
hypoglycaemia (p=0.05).
In the euglycaemia study (Study 2) significant differences between the groups were
found only in reaction time during study period 2 (T2, RVIP-RT p=0.04) and in

















































SCORES OF COGNITIVE TESTS DURING STUDY 1 (HYPOGLYCAEMIA)
GROUP A GROUP B
Normal Impaired
awareness awareness





1 - 4.5 mmol/1
2-2.5 mmol/1





1 - 4.5 mmol/1
2 - 2.5 mmol/1


































RVIP - 'reaction time' / ms
1-4.5 mmol/1 478+70 548+120 NS
2-2.5 mmol/1 542+82 632+135 p=0.09
3 - 4.5 mmol/1 484+78 567+93 p=0.05
PASAT - 4-second
1 - 4.5 mmol/1 55.5+3.4 54.5+4.1 NS
2 - 2.5 mmol/1 43.9+9.4 44.1 + 10.2 NS
3-4.5 mmol/1 56.8+2.9 53.5+7.2 NS
PASAT - 2-second
1 - 4.5 mmol/1 36.3+ 11.1 33.7+10.4 NS
2 - 2.5 mmol/1 20.3+8.3 23.7+11.3 NS
























1 - 4.5 mmol/1
2 - 4.5 mmol/1
3-4.5 mmol/1
RVIP - reaction time / ms
1 - 4.5 mmol/1
2 - 4.5 mmol/1
3 - 4.5 mmol/1
PASAT - 4-second
1-4.5 mmol/1
2 - 4.5 mmol/1
3-4.5 mmol/1
PASAT - 2-second
1 - 4.5 mmol/1
2 - 4.5 mmol/1
3-4.5 mmol/1
DSST
1 - 4.5 mmol/1
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COGNITIVE FUNCTION TEST RESULTS DURING:
i) STUDY 1 (hypoglycaemia) ii) STUDY 2 (euglycaemia). MEAN ± SEM
GROUP A (normal awareness) - solid lines, solid circles.
GROUP B (impaired awareness) - dotted lines , open circles.
a) TMB time for completion (sees).
b) PASAT test scores. The upper lines indicate the PASAT at 4 second
intervals and the lower line indicate the PASAT at 2 second intervals.
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Progressive impairment in cognitive function during acute hypoglycaemia of
increasing severity is well recognised using different tests of cognitive function and
all of the cognitive function tests employed in this study examined complex
cognitive processes which have been shown previously to be most affected by acute
hypoglycaemia (Holmes et al 1983, Herold et al 1985, Pramming et al 1986,
Hoffman et al 1989, Stevens et al 1989). This study of Type 1 diabetic patients
confirmed that deterioration of complex cognitive functions becomes evident during
controlled hypoglycaemia.
A previous study which addressed the effects of acute hypoglycaemia on cognitive
function in patients with diabetes (Herold et al 1985), suggested that those patients
who experienced predominantly neuroglycopenic rather than autonomic symptoms
during hypoglycaemia appeared to have a greater deterioration in reaction times,
although the study was not designed to examine the relationship between either
symptoms or awareness of hypoglycaemia and cognitive function. A subsequent
study of acute hypoglycaemia in diabetic patients who had impaired awareness of
hypoglycaemia demonstrated a significantly poorer performance in the Trail
Making B test than "aware" diabetic controls, both at baseline euglycaemia and
during hypoglycaemia (venous blood glucose 1.7mmol/l) (Hepburn et al 1991b),
although the effect on recovery of cognitive function following hypoglycaemia was
not examined. However in that study the patients were not matched for
intelligence or previous history of severe hypoglycaemia (Hepburn et al 1991b).
In the present study patients were selected on the basis of a clinical history of
subjective impairment of awareness of hypoglycaemia and not on the response to
experimental hypoglycaemia. This approach was necessary because
hypoglycaemia induced in a laboratory, particularly when using a
hyperinsulinaemic glucose clamp, does not simulate the ability of the patient to
137
detect the onset of hypoglycaemia in normal daily life. Although it is
acknowledged that retrospective estimates of hypoglycaemia may be inaccurate, it
was important to match the groups for history of exposure to severe hypoglycaemia
as this factor can affect cognitive function (Deary et al 1993a) and would confound
the results. Although in the present study the overall relationship between
awareness of hypoglycaemia and cognitive dysfunction during hypoglycaemia was
manifested only as a trend towards a greater deterioration, the combination of
cognitive tests that were employed was very sensitive in detecting changes during
hypoglycaemia. The overall effect of awareness may have reached significance if
a larger number of patients had been studied. Further analysis of the individual
tests was therefore considered to be justified as they appeared to be affected
differently depending on the study conditions (viz: the Test by Study by Time
interaction was significant overall). For example the pattern for deterioration of
cognitive function on the DSST was different from the TMB. ANOVA revealed
an overall effect of awareness on the TMB and RVIP tests: TMB scores were
affected differently between the groups by the effect of hypoglycaemia at
comparable time points (Awareness by Study by Time interaction). For RVIP hits
an overall effect of awareness was also identified at certain time points,
irrespective of the study conditions for the RVIP hits. Direct comparison of
scores between the two groups confirmed that patients with impaired awareness of
hypoglycaemia had a poorer performance for RVIP hits during hypoglycaemia, and
also a delayed recovery in their performance both for the RVIP hits and TMB,
compared with those patients who had normal awareness of hypoglycaemia. Not
all of the tests were affected equally by awareness, even though the tests were
sensitive to the effects of hypoglycaemia, suggesting that neuroglycopenia may
affect some neuronal pathways more than others in patients who have developed
impaired awareness of hypoglycaemia.
An overall trend towards an effect of Awareness irrespective of Time or Study was
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observed for RVIP misses and reaction time. Direct comparisons between the
groups in the hypoglycaemia study (Study 1) revealed that the patients with
impaired awareness were significantly less cautious, scoring more false alarms
during hypoglycaemia (RVIP misses). They also tended to have slower responses
during hypoglycaemia (RVIP RT), and during the recovery phase were
significantly impaired compared to aware group (RVIP RT p = 0.05). In the
euglycaemia study, all scores tended to improve with time which indicates that a
"learning/practice" process was occurring and confirms that the deterioration in
performance during the hypoglycaemia study could not be attributed to fatigue.
However in the euglycaemia study the patients with impaired awareness became
less cautious, scoring more false alarms towards the end of the study (increased
RVIP misses at T3). They also appeared to "learn" more slowly than the aware
group with respect to RVIP reaction times (RVIP RT at T2) although they did
demonstrate a "catch up" effect later, as shown by the absence of a significant
difference in reaction times at T3. These results suggest that overall degree of
caution and speed of performance (measured by RVIP misses and RVIP reaction
times) may be impaired in patients with impaired awareness of hypoglycaemia and
that this function deteriorates further during hypoglycaemia. However, in the
patients with normal awareness of hypoglycaemia caution was observed to
increase during hypoglycaemia so that they scored fewer misses in the RVIP. This
finding is in keeping with the conclusions of previous studies of patients with
Type 1 diabetes with and non-diabetic subjects (Holmes et al 1983, Holmes et al
1984, Herold et al 1985, Cox et al 1991 and 1993a) in which accuracy of
performance was maintained at the expense of speed of performance.
In the present study the patients with impaired awareness of hypoglycaemia
performed less well than the aware patients during hypoglycaemia (2.5mmol/l) in
one test alone (RVIP misses). However the degree of cognitive dysfunction may
depend on the severity of hypoglycaemia induced; more abnormalities may have
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become apparent at lower blood glucose concentrations which would surmount the
glycaemic threshold for the induction of cognitive dysfunction (Pramming et al
1986, Driesen et al 1991). In addition, at baseline euglycaemia the scores on the
TMB did not differ between the diabetic groups, in contrast to the study by
Hepburn et al (1991b) in which the patients were neither matched for IQ nor for
history of previous exposure to severe hypoglycaemia, which probably directly
affects cognitive function (Langan et al 1991, Deary et al 1993a). The method of
induction of hypoglycaemia also differed from the present study so that direct
comparisons are not applicable (Heine 1993). Although the hyperinsulinaemic
glucose clamp technique is "unphysiological", at present it is the only method
available which will allow prolonged testing of cognitive function at a constant and
controlled level of hypoglycaemia.
It has been suggested that a "diabetic encephalopathy" may result from a
combination of chronic hyperglycaemia and recurrent severe hypoglycaemia
(Khardori et al 1986, Pozzessere et al 1988, Pozzessere et al 1991, Ryan et al
1992, Dejgaard et al 1991). It is possible that some patients who develop
impaired awareness of hypoglycaemia have a form of diabetic encephalopathy. In
addition, the same metabolic disturbances may increase susceptibility of the brain
to neuroglycopenia resulting in a progressive decline in intellectual function and
more pronounced impairment of cognitive function during acute hypoglycaemia.
This hypothesis is supported by the evidence from a study in which cognitive
function appeared to be more affected in diabetic patients than in non-diabetic
controls during acute hypoglycaemia (Wirsen et al 1992).
In the present study the RVIP reaction times tended to be slower at all times during
hypoglycaemia in the diabetic patients with impaired awareness. However RVIP
reaction time is probably not an accurate measure of true reaction time as the
patients are not instructed to complete the task as quickly as possible. However
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this abnormality of cognitive function may indicate that the diabetic patients with
impaired awareness of hypoglycaemia are more susceptible to the effects of the
chronic metabolic disturbances of diabetes both on central and peripheral nerve
function. In addition, the patients with impaired awareness of hypoglycaemia
scored more RVIP misses at all times irrespective of the prevailing blood glucose
concentration, suggesting that permanent neurological damage may have developed
in these patients.
The plasma catecholamine concentrations were measured in view of a potential
change in cognitive function occurring through a stimulatory effect on cerebral
function. The effects of catecholamines and adrenoceptor blocking drugs , such
as beta blockers, on cerebral function are controversial (Solomon et al 1983,
Herrick et al 1989, Madden et al 1986, Deary et al 1991b). The glycaemic
thresholds for the secretion of counterregulatory hormones in response to
hypoglycaemia are influenced by prevailing glycaemic control, the frequency of
exposure to hypoglycaemia and the duration of diabetes (Simonson et al 1985,
Amiel et al 1988, Heller and Cryer 1991), and are impaired in patients who have
chronic changes in their awareness of hypoglycaemia (Hepburn et al 1991b).
These variables may account for the wide variation in the plasma catecholamine
responses to hypoglycaemia which was observed in the present study and also for
the skewed distribution within the patient groups. Cognitive testing may also
increase the plasma catecholamines (Frankenhaeuser 1971) and make interpretation
of the data difficult. In the present study the plasma catecholamine responses to
acute hypoglycaemia of the two groups were compared using non-parametric tests
and no significant differences were found at any time point. This would refute the
possibility that increased plasma concentrations of catecholamines had provided an
effective "stimulation" or "arousal" during hypoglycaemia in the aware group so
resulting in their better performance. Although there was a rise in catecholamine
levels during hypoglycaemia there were no differences between the groups which
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was surprising in view of the data reported by Hepburn and colleagues (1991b)
which showed that the threshold for release of counterregulatory hormones
occurred at a lower blood glucose in the patients with impaired awareness and that
the magnitude of the response was also diminished in comparison with the patients
with normal awareness. In the present study the plasma catecholamine
concentrations were greatly skewed by one patient with impaired awareness who
had very poor glycaemic control with a total glycosylated haemoglobin of around
15%. It is likely that at a blood glucose of 2.5 mmol/1 she was well above her
threshold for release of counterregulatory hormones and therefore perceived the
degree of hypoglycaemia as much more profound resulting in a greater magnitude
of catecholamine secretory response. In addition, as noted previously, many of
the nor-adrenaline concentrations fell at the lower end of detection of the assay
which may have introduced inaccuracies.
Previous studies have alleged that cognitive function improves during prolonged
hypoglycaemia in non-diabetic and insulin-dependent diabetic subjects suggesting
that cerebral adaptation to neuroglycopenia may occur (Kerr et al 1989 and 1991a)
although the study described in Part III Chapter 1 did not support these
observations. In the present study the same order of the cognitive tests was
maintained to avoid any potential effect on the tests scores during hypoglycaemia.
The two tests that differed with respect to awareness of hypoglycaemia were the
last to be administered. Although it is unlikely that cerebral adaptation developed
during hypoglycaemia in the aware group of diabetic patients in the light of the
previous data described, it is not possible to exclude its development so resulting in
a better performance in the later cognitive tests.
Some studies have suggested that the glycaemic thresholds for changes in cognitive
function are higher in subjects with strict glycaemic control ie cognitive function is
preserved until lower blood glucose concentrations (Jones et al 1991, Ziegler et al
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1992), whereas other studies have shown that there is no change in threshold
(Widom and Simonson 1990) or in fact that cognitive dysfunction may even occur
at a higher blood glucose in patients with strict glycaemic control (Amiel et al
1991). In the present study the groups were matched for prevailing glycaemic
control to avoid the possibility of this confounding variable.
Some studies have suggested that recovery of cognitive function is delayed
following normalisation of blood glucose both in non-diabetic and diabetic subjects
(Herold et al 1985, Ryan et al 1990, Blackman et al 1992, Eckert et al 1992). To
our knowledge comparisons between groups on the basis of chronic changes in
awareness of hypoglycaemia have not been made previously. Heller et al (1987)
demonstrated a delayed recovery in reaction times after hypoglycaemia
(arterialised blood glucose 2.5mmol/l) in insulin-treated diabetic patients who did
not develop symptoms of hypoglycaemia during the study, compared with
symptomatic diabetic patients and non-diabetic subjects but the groups were not
matched for duration of disease, glycaemic control or IQ. This delayed recovery
would also be consistent with a diminished cerebral reserve to resist the effects of
neuroglycopenia.
Accurate assessment of the symptoms of hypoglycaemia was not possible in the
present study, as the cognitive test batteries were prolonged and SPET scans were
also performed (see Part III Chapter 4) and, in order to avoid interruption,
prohibited regular questioning about symptoms. In addition, cognitive testing per
se induces symptoms such as anxiety which would interfere with interpretation of
the symptom scores. However, we observed that most patients in both groups had
few symptoms of hypoglycaemia at an arterialised blood glucose of 2.5 mmol/1,
suggesting that the threshold for symptomatic responses was lower than that for
cognitive dysfunction. This observation is consistent with previous reports
(Pramming et al 1986, Mitrakou et al 1991). The glycaemic thresholds at which
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cognitive function deteriorated during hypoglycaemia was examined in diabetic
subjects using four-choice reaction time (Maran et al 1992). Those patients who
had loss of awareness of hypoglycaemia exhibited cognitive dysfunction at similar
blood glucose concentrations as non-diabetic subjects, despite having no symptoms
of hypoglycaemia. These observations are of practical importance to diabetic
management. Diabetic patients who have impaired awareness of hypoglycaemia,
should be instructed that although they may feel entirely "normal" on recovery
from an episode of hypoglycaemia, their cognitive function may remain impaired
for a considerable time. Thsks such as driving or operating machinery should not
be resumed for a period of at least 30-45 minutes after restoration of blood glucose
to normal, and activities involving intellectual input should not be continued
immediately otherwise performance is likely to be suboptimal.
In summary:-
Patients with impaired awareness of hypoglycaemia experience:
- greater cognitive dysfunction (in some tests) than patients with normal
awareness of hypoglycaemia






CHANGES IN CEREBRAL BLOOD FLOW DURING ACUTE
HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES




Impaired awareness of hypoglycaemia occurs in 50% of patients who have a
duration of diabetes of 20 or more years (Pramming et al 1991) and has been
discussed in Part I , Chapter 1. The mechanism which results in impaired
awareness of hypoglycaemia is not known but one possible mechanism which has
been suggested is a deficiency of the glucose sensor mechanism (Frier 1993)
which may be located in the brain (Biggers et al 1989, Skov and Pryds 1992) or
possibly in the liver (Donovan et al 1993). In the previous study, Part III Chapter
3, it was observed that diabetic patients with impaired awareness of hypoglycaemia
experience greater and more prolonged cognitive dysfunction in response to
hypoglycaemia when compared with patients with normal awareness. The
mechanism responsible for these differences is not clear but could result from
differences in delivery, uptake and metabolism of glucose by cerebral tissue.
Technological advances have enabled more detailed analysis of cerebral
metabolism and blood flow using Single Photon Emission Tomography (SPET)
and this technique has been used to study a variety of neurological diseases (Launes
et al 1989, Holman et al 1991, Grunwald et al 1991). Before the advent of this
sophisticated scanning technique, crude estimates of cerebral blood flow had
provided conflicting results with respect to the effect of hypoglycaemia. Some
studies had described that there were no changes in cerebral blood flow (Eisenberg
and Seltzer 1962, Kety et al 1948) whereas others had described an increase in
cerebral blood flow during acute hypoglycaemia induced as part of insulin-shock
treatment (Delia Porta et al 1964). More recent studies have demonstrated an
increase of approximately 20% in cerebral blood flow during hypoglycaemia (Neil
et al 1987, Thllroth et al 1992, Kerr et al 1993) which persists after the restoration
of euglycaemia. Studies of cerebral blood flow using SPET have also been
performed both in non-diabetic subjects and in patients with Type 1 diabetes during
acute hypoglycaemia (Thllroth et al 1992, 1993), and at euglycaemia in subjects who
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had a history of recurrent severe hypoglycaemia (MacLeod et al in press).
The aim of this study was to try and identify any differences in rCBF during acute
hypoglycaemia between diabetic patients with impaired awareness of
hypoglycaemia and patients with normal awareness of hypoglycaemia, which may
explain the differences in cognitive function during acute hypoglycaemia described
earlier (Part III Chapter 3). Any difference in blood flow between patients with
and without impaired awareness of hypoglycaemia may also give an indication as
to which region of the brain may be responsible for sensing changes in blood




This study was combined with the study described in Part III chapter 3. The
selection method and clinical characteristics of the subjects and the protocol for
induction of hypoglycaemia has been described previously (Part III Chapter 3). In
the present study SPET scans were only performed during Study 1 (ie
hypoglycaemia study day) at the times shown in figure 3.4.1. The first scan was
performed during euglycaemia after completion of the cognitive test battery (Tl),
and the second scan was performed during hypoglycaemia (2.5 mmol/1) after
completion of the second cognitive test battery.
SPET Imaging Technique
A cannula for injection of the 250 MBq bolus of isotope was inserted at the
beginning of the study at the same time as the insertion of the cannulae for
manipulation of the blood glucose. A single slice multi-detector dedicated head
scanner (Multi-X 810, Strichman Medical Equipment Inc., Boston, USA) was used
to examine subjects after repeated injections of half-dose fractions of
""Technetium Exametazime. The maximum in-slice resolution of the scan is
given as 7.5mm (full width, half maximum) by 15 mm slice thickness, when using
572 hole collimators. The sensitivity of the instrument has been measured as 520
counts per second in a head sized phantom containing 1 KBq/ml (Ebmeier et al
1991). During injection of the isotope the patient lay on the imaging table with
eyes covered and ears plugged to reduce sensory input. The noise in the study
laboratory was kept to a minimum for five minutes after the start of the injection.
The patient's head was then positioned in a moulded head rest with the help of two
crossed light beams. To restrict movement, the head was fixed with pressure pads
over the zygomatic arches.
During the first scan in the present study counts were acquired in two slices
parallel to the orbito-meatal line (OML), at 40 and 60 mm above the OML. After
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completion of the first scan, hypoglycaemia was induced as described previously.
The second dose of 250 MBq was then injected during the same conditions as
described above. During the second scan, the whole brain was scanned in parallel
transaxial slices at 1 cm intervals from the OML upwards.
Image Analysis
Local count densities were examined with a region of interest approach. Standard
templates were derived from a neuroanatomical atlas (Thlairach et al 1988) and
fitted by aligning the outer border of the template with the 40% isocontour line of
the brain activity map. This method avoids arbitrary definition of regions of
interest centred on local hot spots, which could introduce a bias. The power of
such analysis would allow detection of regional activation of approximately 5 % in
a group of 10 subjects. The count densities were corrected by determining the
relative contributions of tracer from each of the injections. The normalised count
for a particular region was the regional scan density resulting from each injection,
divided by the whole slice density for that injection of tracer.
Cognitive Tests
The cognitive tests were administered as described in Part HI Chapter 3.
Statistical Analysis
Univariate analysis of variance (ANOVA) was used to assess the effects of
hypoglycaemia on tracer uptake in each region of cerebral blood flow.
There were two independent variables:
i) Awareness with two levels, "normal" (Group A) and "impaired" (Group B)
ii) Scan condition , with two levels, "euglycaemia" (baseline scan) and
"hypoglycaemia" (second scan).
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The 'awareness' variable is important in determining any differences in cerebral
blood flow between the two groups and the interaction of 'awareness by scan
condition' describes differences between the groups at different blood glucose
concentrations.
Comparisons in regional tracer uptake and changes in tracer uptake were
performed between the groups using unpaired t-tests while the effects of
hypoglycaemia per se were examined using paired t-tests. Spearman's rho was
used to correlate psychometric performance during euglycaemia and
hypoglycaemia for those regions in which there was a significant change in blood
flow.
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i - injection of isotope
FIGURE 3.4.1
STUDY DESIGN - SHOWING TIMES OF INJECTION OF ISOTOPE AND
DURATION OF SPET SCAN
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RESULTS
Results of blood glucose concentrations, cognitive tests, blood pressure, heart rate
and symptom scores have been described previously (Part m, Chapter 3). Thble
3.4.1 shows the normalised regional count densities during euglycaemia and
hypoglycaemia for each cerebral hemisphere and each patient group. The results
of the univariate analysis of variance for the individual regions are shown in table
3.4.2 and the further t-test analyses results are shown in table 3.4.3. Analysis of
variance demonstrated a significant effect of awareness on count density in the
right occipital region (lower slice) irrespective of blood glucose conditions
(awareness effect p=0.03) although further analysis with t-tests only showed a
trend towards increased count density in the group with normal awareness at
baseline (p = 0.09). ANOVA did demonstrate a significant effect of
hypoglycaemia on regional count density in the following areas : right putamen
(lower slice, p=0.04), right thalamus (lower slice, p=0.01), and both superior
pre-frontal regions (left p=0.007, right p=0.01). The paired t-test analyses
confirmed these effects, demonstrating increased count densities during
hypoglycaemia in the superior pre-frontal region and right thalamus and decreased
count density in the right putamen (Thble 3.4.3).
The PASAT was the only cognitive test to correlate with changes in tracer uptake
and the results are shown in table 3.4.4. There was a significant positive
correlation between accuracy on the 2-second PASAT and increased uptake in the
right and left superior prefrontal cortex. There was also a similar correlation
observed in the 4-second PASAT in the right putamen (Thble 3.4.4).
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TABLE3.4.1
NORMALISEDC UNTDENSIT ESOFTHR GIO SINTEREST





























































































































































UNIVARIATE ANALYSIS OF VARIANCE OF
NORMALISED REGIONAL COUNT DENSITIES
EFFECT
Scan Condition Awareness Awareness by
Scan
p value p value p value
LEFT RIGHT LEFT RIGHT LEFT RIGHT
Lower slice
Frontal NS NS NS NS NS NS
Ant. cingulate NS NS NS NS NS NS
Ant. temporal NS 0.07 NS NS NS NS
Post, temporal NS NS NS NS NS NS
Occipital NS NS 0.09 0.03 NS NS
Calcarine NS NS NS NS NS NS
Post, cingulate NS 0.06 NS NS NS NS
Caudate 0.06 NS NS NS NS NS
Putamen NS 0.04 NS NS NS NS
Thalamus NS 0.01 NS NS NS NS
Upper slice
Frontal 0.007 oo NS NS NS NS
Ant. cingulate NS NS NS NS NS NS
Parietal NS NS NS NS NS NS
Occipital NS NS NS NS NS NS
Post, cingulate NS NS NS NS NS NS
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TABLE 3.4.3
T-TEST RESULTS OF COMPARISONS OF REGIONAL COUNT DENSITIES
WHERE ANOVA EFFECT P<0.05.
Awareness Effect ANOVA T-test






































































Tallroth and colleagues, using 133Xenon SPET demonstrated an increased cerebral
blood flow especially to the frontal and parietal lobes. By use of an alternative
technique, 133Xenon inhalation, a global increase in cerebral blood flow was
demonstrated during hypoglycaemia (Kerr et al 1993). Hyperinsulinaemia per se
was also shown to increase cerebral blood flow but to a more limited degree.
These studies in human subjects are consistent with the findings in animal studies
although delayed hypoperfusion rather than hyperperfusion has been demonstrated
in animals, following the restoration of euglycaemia (Abdul-Rahman et al 1980,
Siesjo and Abdul-Rahman 1979, Bryan 1988).
The changes in cerebral blood flow demonstrated by the present study reflect
changes observed during euglycaemia in patients with diabetes and a history of
previous severe hypoglycaemia (MacLeod et al in press). In that study, it was
demonstrated that patients with diabetes had increased frontal lobe blood flow
during euglycaemia compared with non-diabetic subjects, and, that in patients with
a history of severe hypoglycaemia the frontal blood flow was augmented compared
with diabetic patients who had not previously been exposed to severe
hypoglycaemia. Other neurophysiological and neuropsychological studies have
demonstrated that the frontal lobes appear to be particularly susceptible to the
effects of hypoglycaemia (Holmes et al 1983, Pramming et al 1986). Therefore
this increase in blood flow to the frontal lobes in response to hypoglycaemia may
serve as a protective mechanism which has evolved to prevent a deterioration in
cerebral function. The mechanism by which this occurs may involve the
increased availability or function of glucose transporters, or the recruitment of
capillaries as has been suggested previously (Blomqvist et al 1991, McCall et al
1986,Pelligrino et al 1990, Skov and Pryds 1992). Interestingly it has also been
demonstrated that there appear to be increased numbers of Glut 1 transporters in
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the posterior regions of the brain, compared with frontal regions (Brant et al 1993)
and it could be surmised that the increased flow to the frontal areas may be
necessary to overcome this relative deficiency of transporters. The results from
the present study support this hypothesis: the greater the increase in frontal blood
flow, the smaller the degree of cognitive dysfunction during hypoglycaemia, as
measured by the PASAT. This would suggest that cerebral blood flow changes
diminish the effect of acute hypoglycaemia on cognitive function.
The effect of awareness of hypoglycaemia on regional blood flow was less marked
and insufficient to explain the differences in cognitive function between the groups
during hypoglycaemia. Unfortunately it was not possible to perform three scans
during the study in order to assess any differences in cerebral blood flow during
the recovery period, as this would have exposed the patients to an excessive
amount of radiation. As has already been discussed, impaired awareness of
hypoglycaemia probably has a multifactorial aetiology and it is unlikely that a
single area of abnormal cerebral blood flow would underlie this phenomenon. In
addition, the resolution of the SPET technique would not be adequate at
identifying subtle changes in cerebral blood flow, especially in the brain-stem.
As the t-test analysis did not demonstrate a significant effect of hypoglycaemia, this
suggests that the changes in blood flow were small and below the power of
resolution of the scan. Further analysis using other techniques such as PET may









In clinical practice patients with diabetes frequently report feeling miserable or
tearful during or after an episode of acute hypoglycaemia and patients who have
experienced many episodes of severe hypoglycaemia have been reported to be more
anxious and to score lower on "happiness" ratings (Wredling et al 1992).
Gonder-Frederick and colleagues assessed mood changes associated with
fluctuations in blood glucose concentrations in patients with insulin-dependent
diabetes (Gonder-Frederick et al 1989). They demonstrated that low blood
glucose concentrations tended to be associated with negative mood states, primarily
'nervousness'. However there have been few dynamic studies performed during
a single episode of acute hypoglycaemia to assess the nature and progression of
changes in mood.
Moods are emotion-like experiences that are more persistent than emotional
reactions, and lack reference to specific objects, by contrast with motivations, such
as hunger, and emotions, such as fear (Matthews 1992). A great deal of research
has been conducted on self-reported mood checklists in order to reveal their
psychometric structure. Recently, some consensus has been achieved by accounts
of mood which posit two or three dimensions. This contrasts with earlier research
which assessed as many as 12 separate dimensions of mood (Nowlis 1965).
Matthews' review (1992) uses four mood dimensions in order to describe
psychometric accounts of mood: 1) energetic arousal, 2) tense arousal, 3) hedonic
tone and 4) general arousal. Of those offering two-dimensional solutions, some
researchers characterise mood only in terms of energetic and tense arousal (Thayer
1989, Cox and Mackay 1985, Watson and Tellegen 1985), whereas an alternative
two dimensional scheme includes hedonic tone and general arousal (Russell 1979,
Diener et al 1985). In addition, McConville and Cooper (1992) suggest that
hedonic tone and 'state extraversion' might offer the most parsimonious account of
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mood. Three dimensional mood structures assess energetic arousal, tense arousal
and hedonic tone (Matthews et al 1990, Sjoberg et al 1992). This three
dimensional structure will be used in the present study, though it should be noted
that they are not orthogonal; hedonic tone is moderately positively correlated with
energetic arousal and negatively correlated with tension (at around 0.3 for both
measures, Matthew 1992).
As may also be said of personality and ability dimensions, psychometric research
cannot validate the structure of mood. At best, psychometric analysis may reveal
a structure that is validated by other means. One approach of the validation of
mood dimensions is to attempt to discover their biological bases, by means of
experimental manipulations. Thayer (1989) has reviewed studies of drug
manipulations of mood and demonstrated that no straight forward account of
neurotransmitters and mood states can be offered at present. Manipulations such
as carbohydrate ingestion, exercise, sleep deprivation and relaxation have been
shown to affect energy and tension differently but have not afforded much advance
in understanding the structure of mood (Thayer 1989, Johnson 1982, Matthews et
al 1990).
The present investigation introduces a further biological method of manipulating
mood states - namely a controlled hypoglycaemic episode using the
hyperinsulinaemic glucose clamp technique (De Fronzo et al 1979). We
hypothesised that subjects who experience hypoglycaemia will have different
responses to the two types of arousal: as a result of the autonomic activity induced
by hypoglycaemia we expect tense arousal to increase; and as a result of
neuroglycopenia we expect energetic arousal to decrease. If such a state of 'tense
tiredness' (Thayer 1989) can be demonstrated, ie. a state in which two types of
arousal can be made to move in opposite directions, this will provide some validity
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for the inclusion of two dimensions of arousal in addition to hedonic tone.
Additionally, mood research may benefit from the addition of a biological
procedure in which the physiological mechanisms are relatively well understood.
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METHODS
This study was performed in conjunction with study 1 and the subjects,
experimental protocol and study design are as described in Part III chapter 1.
Hypoglycaemia (arterialised blood glucose 2.5 mmol/1) was induced and
maintained for a period of sixty minutes on two occasions (Studies B and C) and on
a third occasion euglycaemia was maintained throughout (4.5 mmol/1) (see figure
3.1.1). The euglycaemic condition (A) served as a control/placebo condition for
the other two conditions (B and C)
Assessment ofMood and Symptoms
The UWIST Mood Adjective Checklist (UMACL) [Matthews et al 1990) was used
to assess mood (described in Part II). Each subject was requested to complete the
questionnaire at each of the seven time points shown in figure 3.1.1. The
adjectives were graded by intensity on a scale of 1 to 4 and were classified into
three groups : hedonic tone, tense arousal and energetic arousal (see appendix).
Each dimension is indexed by eight items and higher scores indicated a high
"happiness" rating for hedonic tone, a high "anxiety" rating for tense arousal and a
high "energy" rating for energetic arousal. The maximum score which could be
attained for each of the three mood components was 32 and the minimum score
was four. Symptoms were assessed as described previously at the same time
points as the assessment of mood (Part HI chapter 1).
Statistical Analysis
Analysis of variance (ANOVA) was used to assess the effects of hypoglycaemia on
mood. In this study the two hypoglycaemia studies (B and C) served as replication
of the hypoglycaemia condition and the scores obtained during the hypoglycaemia
studies were meaned for the purpose of analysis. There were two main
independent variables:
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1 - Condition, a within subjects factor with two levels, "euglycaemia" (condition
A), " hypoglycaemia" (mean [Condition B + Condition C]); the effect of
condition, therefore, incorporates any effect of hypoglycaemia on mood.
2 - Time, a within subjects factor with seven levels, according to each of the time
points of administration of the questionnaire.
The three dependent variables were the three UWIST mood factors. The three
factors hedonic tone, energetic arousal, and tense arousal were analysed separate
analyses of variance. In the present study conservative post hoc tests were not
thought to be appropriate as the study was predominantly exploratory and, in order
to investigate the time course of changes rather than the mere presence or absence
of such changes in mood, several time points at which mood was measured were
included. It was anticipated that the actual changes between many of these time
points would be small and also highly variable. For example the changes between
the scores at the end of euglycaemia and the beginning of hypoglycaemia would be
much greater than the changes between the scores at baseline and the end of the
initial euglycaemia. However, in the ANOVA the mood scores at each time point
are treated equally resulting in a highly conservative analysis.
The overall significance in the multivariate tests was calculated from the Wilks*
Lamda test statistic. Significant results were further analysed using t-tests to




Results of the symptom scores at the 7 time points have been described previously
(Part III Chapter 1). In summary, significant increments in autonomic and
neuroglycopenic symptom scores were recorded reaching a maximum at the end of
the period of hypoglycaemia.
Mood Questionnaires
The results of the mood questionnaire factors in the different experimental models
are shown in figure 3.5.1 a-c and the analyses of variance in table 3.5.1. The
mood profiles were very similar in both the hypoglycaemia conditions B and C.
Table 3.5.2 shows the comparisons (using t-tests) between the hypoglycaemia
condition (ie mean {B+C} ) and the euglycaemia placebo condition A.
Hedonic Tone (Figure 3.5.1 a) In the euglycaemic control condition (A)
the scores for hedonic tone did not change throughout the condition. However, in
the hypoglycaemia studies hedonic tone decreased significantly during
hypoglycaemia, but returned towards normal during recovery from hypoglycaemia
(ANOVA Condition by Time interaction p=0.016; Condition effect p=0.027).
Further analysis using t-tests demonstrated a significant difference from the control
condition after 30 and 60 minutes of hypoglycaemia (p=0.007 and p=0.001).
Tense arousal (Figure 3.5.1 b) Little change in the tense arousal scores
during the euglycaemic control condition was observed; during hypoglycaemia
there was a significant increase in tension (ANOVA Condition by Time interaction
p=0.001; Condition effect p=0.001). Further analysis with t-tests confirmed a
significant increase in tension scores from the beginning of hypoglycaemia which
did not return to normal until 30 minutes after restoration of euglycaemia ("hypo"
p = 0.001, "hypo + 30 mins" p<0.001, "hypo + 60 mins" p<0.001,
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"euglycaemia+15 mins" p=0.012).
Energetic arousal (Figure 3.5.1 c) During the euglycaemia control
condition there was a reduction in energy scores with a nadir at the fifth time
point; however during hypoglycaemia there was a more profound reduction in
energy scores during hypoglycaemia, although this just failed to reach significance
on testing with ANOVA (Condition by Time interaction p = 0.099; Condition
effect p=0.056). Analysis with t-tests did indicate a lower energy score after 30
minutes of hypoglycaemia which persisted until the end of the condition ("hypo+
30 mins" p = 0.039, "hypo + 60 mins" p = 0.014, "euglycaemia+15 mins"
p=0.045, "euglycaemia+30 mins" p=0.009).
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TABLE 3.5.1
UNIVARIATE ANALYSIS OF VARIANCE FOR THE
MOOD SCORES ACROSS TIME
EFFECT
Mood component Condition Time Condition
by Time
Hedonic tone 0.027 0.003 0.016
Tense arousal 0.001 <0.001 0.001
Energetic arousal 0.056 < 0.001 0.099
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TABLE 3.5.2
T-TEST SIGNIFICANCE AT SPECIFIED TIME POINTS COMPARING
THE EFFECT OF EUGLYCAEMIA vs HYPOGLYCAEMIA ON MOOD
Mood component Time of testing Significance of t-test
{A vs mean [B+C]}
Hedonic tone Baseline (0) NS
Euglycaemia (E) NS
Hypoglycaemia (H) NS
Hypo + 30 mins (H+30) 0.007
Hypo + 60 mins (H+60) 0.001
Restoration euglycaemia(E+15) NS
End (E+30) NS
Tense arousal Baseline (0) NS
Euglycaemia (E) NS
Hypoglycaemia (H) 0.001
Hypo + 30 mins (H+30) <0.0005
Hypo + 60 mins (H+60) <0.0005
Restoration euglycaemia(E+15) 0.012
End (E+30) NS
Energetic arousal Baseline (0) NS
Euglycaemia (E) NS
Hypoglycaemia (H) NS
Hypo + 30 mins (H+30) 0.039
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FIGURE 3.5.1
CHANGES IN MOOD DURING ACUTE HYPOGLYCAEMIA
a - Hedonic tone
b - Tense arousal
c - Energetic arousal
Solid area - Study A;close hatched area - Study B;wide hatched area - Study
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DISCUSSION
Previous studies have shown that for individual diabetic patients treated with
insulin, an idiosyncratic relationship exists between mood and blood glucose
concentrations (Gonder-Frederick et al 1989). There appears to be much variation
in the type of mood change experienced at high blood glucose concentrations with
some patients reporting positive mood states (eg confident and cheerful) while
others report negative mood states (eg angry and sad). However, low blood
glucose concentrations appear to be mostly associated with negative mood states
such as 'nervousness' (Gonder-Frederick et al 1989) although the 'mood scales'
utilised did not differentiate between the different components of mood as
described by Thayer (1989) and Matthews (1992).
In the present study a fall in hedonic tone, a rise in tense arousal and a fall in
energetic arousal were observed during acute insulin-induced hypoglycaemia.
These observations of increased negative mood states are consistent with the earlier
results reported by Gonder-Frederick et al (1989). Acute insulin-induced
hypoglycaemia results in a variety of counterregulatory neuronal and hormonal
events (see Part I Chapter 1) and it is possible that some of these events may be
responsible for the changes in mood described. As discussed earlier, the
psychometric structure of mood has been agreed although there are few well-
understood biological interventions of mood and hypoglycaemia provides one
possible method to investigate the biological / physiological basis for changes in
mood.
Thayer's model of mood (1989) includes the two components 'tense arousal' and
'energetic arousal' which act in opposite directions to produce the state of 'tense
tiredness' which indicates declining physical resources together with subjective
tension. Tense arousal is a negative mood tone associated with feelings of tension
and anxiety or fearfulness and often combined with muscular tension. Energetic
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arousal is a positive affective mood associated with decision-making and action.
This state of 'tense tiredness' is thought to be important as it may be relevant to
certain clinical states such as depression. In the present study the observed
changes in mood during hypoglycaemia, with an increase in tension and a fall in
energetic arousal fulfil this model of 'tense-tiredness'.
In the present study it is not possible to identify the separate biological bases for
the changes in each mood factor. It is possible that activation of the autonomic
nervous system may result in changes in mood resulting in increased tension or
anxiety; however it is most likely that the mood changes result from a combination
of central and peripheral neuroglycopenia and the counterregulatory hormonal
changes associated with hypoglycaemia. As the time course for the changes in
mood differed for energetic arousal compared with hedonic tone and tense arousal,
this suggests that different biological factors are responsible. It would be of
interest in further larger studies to attempt to correlate the changes in
counterregulatory hormonal responses, and physiological changes such as
haemodynamic responses and tremor, with the changes in each of the mood
components.
In conclusion, hypoglycaemia provides a useful biological model with which to
investigate changes in mood. In clinical practice these fluctuations in mood
experienced during hypoglycaemia are important both to patients with diabetes and
their relatives and friends, and may potentially interfere with social and work
interactions. The effects of recurrent episodes of acute hypoglycaemia on mood
are not known and require further assessment to establish whether these changes
may become irreversible with time. In addition changes in other mood factors
during acute hypoglycaemia such as anger would be of interest and of great
importance to individual patients, particularly with regard to personal relationships
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and interactions. This study provides further evidence for a detrimental effect of
hypoglycaemia on psychological function.
In summary hypoglycaemia results in:
- lower hedonic tone which was rapidly restored to normal with the
restoration of euglycaemia;
- higher tense arousal which was less rapidly restored to normal






THE FREQUENCY AND MORBIDITY OF HYPOGLYCAEMIA IN PATIENTS
WITH TYPE 1 (INSULIN-DEPENDENT) DIABETES WHO HAVE
IMPAIRED AWARENESS OF HYPOGLYCAEMIA
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INTRODUCTION
Hypoglycaemia is a common and potentially dangerous side-effect of treatment
with insulin in diabetic patients with a significant morbidity (Paz-Guevera et al
1975, Deckert et al 1978, Hepburn et al 1989, MacLeod et al 1993, Frier 1993).
When severe hypoglycaemia is defined as the need for external assistance to effect
resuscitation, retrospective estimates of the frequency of severe hypoglycaemia in
unselected diabetic populations range from 1.1 to 1.6 episodes per patient per year
(Pramming et al 1990, Reichard et al 1991, MacLeod et al 1993). Alterations in
awareness of hypoglycaemia have been recognised for many years in patients with
Type 1 diabetes and have been observed to predispose to a greater frequency of
severe hypoglycaemia (Maddock and Trimble 1928, Cooke 1934, Lawrence 1941,
Maddock and Krall 1953, Balodimos and Root 1959). The aetiology of impaired
awareness of hypoglycaemia is probably multifactorial and has been discussed
previously (Part I Chapter 1).
In a retrospective survey (Pramming et al 1990) almost 50% of patients with Type
1 diabetes were estimated to have experienced a change in the symptoms of
hypoglycaemia after 20 years of insulin treatment, and this acquired defect has
been shown to be associated with a higher frequency of severe hypoglycaemia
(Hepburn et al 1990, Pramming et al 1990, MacLeod et al 1993). Severe
hypoglycaemia produces profound neuroglycopenia which may impair the patient's
subsequent recollection of the episode, and therefore retrospective assessments may
underestimate the true frequency of severe hypoglycaemia experienced by affected
patients. In the present study the frequency of severe hypoglycaemia in patients
with Type 1 diabetes with normal awareness of hypoglycaemia was documented
prospectively over 12 months and compared with that of a matched group of
patients who had persistent impairment of awareness of hypoglycaemia.
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METHODS
Definition of impaired awareness of hypoglycaemia
The symptoms which patients usually experienced during hypoglycaemia, were
documented and each symptom assessed on a visual analogue scale of 1 to 7 (see
Appendix) (l = "not present 7 = "present a great deal"); the symptoms were
subdivided into autonomic, neuroglycopenic and non-specific groups (table 4.1.1).
Awareness of hypoglycaemia was defined as "normal" if the patient had not
experienced any subjective alteration since the diagnosis of diabetes and described
the development of predominantly autonomic warning symptoms associated with
the onset of acute hypoglycaemia (Hepburn et al 1991a). The patients with
normal awareness of hypoglycaemia also scored between 1 and 2 on a visual
analogue scale of 1 to 7 which was used to record usual awareness of
hypoglycaemia (1 = "always aware of the onset of hypoglycaemia"; 7 = "never
aware of the onset of hypoglycaemia"). Patients were considered to have
impaired awareness if they had noticed a definite change in their warning
symptoms of hypoglycaemia for at least two years, associated with a reduction in
autonomic symptom scores so that predominantly neuroglycopenic symptoms were
now experienced (table 4.4.1) and they had scored more than 4 on the visual
analogue scale assessing awareness.
Patient Groups
Sixty patients with Type 1 diabetes who were attending the diabetic outpatient
review clinic of the Royal Infirmary of Edinburgh were recruited and divided into
two groups on the basis of their self-reported awareness of hypoglycaemia:
Group 1-31 patients with normal awareness of hypoglycaemia.
Group 2 - 29 patients with impaired awareness of hypoglycaemia.
On questioning, the two groups had not differed in their symptom profiles of
hypoglycaemia at the time of diagnosis of diabetes, but the patients with impaired
awareness now experienced significantly fewer autonomic symptoms than those
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patients with normal awareness (table 4.1.1). As the scores of symptoms
experienced during hypoglycaemia at the time of diagnosis rely entirely on patient
recall and may be inaccurate, it is not possible to compare these derived scores
directly with the scores attained for their current symptom profile. Where
possible, confirmation of impaired awareness was obtained by questioning
spouses, partners or other close relatives about the patients' recent history of
hypoglycaemia and their symptomatic responses.
Patient Characteristics
The characteristics of each patient group are shown in table 4.1.2. The groups
were matched for age, duration of diabetes, age of onset and glycaemic control at
the start of the survey. Details of complications of diabetes were ascertained by
physical examination including direct ophthalmoscopy, and also from clinical
records. The presence of microalbuminuria was assessed by urinary
albumin/creatinine ratios or if frank proteinuria (Albustix positive) was present, the
magnitude was quantitated by 24 hour urine collections. Both groups had few
diabetic complications and did not differ in the incidence or severity of retinopathy,
neuropathy, or nephropathy (Table 4.1.2). Autonomic function tests were
performed in all patients (Ewing et al 1985) and scores indicated that three (10.3%)
of the 29 patients with impaired awareness had abnormal autonomic function and
three (9.7%) of the 31 patients with normal awareness had abnormal autonomic
function. Total glycated haemoglobin was measured using high-speed liquid
chromatography based on an ion exchange reversed-phase partition method (Hi
Auto Ale HA 8121) (non-diabetic range for our laboratory 4.5-8%) at intervals
during the study (non-diabetic range for our laboratory 4.5-8%) and did not differ
between the groups at the beginning or at the end of the study.
The number of daily injections of insulin did not differ between the groups; over
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70% of both groups were taking a twice daily regimen (figure 4.1.1). Four
patients in each group were using animal insulin and all the other patients had been
using human insulin for at least five years prior to the study. The pattern of home
blood glucose monitoring did not differ significantly between the groups; 52% of
patients with normal awareness and 62% with impaired awareness monitored
capillary blood glucose regularly, at least on alternate days.
Protocol for survey
Patients were asked to document all episodes of hypoglycaemia within 24 hours of
its occurrence and details about each hypoglycaemic episode were documented:
time of day of episode, activity at time of hypoglycaemia (including sleeping), any
obvious predisposing factors (eg delayed or missed meals, strenuous exertion), the
treatment required, the need for external help and any resultant morbidity, such as
physical injury, loss of consciousness, convulsions or accidents (see Appendix).
Severe hypoglycaemia was defined as any episode requiring external assistance or
resulted in coma. Witnessed accounts (by relatives, friends or colleagues) of each
episode of hypoglycaemia were recorded wherever possible.The patients were
asked to monitor capillary blood glucose either visually or using a meter on a
regular basis and complete three 10 point diaries during each three month period
(see Appendix). After enrolment patients were reviewed at three monthly
intervals and glycaemic control was reappraised at each visit and any necessary
adjustments in insulin doses were made. If considered to be appropriate, changes
in insulin regimen were made in patients experiencing severe hypoglycaemia: two
of the patients with impaired awareness of hypoglycaemia were changed to multiple
injection insulin regimens to try and avoid hypoglycaemia; no changes in glycaemic
control were observed as a result of these changes.
A questionnaire documenting "fear" of hypoglycaemia (Cox et al 1987) was
undertaken at the beginning of the study to identify any differences in attitude and
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behavioural responses towards hypoglycaemia. The patients' driving history and
the number and nature of any previous road traffic accidents were documented.
Statistical Analysis
Demographic data were analysed using t-tests for unpaired samples. All other
data which were not normally distributed were analysed using Wilcoxon rank sum
tests and where applicable, Chi-squared tests were used to analyse group
differences.
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Frequency and Time of Day of Hypoglycaemia
The frequency of all episodes of hypoglycaemia is shown in table 4.1.3.
Approximately 85 % of all episodes of severe hypoglycaemia were verified by
witnesses. The patients with impaired awareness of hypoglycaemia experienced
significantly more episodes of severe hypoglycaemia than the patients with normal
awareness, but the frequency of mild episodes did not differ significantly between
the two groups.
The number of episodes of severe hypoglycaemia occurring either while awake or
asleep are shown in figure 4.1.2 and the times of occurrence throughout the day of
the episodes of severe hypoglycaemia are shown in figure 4.1.2. The periodicity
of severe hypoglycaemia differed between the two groups. In the patients with
normal awareness, 60% of all episodes occurred between midnight and 08.00h,
and 53% of all episodes occurred during sleep, compared with the patients with
impaired awareness in whom 31% of all episodes occurred between midnight and
08.00h and 31 % of episodes occurred during sleep. The patients with normal
awareness of hypoglycaemia therefore experienced a significantly greater
proportion of episodes of severe hypoglycaemia during the night (usually during
sleep) compared with those with impaired awareness (p=0.05). The patients with
impaired awareness of hypoglycaemia experienced a significantly greater
proportion of episodes during the evening before retiring to bed compared with the
patients with normal awareness of hypoglycaemia. No differences in the
identifiable causes of hypoglycaemia could be ascertained between the two groups.
In the patients with normal awareness 60% of the episodes of severe
hypoglycaemia could not be explained , as were 54% of the episodes in the patients
with impaired awareness. The methods by which severe hypoglycaemia was
treated did not differ proportionately between the groups; 14% of episodes (n=2)
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in patients with normal awareness required glucagon compared with 21% (n=17)
of episodes in patients with impaired awareness; all other episodes were treated
with oral carbohydrate.
Morbidity
Only five episodes of severe hypoglycaemia required hospital treatment. On two
different occasions the same patient required admission for treatment, on one
occasion suffering a fractured neck of femur and on the other a head injury. Two
of the other three episodes occurred in another patient who had impaired
awareness. Five (33%) of the fifteen episodes of severe hypoglycaemia in the
patients with normal awareness of hypoglycaemia resulted in loss of consciousness
compared with 29 (35%) of the 82 episodes in the patients who had impaired
awareness. Only two patients, both of whom had impaired awareness of
hypoglycaemia experienced convulsions during hypoglycaemia; one experienced
nocturnal convulsions associated with hypoglycaemia on five separate occasions
and the other experienced hypoglycaemic convulsions on two occasions, also
during the night. Neither patient had evidence of idiopathic epilepsy, not
associated with hypoglycaemia.
Fear of Hypoglycaemia
Responses to the "fear" questionnaire indicated that patients with normal awareness
of hypoglycaemia worried less about hypoglycaemia (median score 31.5) than
patients with impaired awareness (median score 41)(p=0.008). However despite
their increased concern and anxiety, the patients with impaired awareness had not
modified their behaviour (median score 30) in an attempt to avoid hypoglycaemia,
when compared with the patients with normal awareness (median score 29).
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Home blood glucose monitoring
Similar numbers of blood glucose measurements were made by both groups with a
mean number of 90 recordings per patient. The mean number (in 12 months) of
home blood glucose measurements with values less than 3.0 and 2.5 mmol/1
respectively and which were not accompanied by symptoms of hypoglycaemia were
significantly fewer in the patients with normal awareness of hypoglycaemia
compared with the patients with impaired awareness (blood glucose values < 3.0
mmol/1 p< 0.001; blood glucose <2.5 mmol/1 p<0.0001) (Figure 4.1.4).
Driving Experience
The questionnaire assessed overall driving experience since commencing treatment
with insulin, and was not restricted to the study period. Twenty four patients with
normal awareness of hypoglycaemia held a valid driving licence (restricted to three
years); eight had previously experienced hypoglycaemia while driving but none of
the episodes had resulted in road traffic accidents. Eleven of these patients had
been involved in minor motor vehicle accidents at other times which were not
related to hypoglycaemia. Only 11 patients with impaired awareness of
hypoglycaemia currently held valid driving licences; five patients with impaired
awareness had ceased driving voluntarily because of concern about the risk of
causing accidents during hypoglycaemia, and no longer held driving licences: one
patient's licence had been revoked by the licensing authority. However, of those
patients who had impaired awareness and had continued to drive, five had
experienced hypoglycaemia while driving. Only one such patient had been involved
in a road traffic accident, which was not related to hypoglycaemia and was the fault
of a third party. Comparison of the accident rates of both groups using chi-
squared tests showed that the patients with impaired awareness tended to have
fewer driving-related accidents overall (0.05 <p<0.1).
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TABLE 4.1.2
DEMOGRAPHIC DATA OF PATIENTS WITH TYPE 1 DIABETES
Group 1 Group 2 Significance
(Normal awareness) (Impaired awareness)
n 31 29
Gender distribution (M/F) 18/13 17/12 NS
Age (years) 43.9+10.6 48.4+11.7 NS
Age of onset (years) 25.3±10.3 27.8+ 10.8 NS
Duration of IDD (years) 18.6+7.6 21.0+8.1 NS
Daily insulin dose (units/kg) 0.63+0.09 0.69+0.10 NS
HbAl (%) start of study 10.0+1.2 10.2+ 1.5 NS
end of study 10.2+1.4 10.0+1.2 NS
(mean+SD)
Complications /number of patients (percentage)
Microalbuminuria 4 (12.9) 4 (13.7) NS
Proteinuria 0 1 (3.4) NS
(<0.3g/l)
Retinopathy
Background 23 (74.4) 26 (89.6) NS
Proliferative 8 (23.6) 3 (10.4) NS





FREQUENCY OF HYPOGLYCAEMIA IN PATIENTS WITH
TYPE 1 DIABETES.
Group 1 Group 2
(Normal awareness) (Impaired awareness)
n 31 29
Severe
Total no. episodes 15 82 p<0.001
severe hypoglycaemia
Number (percentage) of patients 8 (25.8) 19 (65.5) p<0.01
experiencing > 1 severe episode
No. episodes/patient/year 0.48 2.83 p<0.0001
year
Mild
Total no.episodes 73 137 NS
mild hypoglycaemia
Number (percentage) of patients 25 (80.1) 18 (62) NS
experiencing > 1 mild hypo







TOTAL NUMBERS OF EPISODES OF SEVERE HYPOGLYCAEMIA
OCCURRING IN ONE YEAR IN PATIENTS WITH AND WITHOUT
IMPAIRED AWARENESS OF HYPOGLYCAEMIA.























MEAN NUMBER OF EPISODES PER PATIENT OF
ASYMPTOMATIC HYPOGLYCAEMIA.
(Left hand panel - hypoglycaemia defined as <3.0nunol/l; right hand panel
- hypoglycaemia defined as <2.5mmol/l)
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DISCUSSION
Accurate assessment of the frequency of severe hypoglycaemia in insulin-
treated diabetic patients is confounded by potential incomplete self-reporting
of episodes, possibly in some instances because of transient amnesia caused
by neuroglycopenia. In addition, other events such as transient ischaemic
attacks or syncopal episodes may be misattributed to hypoglycaemia, and
diabetic patients with poor glycaemic control often experience symptoms of
hypoglycaemia within a hyperglycaemic range and so over-estimate the true
frequency of hypoglycaemia (Maddock and Krall 1953, Boyle et al 1988,
Clarke et al 1991, Polonsky et al 1992).
Prospective assessment with recordings of events by patients, supported by
objective witnessed accounts where possible is the most accurate method of
collecting establishing the frequency with accuracy. Despite this approach,
it is possible that the frequency may still be an underestimate particularly in
the patients with impaired awareness of hypoglycaemia. Furthermore in
the present prospective survey treatment regimens were reviewed to try to
prevent further episodes of severe hypoglycaemia. Two of the patients with
impaired awareness who had recorded episodes of severe hypoglycaemia as
well as multiple episodes of asymptomatic biochemical hypoglycaemia were
commenced on multiple injection regimens which was associated with a
reduction in the frequency of both asymptomatic and severe hypoglycaemia
over the subsequent six months. This therapeutic change was considered to
be essential but will have modified the estimated true frequency of severe
hypoglycaemia, introducing an underestimate in the group with impaired
awareness of hypoglycaemia. It is also possible that episodes of
hypoglycaemia occurring during sleep, which were principally nocturnal,
were not always detected in some of the patients in either group who were
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not awakened by hypoglycaemia. However despite these possible
inaccuracies in reporting, the frequency of severe hypoglycaemia was
observed to be almost six fold higher in Type 1 diabetic patients with
impaired awareness of hypoglycaemia. Although the frequency of mild
hypoglycaemia did not differ between the groups, such estimates are
recognised to be inaccurate. Pramming et al (1990) have shown
discrepancies between prospective and retrospective estimates, with poor
recall by patients at intervals of more than one week. In the present study,
patients with impaired awareness frequently recorded low random blood
glucose concentrations which were unaccompanied by symptoms, and this
was significantly more common than in the group with normal awareness.
The proportion of all patients who had experienced hypoglycaemia was
shown to be greater in the present study, which may reflect a tendency to
underestimate the frequency of hypoglycaemia in retrospective studies
(Goldgewicht et al 1983). In the present study the overall incidence of
severe hypoglycaemia in all of the patients was estimated at 1.6 episodes
patient"1 year"1 which is very similar to frequencies estimated previously,
both retrospectively (MacLeod et al 1993) and prospectively (Pramming et al
1991). The use of a similar definition of severe hypoglycaemia is
essential to compare studies; in several previous studies (Casparie et al
1985, Nilsson et al 1991, DCCT 1991) the incidence of hypoglycaemia was
reported to be lower than the present study because only episodes requiring
resuscitation with parenteral glucagon or intravenous glucose or admission
to hospital had been documented. If such a definition had been used in the
present study the incidence of severe hypoglycaemia in the patients with
normal awareness would have been much lower at 0.06 episodes patient"1
year"1 and in the patients with impaired awareness at 0.23 episodes patient"1
year"1, although the relative difference in frequency between the two groups
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would be preserved. Using this modified and less complete definition the
incidence of severe hypoglycaemia for the patients with normal awareness in
the present study would then be consistent with rates reported retrospectively
in other earlier studies (Nilsson et al 1988, Mulhauser et al 1985). In the
Diabetes Control and Complications Trial (DCCT) in which data was
collected prospectively the incidence of severe hypoglycaemia in patients
receiving intensive insulin therapy was noted to be 0.62 episodes patient"1
year"1 (DCCT Research Group 1993). However there were important
differences in the study population which was much younger, had a shorter
duration of diabetes and most importantly patients with a history of recurrent
severe hypoglycaemia or hypoglycaemia with no warning symptoms were
excluded (DCCT Research Group 1990). In addition all the patients
participating in the intensive therapy group were seen at monthly intervals in
order to achieve strict glycaemic control. These differences would explain
the higher overall frequency observed in the present study in an unselected
diabetic population.
In assessing the frequency of severe hypoglycaemia many studies have not
differentiated between the patient groups on the basis of awareness of
hypoglycaemia. In the present study the percentage of patients with normal
awareness who had experienced severe hypoglycemia (25.8%) was similar
to previous reports (DCCT Research Group 1991, MacLeod et al 1993),
but the proportion of patients with impaired awareness who had experienced
severe hypoglycaemia was significantly higher with two thirds (65.5%)
reporting severe hypoglycaemia. This proportion is comparable to that
obtained by Hepburn et al (1990) in our department in Edinburgh, in a
retrospective assessment of a group of 69 patients with impaired awareness
of hypoglycaemia from a different population of 302 insulin-treated diabetic
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patients.
Although some studies have not shown an increased incidence in severe
hypoglycaemia in intensively treated patients (Mulhauser et al 1985, Nilsson
et al 1988) others have reported an increased incidence associated with strict
glycaemic control (Barbosa and Johnson 1983, Casparie and Elving 1985,
DCCT Research Group 1993). Both of the diabetic groups in the present
study exhibited a similar quality of glycaemic control throughout the study,
and the groups were also matched for age, duration of diabetes and age at
onset of diabetes. Differences in the frequency of severe hypoglcaemia can
not be attributed to disparity in the quality of glycaemic control.
In the present study severe hypoglycaemia occurred at all times of day in the
patients with impaired awareness but more often in the evening after the
evening meal when the patients were at home. The estimate of the
proportion of severe episodes of hypoglycaemia occurring between midnight
and 8 am was lower in the patients with impaired awareness (31%) than
those patients with normal awareness (60%); 53% of all episodes of severe
hypoglycaemia occurred during sleep in the patients with normal awareness
compared with 31% of all episodes in the patients with impaired awareness
of hypoglycaemia. In the DCCT, 43% of all episodes of severe
hypoglycaemia occurred between midnight and 8am and 55 % of all episodes
occurred during sleep, although the comparative frequencies in patients with
normal awareness and impaired awareness of hypoglycaemia were not
reported. The present study confirms this increased risk of severe
hypoglycaemia occurring during sleep and reflects that even in patients with
normal awareness of hypoglycaemia during waking hours, perception of
hypoglycaemia during sleep may be impaired thereby predisposing to more
profound levels of hypoglycaemia and concomitant neuroglycopenia so
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resulting in need for external help for resuscitaion of the patient.
Previous retrospective studies have suggested that the majority of episodes of
severe hypoglycaemia can be attributed to excessive insulin dosage or to
patient error, with about a quarter being unexplained (Potter et al 1982,
Goldgewicht et al 1983, Casparie and Elving 1985, MacLeod at el 1993).
However in the present study only about half of the episodes were
explicable and this difference may be a consequence of the different methods
of collection of data.
In the present study those patients with impaired awareness of
hypoglycaemia experienced a four-fold increased risk of asymptomatic
biochemical hypoglycaemia. It has been shown that frequent episodes of
hypoglycaemia may impair counterregulation and symptomatic responses to
acute hypoglycaemia (Cryer 1992, Cryer 1993, Dagogo-Jack et al 1993).
Asymptomatic nocturnal hypoglycaemia has also been shown to influence
awareness of hypoglycaemia and reduce the counterregulatory responses to
subsequent episodes of hypoglycaemia (Veneman et al 1993). Therefore
those patients experiencing more asymptomatic episodes of biochemical
hypoglycaemia are at further risk of reduction of symptomatic and
counterregulatory responses to hypoglycaemia which may predispose them
to more episodes of severe hypoglycaemia. Thus an "acute-on-chronic"
exacerbation of pre-existing impaired awareness may occur.
Patients with impaired awareness of hypoglycaemia have been shown
previously to be more worried about hypoglycaemia than patients with
normal awareness, although they do not appear to modify their behaviour
accordingly (Hepburn et al 1992) and severe hypoglycaemia has been shown
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to occur more frequently in patients who experienced difficulty in controlling
their diabetes (Goldgewicht 1983). Similarly patients exposed to recurrent
severe hypoglycaemia have an increased level of anxiety and feel more
unhappy (Wredling et al 1992). The results of the present study are
consistent with these previous findings.
In the present survey, severe hypoglycaemia was associated with moderate
injuries requiring admission to hospital on only two occasions in a single
patient who had impaired awareness of hypoglycaemia. However no
history of hypoglycaemia-related driving accidents was elicited in any of the
patients, and the patients with impaired awareness actually reported
significantly fewer driving related accidents. This was probably a
consequence of altered driving behaviour in such patients who take increased
care when driving, and many drivers who have experienced recurrent severe
hypoglycemia had ceased driving voluntarily so reducing their risk of motor
vehicle accidents. This phenomenon has been reported previously
(Eadington et al 1989, Stevens et al 1989).
The present study confirms that diabetic patients who have the chronic form
of impaired awareness of hypoglycaemia have a six fold increase in
frequency of severe hypoglycaemia. This problem requires regular
reinforcement of education of the causes and risks of hypoglycaemia, and
continuous reappraisal of the targets of glycaemic control, in order to reduce
the frequency of this potentially dangerous complication of insulin therapy.
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In summary:-
Patients with impaired awareness of hypoglycaemia :
- have a six-fold increased risk of severe hypoglycaemia
- experience severe hypoglycaemia at all times of day in comparison to those
subjects with normal awareness who experience predominantly nocturnal
episodes
- frequently experience asymptomatic biochemical hypoglycaemia
- fear hypoglycaemia but do not modify their behaviour accordingly





PERSONALITY AND BEHAVIOURAL CHANGES IN PATIENTS WITH




A higher standard in the quality of glycaemic control has resulted from improved
treatment policies and has contributed to increased longevity and reduced frequency
and morbidity of complications of patients with insulin-treated diabetes. As a
result most patients with Type 1 diabetes now survive for more than 30 years on
insulin therapy. Diabetes mellitus is known to affect cognitive function and in
patients with Type 1 diabetes mellitus, cognitive dysfunction is probably
multifactorial in origin (Ryan 1991). However accumulating evidence suggests
that recurrent severe hypoglycaemia has a progressive, deleterious effect on
psychological and cerebral functions (Lawrence et al 1942, Murphy and Purtell
1943, Wilder 1943, Jones 1947, Fineberg and Altschul 1951, Bale 1973, Wredling
et al 1990, Langan et al 1991, Deary et al 1993a). Changes in mood, personality
and social function have been described in diabetic patients with a history of
recurrent severe hypoglycaemia (Wredling et al 1992) but the "natural history" of
these changes has not been described. Quantitative measurement in this field of
investigation is difficult and this clinical study was to provide descriptive data, with
some preliminary, semi-quantitative analysis, of changes in behaviour, personality
and intelligence which have been observed in a group of five patients with Type 1
diabetes of long duration. All of the patients had experienced multiple episodes of
severe hypoglycaemia before the development of pronounced changes in
personality and cognitive function, and it is surmised that this recurrent exposure to
severe neuroglycopenia may have contributed to the abnormalities observed.
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PATIENTS AND METHODS
A multi-faceted approach was taken, incorporating both carer-based and hospital-
based accounts in conjunction with information from standard questionnaires, in
order to obtain a balanced view of this complex problem. Investigation was
carried out by utilising four methods of approach :
1) carers' descriptive accounts of personality and behaviour changes in the
patients;
2) clinical case histories from hospital records and carers;
3) carer-based, semi-quantitative measurements of changes in behaviour and
personality.
4) measurement of premorbid and present IQ.
Five patients with Type 1 (insulin-dependent) diabetes, all of whom attended the
diabetic clinic at the Royal United Hospital, Bath, were studied and their spouses
were questioned. All of the spouses had independently identified changes in
cognitive function and personality of varying severity in their partners. These
carers have formed a self-help group to address some of the problems they are
experiencing with their partners. The establishment of this formal group drew
attention to the existence of this small cohort of patients who had similar
disabilities and in whom severe hypoglycaemia appeared to be a primary causal
factor. All of the patients had exhibited strong motivation to achieve good
glycaemic control and had attended diabetic out-patient clinics on a regular basis.
Some of the patients were so disabled intellectually that reliable information
concerning their past history and personality had to be obtained from their spouses
and from hospital case records. The presence and severity of diabetic
complications had been ascertained by Dr JP O'Hare and Dr JP Reckless their
local medical specialists and further information was extracted from hospital
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records. A retrospective assessment was made of the number of episodes of
severe hypoglycaemia and of ketoacidosis. An episode of severe hypoglycaemia
was defined as one which could not be self-treated and required help from another
person, irrespective of whether coma had occurred.
The carers were asked to complete a series of questionnaires about the individual
patients. The questionnaires, have been well validated previously and are widely
used in clinical psychology. They are intended to be answered by the patients
themselves, but in the present study, because the patients had significant
disabilities, the carers were asked to complete the questions by proxy, responding
as if they were the patient. This practice of obtaining information from
'significant others' is widely recognised to be of value in psychiatric interviews.
The following questionnaires: "cognitive function", "Nottingham Heath Profile"
and "Eysenck Personality Questionnaire" were completed twice under the
supervision of a single investigator (AEG) :
a) to assess the patient's premorbid state (before exposure to multiple episodes
of hypoglycaemia); ie to assess "how the patients used to be".
b) to assess the present situation ie to assess "how the patients are
now".
Cognitive function : a 35 item questionnaire (Thylor 1990) was used in which
questions were directed at changes in memory, concentration and comprehension
with particular reference to everyday activities:
eg - How often do you forget where things are normally kept or look for them
in the wrong place?
- How often do you have difficulty doing calculations ?
- How often do you have difficulty planning things out in advance?
Possible answers to these questions were "very often", "quite often",
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"occasionally", "very rarely" or "never", which scored from 4 to 0 respectively,
with a higher score indicating a greater number of problems.
Nottingham Health Profile Part 2 (Hunt et al 1980) : this questionnaire identifies
problems in areas of employment, domestic tasks, home life, social life, sex life
and hobbies. Statements such as "I am having difficulty concentrating at work" or
"I am going out less often these days" are answered by either "yes" or "no", and a
greater number of affirmative responses correlates with increased difficulties in that
particular area. This questionnaire has been validated as a good indicator of
"social interaction".
Eysenck Personality Questionnaire (Eysenck and Eysenck 1986) : this assessment
is used extensively to investigate personality with particular reference to three
dimensions:
a) neuroticism - a tendency to negative mood states;
b) extroversion - a tendency to being sociable, lively or outgoing;
c) psychoticism - a tendency to being "tough-minded", insensitive, with a
liking for "unusual" things and a disregard for danger.
In addition each carer was asked to complete a General Health Questionnaire
(GHQ) both for their spouse and also for themselves, recording how they felt at the
time of questioning. The GHQ identifies psychiatric morbidity, in particular any
tendency to anxiety and minor depressive states. The cut off score for the
presence of psychiatric morbidity was taken as 4/5 (Goldberg and Williams 1988).
The carers were also asked to identify specific problems that had been encountered
with their spouses.
Measurement of IQ
Those patients who were able to comply with formal IQ testing were assessed using
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the National Adult Reading Test (NART)(Nelson 1982) and the Wechsler Adult
Intelligence Scale - Revised (WAIS-R)(Wechsler 1981). The following subtests of
the WAIS-R were used for assessing verbal IQ : "information", "digit span",
"vocabulary", "comprehension" and "similarities", and for performance IQ:
"picture completion", "block design", "object assembly" and "digit symbol".
NART is an assessment of "best" global cognitive function ever attained,
irrespective of time. When this pre-morbid assessment of IQ is compared with
present IQ measured by WAIS-R, it can identify any significant deterioration
occurring over a period of years. The NART IQ estimates were adjusted by seven
points in the present study as the NART tends to overestimate the WAIS-R IQ
(Langan et al 1991). The patients were monitored by carers to ensure that they
were not hypoglycaemic at the time of testing.
Statistics
Changes between pre-morbid and present cognitive abilities, affirmative responses
in the Nottingham Health Profile, and personality traits were assessed using the




Individual case histories are described below and the characteristics of the patients
are shown in tables 4.2.1 and 4.2.2.
Case Reports
Case 1
This 66 year old man developed Type 1 diabetes in 1945 when aged 20 years.
Shortly after commencing insulin therapy, he experienced nocturnal convulsions
which at that time was diagnosed as epilepsy. In 1968, nocturnal convulsions
associated with hypoglycaemia occurred while in hospital. Frequent
hypoglycaemic episodes occurred during his initial years of insulin treatment and at
least two hypoglycaemic episodes resulted in coma and a fractured skull and on
another occasion a fractured femur. Hypoglycaemia unawareness developed after
11 years of diabetes at which time he also experienced frequent episodes of
hypoglycaemia. Several random blood glucose values were low during diabetic
clinic attendances and the patient had increased his insulin dose on several
occasions without seeking medical advice. He has been a heavy smoker and has
chronic respiratory disease.
Over 20 years ago "cerebral retardation" was first observed by his wife and
medical attendants and this has progressed to the extent that he can no longer be
left alone for long or overnight. His wife remarked "he is not the man I married".
The patient and his wife had enjoyed a close relationship, sharing ideas, problems
and emotions, but this had deteriorated because of an increasing lack of
communication. The patient was an engineer but had to retire (aged 51 years)
because of lack of concentration and poor memory. After his wife developed
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breast cancer and co-existing non-insulin dependent diabetes, he has been described
as "manipulative", particularly before being admitted to hospital for respite care.
Although he eventually acknowledged that his wife has developed diabetes he still
denies that she has malignancy. Motivation to pursue any previous interests has
been lost and he is unable to handle any financial affairs. On occasions he has
become "lost" in the local neighbourhood. His insight this has become
progressively limited.
Case 2
This 51 year old man developed Type 1 diabetes when aged 17 years. He coped
well initially with self-management of his diabetes. Random blood glucose values
were occasionally in the range of 2.0-3.0 mmol/1 and the advent of the
measurement of glycated haemoglobin revealed levels within the non-diabetic range
indicating strict glycaemic control. Loss of hypoglycaemia awareness developed
after 30 years of diabetes. He has experienced more than 100 episodes of severe
hypoglycaemia, five of which have required hospital admission because of coma
between 1967 and 1990. During severe hypoglycaemia he becomes violent and
aggressive making it impossible for his wife to treat him effectively.
His wife first noticed psychological changes when the patient was in his late 40's.
He developed fluctuating moods and was very anxious about his work
performance. He doubts his ability to cope with his job as an electrician and is
contemplating early retirement. Although the patient's ability to participate in
social and household activities has declined, communication with his wife remains
satisfactory and he has retained considerable insight into his condition.
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Case 3
This 62 year old man developed Type 1 diabetes at the age of 30 years. He had
previously been a pilot and navigator in the RAF but diabetes necessitated a change
of employment to work as an estate agent and subsequently a council senior
valuer. Random blood glucose values have been variable with several high and
low readings. Nocturnal hypoglycaemia became frequent (particularly between
1970 and 1980) and worsened when he was threatened with dismissal from work
because of poor performance. During 20 years of treatment, he has suffered more
than 20 episodes of hypoglycaemic coma, although most have been treated by his
wife. On several occasions transient hemiparesis occurred during severe
hypoglycaemia, but cerebral angiography was normal. He developed
hypoglycaemia unawareness when aged 60 years.
After 20 years of diabetes the patient's wife became concerned about an obvious
deterioration in her husband's cognitive abilities, which was associated with lack of
confidence, diminished motivation and reduced conversational skills. The time
taken to complete household tasks has increased considerably. Interests in the arts
have been retained but his ability to concentrate has decreased and he often sleeps
through a concert. The patient appreciates that he has cognitive problems, but is
reluctant to discuss them with his wife.
Case 4
This 50 year old man developed Type 1 diabetes when aged 10 years and his
mother imposed very strict control of his diabetes during childhood and
adolescence. During this time he had one episode of hypoglycaemic coma
requiring admission to hospital and missed schooling because of his diabetes. In
adult life he had three admissions to hospital in hypoglycaemic coma but has, in
addition, suffered about 10 episodes of severe hypoglycaemia per year requiring
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the intervention of his wife and emergency medical services. Since the advent of
glycated haemoglobin, most of his values have been in the non-diabetic range.
Within the last decade he developed impaired awareness of hypoglycaemia with a
predominance of neuroglycopenic symptoms.
He trained as a printing apprentice then became a lecturer at a technical college.
One year before the present assessment his wife noticed impairment of his memory
increasing irritability. The patient has experienced difficulty in coping with his
job but formal memory assessment revealed only minor abnormalities. He
resigned as church treasurer because he no longer felt able to cope with the work
or responsibility. Personal communication with his wife has remained excellent,
and he is able to discuss problems such as the prospect of taking early retirement.
Case 5
This 55 year old man developed Type 1 diabetes at the age of 32 years. On two
occasions (1982 and 1984) he required hospital admission for stabilisation of his
diabetes because of fluctuating blood glucose values. Several glycated
haemoglobin values have indicated very strict control. During the last 10 years he
has experienced about six episodes of severe hypoglycaemia. The development of
severe glaucoma with deterioration of vision necessitated his early retirement at the
age of 48 years. He developed impaired symptomatic awareness of
hypoglycaemia about four years ago.
About 10 years ago the patient's wife noticed changes in his behaviour and
intellectual abilities. Initially he appeared to have a poorer short term memory
and seemed devious, concealing dates of diabetic clinic appointments and then
pretending that he had attended. In recent years he has become garrulous,
particularly in company, although the content of his conversation often lacks logic
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and rational discussion has become difficult. He can no longer be left to
supervise his grandchildren as he actively encourages them to misbehave. His
wife is now reluctant to leave him alone more than two hours. His personal
hygiene and interest in his appearance have deteriorated while previously he
attended to these aspects with great care. His visual impairment and diabetic
cheiroarthropathy have compounded all of the above problems. A psychiatric
assessment did not identify any abnormality. He has good insight but rarely admits
to his problems except during outbursts of anger.
Carers' Assessment
All of the patients' carers had noticed behavioural changes in their partners before
the patients themselves had been aware of any difficulties. Two of the patients
(cases 2 and 4) have only recently been affected so that communication between
husband and wife is still "open" and satisfactory. However the other three carers
all commented that conversation and rational discussion with their spouses had
become very limited; all of the patients appeared to have "good days" and "bad
days". There are occasions when the patients may appear and behave "normally"
in company (for example during diabetic out-patient clinic attendance) and this had
previously interfered with attempts to convince professional attendants of their
problems. Two of the carers had given up their own jobs to spend more time
looking after their partners. Another carer who has a stressful job, felt that the
demands being made at home had compromised her work and have necessitated her
resignation. All of the couples have had to reduce their social activities either
because the patients tire rapidly or because the patients display a complete lack of
interest. The carers have tried not to expose their partners to situations which are
stressful or potentially embarrassing to both. With the exception of cases 2 and 4
all carers had found that holidays away from home were stressful and were seldom
appreciated by the patients. All of the carers had attempted to continue pursuing
their personal interests and maintain attendance at social events. Carer 1 found
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respite care to be very helpful and carer 3 employs a person to look after her
husband, so that she can have weekends away from home.
The carers' group was well informed about financial benefits such as attendance
allowance. They expressed that their principal desire was to have medical
recognition of the extent and nature of their problems and to help others with
similar problems. The psychological support obtained from other members of the
group was considered to be of great value. With the exception of carer 2, the
carers did not find that management of the patients' diabetes, including the
treatment of hypoglycaemia, presented any significant difficulties. The major
concerns of the carers were how the patients would be looked after if the carer was
ill or if the patient could no longer be left alone at any time.
When asked about changes in their own mood, four out of the five carers said they
had become more irritable, depressed and anxious. Their responses to the
General Health Questionnaire are shown in table 4.2.3.
Results of Personality and Cognitive Assessments
1. Cognitive function questionnaire - (table 4.2.4). Carers' estimates of
premorbid and present cognitive function indicated that the patients had significant
changes in cognitive abilities (p=0.04), suggesting that increased difficulties with
concentration and memory in daily activities had occurred.
2. Nottingham Health Profile - (table 4.2.5). In the premorbid assessment only
one carer identified any problems with their spouse in the spheres of employment,
household activities, home-life, social life and hobbies. However, in the
assessment of current problems at the time of questioning, all carers could identify
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some difficulties with their spouses in the areas of employment, household
activities, home life, hobbies and sex life and four of the five carers identified
problems with the patients' social life.
3. Eysenck Personality Questionnaire - Answers from four out of five carers
revealed that their spouse showed an increase in neuroticism and all five carers
observed a decrease in extraversion. Table 4.2.6 and figure 4.2.1 indicate that
comparison of pre-morbid and present scores showed a tendency towards an
increase in neuroticism and a decrease in extraversion although psychoticism was
not greatly changed. The "lie" score which attempts to measure a tendency on the
part of some subjects to "fake good", was unchanged which suggests that carers did
not have an unrealistic "ideal" view of their spouses premorbid personality.
Overall, this suggests that the patients appeared to have a tendency to experience
more "negative" mood states and had become less sociable following multiple
episodes of severe hypoglycaemia.
4. General Health Questionnaire - (table 4.2.3) Carers' assessments suggested
that psychiatric morbidity, in particular a tendency to anxiety, was present in all
the patients and was evident also in three of the five carers.
5. Intelligence - (table 4.2.7) Only three of the five patients were able to
cooperate fully in the testing of both NART and WAIS-R; two of these patients
exhibited a marked decline both in verbal and performance IQ (ie difference
between the NART and WAIS-R scores. Patient 5 refused to do the NART and
patient 1 refused to do one section of both the verbal and performance sections in
the WAIS-R.
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TABLE 4.2.3
RESULTS OF CARERS' ASSESSMENTS OF PRESENT PSYCHIATRIC





2 * 8 *14
3 *11 3
4 * Q *11
5 *17 1
*
- suggests psychiatric morbidity
TABLE 4.2.4
RESULTS OF CARER'S ASSESSMENTS OF CHANGES IN PATIENTS'
COGNITIVE FUNCTION (higher scores equate with impairment of function)







Median 31 85 p = 0.04
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TABLE 4.2.5
RESULTS OF CARER'S ASSESSMENTS OF PATIENTS' SOCIAL
FUNCTIONING USING THE NOTTINGHAM HEALTH PROFILE (scored
as number of affirmative replies to problems in each area)
PREMORBID PRESENT
SCORE SCORE
median median p value
Areas affected:
Work 0 3 0.07
Household activities 0 3 0.04
Home life 0 3 0.07
Social life 0 3 0.1
Hobbies 0 2 0.04
Sex life 0 1 0.07
TABLE 4.2.6
RESULTS OF CARERS' ASSESSMENTS OF PATIENTS PRESENT AND
PREMORBID PERSONALITIES USING
THE EYSENCK PERSONALITY QUESTIONNAIRE
PREMORBID PRESENT
SCORE SCORE
median median p value
Neuroticism 8 14 .08
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FIGURE 4.2.1
DIAGRAM TO SHOW CHANGES IN PERSONALITY IN INDIVIDUAL
PATIENTS AS ASSESSED BY CARERS USING EYSENCK PERSONALITY




The pathogenesis of cerebral dysfunction in diabetes may be multifactorial.
Premature vascular disease may present as multi-infarct dementia and patients with
diabetic neuropathy have been shown to exhibit changes in cognitive function
(Ryan et al 1992). It is possible that metabolic disturbances such as
hyperglycaemia and hypoglycaemia interact with co-existing vascular disease in
promoting cognitive and psychological dysfunction in diabetic patients (Ryan et al
1993). This putative multifactorial aetiology, in association with the difficulties of
assessing changes in cognitive function and personality in brain damaged patients,
presents difficulties for investigation in this area, and few studies have been
reported. In the present study of a small self-selected group of diabetic patients it
was felt that a "multi-faceted" approach to assessment would be the most practical
method to address and define the nature of these problems.
The present report describes five patients with Type 1 diabetes, who had a history
of multiple episodes of severe hypoglycaemia and minimal evidence of vascular
disease at the time their cognitive problems commenced. Changes in cognitive
function were identified and significant difficulties were revealed with particular
reference to daily activities and social function in association with psychiatric
morbidity and personality changes. The contribution of other medical disorders is
difficult to assess. In patient 1 possible chronic epilepsy, and obstructive airways
disease may have contributed to the impairment of cognitive function through
effects of medication (Thompson and Trimble 1982, Meador et al 1990), cerebral
ischaemia and hypoxia, and other chronic diseases, such as glaucoma resulting in
blindness (patient 5), may have compounded the changes in personality that were
observed. Although some of these patients had developed peripheral neuropathy,
the cognitive changes predated the development of overt neuropathy, although this
does not preclude early insidious damage or the development of a central
neuropathy (Dejgaard et al 1991). Glycaemic control in many of these patients
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appeared to have been very strict for several years despite the attempts of their
medical attendants to encourage relaxation of glycaemic control, which is
recognised to predispose to an increased frequency of severe hypoglycaemia
(DCCT 1991, DCCT 1993). In addition the period of strict glycaemic control
took place at a time when this was not a universal policy in diabetic management.
It is feasible that a contributory factor to the induction of cognitive dysfunction was
the exposure to recurrent severe hypoglycaemia in many of these patients.
Hypoglycaemia of varying severity is a common side effect of insulin therapy in
diabetic patients. The frequency of mild to moderate hypoglycaemia is difficult to
estimate with accuracy unless monitored prospectively, but retrospective estimates
of the frequency of episodes of severe hypoglycaemia are more robust (Pramming
et al 1991) and have ascertained with reliability (MacLeod et al 1993). It has been
estimated that at some time during treatment with insulin 30% of diabetic patients
experience a hypoglycaemic coma, while 10-20% of patients experience coma once
a year, and 3% of patients suffer severe recurrent hypoglycaemia (Gale 1986).
The patients in the present cohort probably fall within this last group. Chronic
impairment of awareness of hypoglycaemia is associated with an increased
frequency and morbidity from severe hypoglycaemia (Hepburn et al 1990; see Part
IV Chapter 1). Most of the patients in the present study had some degree of
reduced awareness of hypoglycaemia which probably contributed to their history of
frequent severe hypoglycaemia, although the fact that many of the severe episodes
of severe hypoglycaemia pre-dated the onset of changes in awareness of
hypoglycaemia would also support the hypothesis that impaired awareness of
hypoglycaemia per se results from recurrent exposure to hypoglycaemia (Clarke
et al 1991). The morbidity of some of the episodes of hypoglycaemia was
significant with three of the patients giving a history of transient hemiplegia, skull
fracture or convulsions, all of which may have contributed to the subsequent
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development of cerebral dysfunction.
Personality and cognitive changes occurring as a result of recurrent hypoglycaemia
have been described previously in patients with diabetes (Murphy and Purtell 1943,
Wilder 1943, Jones 1947, Fineberg and Altschul 1951, Bale 1973, Wredling et al
1990, Langan et al 1991), but data is limited. Changes in IQ following severe
hypoglycaemia have been documented in patients with Type 1 diabetes (Langan et
al 1991, Deary et al 1993a). Langan and colleagues (1991) found a difference in
the IQ decrement of 5.8 points in performance IQ in insulin-treated diabetic
patients who had experienced five or more episodes of severe hypoglycaemia
compared with no IQ decrement in patients without recurrent hypoglycaemia. The
same diabetic patients had lower WAIS-R performance and verbal IQ scores
when compared with a matched control group of 100 non-diabetic subjects (Deary
et al 1993a) but after controlling for the frequency of severe hypoglycaemia, the
performance IQ was similar in the diabetic and the control groups while a
significant difference in verbal IQ persisted. This suggests that performance IQ
may be reduced by previous exposure to severe hypoglycaemia while the lower
verbal IQ in the diabetic patients may be attributable to other factors such as the
social impact of the disorder. In the present study, only three of the five patients
were able to cooperate fully with cognitive testing which suggests that some form
of personality/cognitive impairment per se may be present. NART is not an
accurate measure of pre-morbid IQ in subjects of high intelligence and therefore
the results obtained from patient 3 are unreliable (Nelson 1982). The other
patients did however exhibit changes in both verbal and performance IQ suggesting
that not only may hypoglycaemia have had an effect on their performance IQ but
their lower verbal IQ may reflect some of the social problems which they had
encountered.
The patients in this study represented a group which had been selected through
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their carers. The carers constitute an educated and articulate group who are able to
identify the nature of the problems and voice their anxieties. This introduces an
additional selection bias; the patients may not be typical of the diabetic population
as a whole, and comparison with an "appropriate" control group is unlikely to be
meaningful. Most of these patients had a high pre-morbid intelligence and had
held jobs which required training and skills. In such patients the cumulative
effects of recurrent cerebral injury, of whatever aetiology, may be more apparent
than in a group of patients who have a lower pre-morbid intelligence and more
limited cognitive abilities. In addition the effect of "chronic disease" per se in
causing cognitive and personality changes is unknown. A further problem with
studying patients who have such changes in personality and cognitive function is
that data obtained from the patients may not be accurate and the spouses may
provide different information. In addition it has to be acknowledged that
information from the carers may be biased as they have been exposed to the
problem for many years, so encouraging their desire to promote greater awareness
and acknowledgement that cognitive dysfunction and personality change may be
complications of diabetes and severe hypoglycaemia.
The questionnaires had previously been validated for use on patients and required
only minor changes for adaptation to use with the carers. Very few pre-existing
questionnaires have addressed a carer's assessment or opinion of any changes
evident in the patients with whom they live. Premorbid personality assessment is
also extremely difficult and at present no validated measures of this entity exist.
A well validated personality questionnaire was therefore used and adapted for each
carer's assessment of premorbid personality, as patients are unlikely to identify
their own changes in personality with accuracy. However the results of the
personality questionnaires do exhibit descriminant validity, because, while the
neuroticism scores increased and the extraversion scores decreased, the
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psychoticism scores were unchanged and the "lie score" actually decreased.
Loss of employment through dismissal or inability to cope with a job, was a major
problem for the patients in the present study. Patients with demanding
occupations requiring intellectual skills may be disproportionately affected. Early
retirement has invoked personal resentment and loss of self esteem, which may
compound the established neuropsychological disability. A Swedish study
(Wredling et al 1992) of diabetic patients with a history of recurrent severe
hypoglycaemia found that such patients exhibited higher anxiety and lower
happiness ratings compared to a control group of diabetic patients who had no
history of severe hypoglycaemia. In that study (Wredling et al 1992) the patients
had rated their own degree of neuroticism which was not found to differ between
the groups, in contrast to the present study.
The frequency of these type of cognitive and behavioural changes in the insulin-
treated diabetic population is unknown. It is possible that many patients have
more subtle impairments and most physicians with large diabetic clinics may be
able to identify patients with similar disabilites. The spectrum of cognitive
dysfunction may be wide, and in the majority of patients cognitive and personality
changes may be relatively minor or may be detectable only by close relatives.
The present group probably represent a more extreme end of the spectrum of
disability with severe cognitive dysfunction resulting in adverse effects on the
lifestyle of the patients and their carers , with family and social life suffering
considerably. Many of the spouses of such patients confess to enduring a "living
bereavement", observing their partners to have lost their intellect, charisma and
sense of humour and to have developed a child-like dependence akin to the
problems associated with premature senility or Alzheimer's disease. This
forgotten minority of carers are in need of support, and deserve medical
recognition of the chronic problems with which they have to cope. In the UK,
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there are at present no guidelines for carers to assist with the management of
patients with insulin-treated diabetes who have any form of mental handicap. The
activities of the group of carers in Bath highlighted the necessity for the production
of such information and this has been recognised by the British Diabetic
Association. It is important that in every diabetic patient the quality of glycaemic
control is optimised to avoid severe hypoglycaemia, a goal which is much more
difficult to achieve in patients who have sustained personality changes and
cognitive deficits. Prospective studies both in newly diagnosed diabetic patients
and patients with long-standing diabetes, to examine changes in personality and
cognitive dysfunction, are required to define the nature of such problems with
greater precision, particularly in those at increased risk of severe hypoglycaemia.
This was unfortunately not addressed by the Diabetes Control and Complications




CONCLUSIONS AND FUTURE RESEARCH
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The conclusion of the Diabetes Control and Complications Trial in the USA
(DCCT 1993) has provided unequivocal evidence that strict glycaemic control in
patients with Type 1 diabetes, retards the progression of diabetic microangiopathy.
These findings have major implications for the management of patients with Type 1
diabetes, both in the day to day clinical management of such patients and in the
organisation and delivery of diabetic care. However, in order to achieve the
levels of glycaemic control in the DCCT, monthly outpatient review visits were
required and frequent medical contact with the patients was maintained, which
clearly would be a major imposition on limited specialist resources if strict
glycaemic control was to be attempted in all patients with Type 1 diabetes. Even
with close medical supervision the incidence of severe hypoglycaemia was
increased threefold in those patients on receiving intensive insulin therapy.
Therefore, the institution of intensive insulin therapy without frequent reassessment
and close supervision of the patient may lead to an unacceptably high incidence of
severe hypoglycaemia. The DCCT neither included patients with impaired
awareness of hypoglycaemia nor patients with a previous history of recurrent
severe hypoglycaemia (DCCT 1990). In such patients, who are already at an
increased risk of severe hypoglycaemia (Hepburn et al 1990), if intensive insulin
therapy predisposes to further hypoglycaemia, the resultant morbidity from such
episodes may well outweigh the potential benefits obtained from intensive insulin
therapy.
If the recommendations from the DCCT (DCCT 1993) are to be implemented on a
wide scale it is mandatory that we continue to research and establish the risks and
complications of hypoglycaemia in patients with Type 1 diabetes, particularly
those at increased risk of hypoglycaemia. The studies outlined in the present
thesis have attempted to address some of these problems.
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Acute Hypoglycemia and Cognitive Function
The studies described in this thesis provide further information about the nature
and degree of cognitive dysfunction experienced during acute hypoglycaemia.
Two of these studies were performed in non-diabetic subjects, and although the
results cannot be directly applied to patients with insulin-treated diabetes, it was
essential that these studies were performed before attempting to address the
problems in diabetic patients. From the results of these studies it appears that
short term cerebral adaptation to hypoglycaemia does not occur in non-diabetic
humans and that IQ only plays a minor role in determining the degree of cognitive
dysfunction experienced during acute hypoglycaemia in non-diabetic individuals.
Both of these studies should be repeated in larger cohorts of subjects and in patients
with insulin-treated diabetes. In addition, more specific areas of cerebral
functioning require further investigation eg. the effect of hypoglycaemia on visual
function.
Patients with insulin-treated diabetes who have impaired awareness of
hypoglycaemia appear to be at a greater risk of cognitive dysfunction during acute
hypoglycaemia. This is important in the management of insulin-treated diabetes; it
emphasises the need for individualisation of treatment regimens in order to
minimise the risks and morbidity associated with hypoglycaemia. Insulin
regimens need to be tailored to the patients' physical activities and working
conditions, and also the potential risk to employment which may result in patients
with excessively strict glycaemic control and chronic impaired awareness of
hypoglycaemia will need to be assessed. There is a need for the continued
education of all health professionals involved in the care of diabetic patients in
order that the necessary information can be relayed to the patients.
Mood changes during acute hypoglycaemia have not previously been studied. The
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hyperinsulinaemic hypoglycaemic glucose clamp not only provides an important
research tool to investigate mood states, but also demonstrates the deleterious
effects of hypoglycaemia on patients' feeling of wellbeing, which may influence
their desire and willingness to achieve strict glycaemic control.
Changes in cerebral blood flow during hypoglycaemia may be an adaptive
mechanism to preserve cerebral function. However the interactions between
cerebral blood flow, cerebral glucose transporters and glucose metabolism remain
unclear and further analysis of functional brain glucose uptake and metabolism is
required, possibly using alternative techniques such as positron emission
tomography (PET).
Recurrent Hypoglycaemia and Cognitive Function
Patients with insulin-treated diabetes who suffer from any form of cognitive
impairment pose a problem to their health professionals as well as to their carers.
Adjustment of insulin doses and monitoring blood glucose require patience and
skill in patients with normal cognitive ability, and will be therefore be that much
more difficult in patients with impaired ability. The study of the carers from Bath
illustrates many of these problems and demonstrates the need for greater
understanding and support for such carers. In addition there is accumulating
evidence to suggest that recurrent severe hypoglycaemia is deleterious to cognitive
function. Although the DCCT (DCCT Research Group 1993) and SDIS (Reichard
et al 1991) showed no effect on cognitive function, there are as yet no large studies
which have attempted to follow patients prospectively for more than 10 years,
particularly those at greatest risk of hypoglycaemia (eg those with impaired
awareness), and to assess any changes in cognitive function.
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The prevention of hypoglycaemia coupled with near normal glycaemic control is
the ultimate goal in the management of patients with diabetes. Further
refinements in the administration of insulin may help achieve this, although until
such treatment is readily and easily available the risk to benefit ratio of
complications resulting from poor glycaemic control and hypoglycaemia must be




SUBJECT EXPLANATION SHEET FOR STUDY 1, STUDY 2 AND STUDY 5
INFORMATION FOR SUBJECTS
Study - To examine whether the brain can adapt to a low blood sugar level
This study is designed to examine adaptive changes in brain function made in response to a low
blood sugar.
During the study, we will lower your blood sugar by giving you an infusion of short acting
(soluble) insulin and on an infusion of sugar solution (dextrose) through a cannula (drip) in to
one of the veins in your forearm. Insulin is a naturally occurring chemical (or hormone) which
is produced in the pancreas, which lowers blood sugar and is used to treat diabetes. The
insulin infusion will be continued throughout the study and the infusion of dextrose will be
varied to control the blood sugar level. The blood sugar will be lowered to 2.5mmol/l and
restored to normal after one hour, the level of the blood sugar will be carefully controlled by
frequent measurement of blood sugar and adjustment of the rate at which dextrose is given.
Symptoms such as sweating, tremor, palpitations, warmness, lightheadedness, dizziness and
inability to concentrate may develop at the low level of blood sugar.
Your IQ will be tested before the study by some simple tests. There will be 3 separate parts to
the study performed on different days in random order. On one occasion, we will perform
tests of your intellectual function with a normal blood sugar. On the other two occasions we
will perform tests of your intellectual function with a lower sugar, doing the tests at different
times throughout the study, to examine whether the length of time which the blood sugar is low
influences the brain function. You will not be aware of the order of the tests.
Blood pressure and heart rate will be recorded during the studies. We will also take blood
samples through a sepiarate cannula in a different vein to measure your blood sugar level. The
study will last approximately 2'A hours. We will ask you to attend on one occasion before the
studies commence to familiarise yourself with the type of tests of intellectual function we will
be performing.
This is a research study which is of no personal benefit to yourself. If you decide at any time
that you no longer want to participate and wish to withdraw, the study will be terminated
immediately.
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PATIENT EXPLANATION SHEET FOR STUDY 3
INFORMATION FOR PATIENTS
Study - To examine whether the brain function of diabetic patients who have symptomatic
loss of awareness of hypoglycaemia are more affected by a low blood sugar level.
This study is designed to examine the effect of inability to perceive the symptoms of low blood
sugar on how the brain is able to cope with mental tests during a period of having a low blood
sugar.
During the study, we will lower your blood sugar by giving you an infusion of short acting
(soluble) insulin and on an infusion of sugar solution (dextrose) through a cannula (drip) in to
one of the veins in your forearm. Insulin is a naturally occurring chemical (or hormone) which
is produced in the pancreas, which lowers blood sugar and is used to treat diabetes. The
insulin infusion will be continued throughout the study and the infusion of dextrose will be
varied to control the blood sugar level. The blood sugar will be lowered to 2.5mmol/l and
restored to normal after one hour, the level of the blood sugar will be carefully controlled by
frequent measurement of blood sugar and adjustment of the rate at which dextrose is given.
Symptoms such as sweating, tremor, palpitations, warmness, lightheadedness, dizziness and
inability to concentrate may develop at the low level of blood sugar although some patients will
be selected for this study because they have lost some or all of their usual symptoms for
hypoglycaemia.
Before the study we will measure your IQ with simple tests. We will then perform tests of
your intellectual function before, during and after a period of a low blood sugar level.
Blood pressure and heart rate will be recorded during the studies. We will also take blood
samples through a separate cannula in a different vein to measure your blood sugar level. The
study will last approximately 2 hours. We will ask you to attend on one occasion before the
studies commence to familiarise yourself with the type of tests of intellectual function we will
be performing.
This is a research study which is of no personal benefit to yourself. If you decide at any time
that you no longer want to participate and wish to withdraw, the study will be terminated
immediately.
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PATIENT EXPLANATION SHEET FOR STUDY 4
INFORMATION FOR PATIENTS PARTICIPATING IN THE
HYPOGLYCAEMIA/SPET SCANNING STUDY
This study is designed to examine the effect of lowering blood sugar below normal levels
(hypoglycaemia) on blood flow in the brain.
During the study we will lower your blood sugar below normal by giving you an infusion of
short-acting (soluble) insulin and an infusion of sugar solution (dextrose) through a cannula
(drip) into one of your forearm veins. Insulin is a naturally occurring chemical (or hormone)
which is produced in the pancreas, which lowers blood sugar and is used to treat diabetes. The
insulin infusion will be continued throughout the study and the infusion of dextrose will be
varied to control the blood sugar level, lowering the blood sugar to 2.5 mmol l"1 and then
restoring it to normal after 30 minutes. The level of the blood sugar will be carefully
controlled by frequent measurements of blood sugar and adjustment of the dextrose infusion
rate. Symptoms such as sweating, tremor, palpitations, warmness, lightheadedness, dizziness,
and inability to concentrate may develop, although some patients will be selected for this study
because they have lost some or all of their usual symptoms of hypoglycaemia.
Before the blood sugar is lowered, the blood flow through the brain will be measured using a
scanner machine which detects gamma rays which will be released from a small amount of
radioactive tracer injected into an arm vein (thorough a cannula). One scan will be performed
when the blood sugar is normal and this will be repeated when the blood sugar has been
lowered below normal. The total radiation dose is approximately equivalent to a kidney X-ray
(intravenous urogram).
In order to take the scan the subject lies on a couch, and the scan is taken by a camera behind
the head. It is exactly like having one's picture taken by a camera but it takes much longer
(about 40 minutes in all) and it is necessary to lie as still as possible. Most people find it quite
comfortable but a member of staff will be close by at all times and you can talk to them and
stop the scan if you are becoming physically uncomfortable. Considerable experience has been
obtained with these scans both in Edinburgh and Glasgow and the same method is used all over
the world. The tracer used in the scan gives off energy like X-rays. It has been used for many
years and is licensed for safe use in medicine.
In addition during the study we will do a few simple tests to assess any changes in intellectual
functon during hypoglycaemia. On another day we will ask you to return and undergo these
tests while your blood sugar is maintained at a normal level using a combined infusion of sugar
and insulin; however in this day we will need to do the brain scan.
As well as measuring the blood flow in the brain using the scanner, we will measure your
heart rate and blood pressure several times during the study. We will also take blood samples
through a separate cannula in a different vein to measure your blood sugar level and some
other important hormones. The study will last approximately L-hours.
This is a research study which is of no personal benefit to yourself. If you decide at any time
that you no longer want to participate and wish to withdraw, the study will be terminated
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SYMPTOM QUESTIONNIARE USED IN CLAMP STUDIES
symptom scores
name : time :
not atall a great deal




















UWIST MOOD ADJECTIVE LIST USED IN CLAMP STUDIES
Matthews Self-Assessment Scale
This mood scale is designed io assess your raced at this tpomcatin time. That meant you are
required to answer the items exactly as you feel just now - don't answer them according to how
you normally feel. It is your present state of mind that is important here.
Please circle the answer (1. 2, 3, or 4 ) that you feel applies to you, for each of the adjectives listed
ie 2. If you feel slightly anxious, then circle number 2 on that item).
Remember to answer all of the items. Work quickly, and don't take too long to think about each
item.
DEFINITELY SLIGHTLY SLIGHTLY DEFINITELY
NOT NOT
Cheerful 1 2 3 4
Anxious 1 2 3 4
Vigorous 1 2 3 4
Nerjous 1 2 3 4
Happy 1 2 3 4
Uneruerprising 1 2 3 4
Jittery 1 2 3 4
Dissatisfied 1 2 3 4
Sluggish 1 2 3 4
Contented 1 2 3 4
Calm 1 2 3 4
Sad 1 2 3 4
Restful 1 2 3 4
Active 1 2 3 4
Satisfied 1 2 3 4
Tired 1 2 3 4
Depressed 1 2 3 4
Alert 1 2 3 4
Tense 1 2 3 4
Composed 1 2 3 4
Energetic 1 2 3 4
Sorry 1 2 3 4
Relaxed 1 2 3 4




NAME : TEST NO. :
TIME :
2
7(9) ... ... 9(11) ... ... 2 (8)
3(10) ... ... 7(16) ... ... 7(9)
4(7) ... ... 6(13) ... ... 5(12)
8(12) ... ... 5(11) ... ... 9(14)
1 (9) ... ... 8(13) ... ... 2(11)
5(6) ... ... 1(9) ... . ... 3 (5)
6(11) ... ... 4(5) ... ... 9(12)
9(15) ... ... 1(5) ... ... 7(16)
1 (10) ... ... 2(3) ... ... 4(11)
3(4) ... ... 6(8) ... . 5(9)
6(9) ... ... 3(9) ... . ... 7(12)
4(10) ... ... 7(10) ... ... 6(13)
3(7) ... ... 5(12) ... ... 8(14)
2(5) ... ... 8(13) ... ... 1 (9)
7(9) ... ... 3(11) ... ... 3(4)
8(15) ... ... 9(12) ... ... 1 (4)
5(13) ... ... 1 (10) ... ... 9(10)
9(14) ... ... 4(5) ... ... 2(11)
4(13) ... ... 8(12) ... ... 5(7)
2(6) ... ... 6(14) ... ... 6(11)




DIGIT SYMBOL SUBSTITUTION TEST
7. DIGIT [T] 2 3 4 5 6 7 8 9SYMBOL
— ± □ L U 0 A X
SAMPLES
2 1 3 7 2 4 8 1 5 4 2 1 3 2 1 4 2 3 5 2 3 1 4 6 3
1 5 4 2 7 6 3 5 7 2 8 5 4 6 3 7 2 8 1 9 5 8 4 7 3
6 2 5 1 9 2 8 3 7 4 6 5 9 4 8 3 7 2 6 1 5 4 6 3 7
9 2 8 1 7 9 4 6 8 5 9 7 1 8 5 2 9 4 8 6 3 7 9 8 6
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PATIENT EXPLANATION SHEET FOR STUDY 7
HYPOGLYCAEMIA SURVEY- Patient Explanation Sheet
Study of patient awareness of hypoglycaemia or "hypos"
After a few years of treatment with insulin some patients find that their "hypos" change so that
the warning symptoms of hypoglycaemia , or low blood sugar , which they experience are
altered or fewer symptoms occur and the symptoms become much less intense. A previous
study which asked patients to recall the nature of their hypos over the previous few months
showed that patients with altered symptoms experienced a greater number of hypos than
patients with normal symptoms. In particular, the patients with altered symptoms, or loss of
awareness of hypoglycaemia, appeared to have hypos of greater severity and were therefore
more susceptible to personal injury or accidents. In order to gain accurate information about
this problem, we will ask patients to record their hypos as they occur rather than asking them
to try to remember details of events which happened several weeks or months earlier. This
will help us to build up information about why some patients experience a loss of their
symptoms of hypoglycaemia and how much this affects their lifestyle. Before commencing this
survey we will ask you some questions about the type of symptoms which you usually
experience during a "hypo".
During the period of the survey (12 months) you will be asked to fill in a record form for each
hypo as well as recording blood glucose on a regular basis as you do at present . We will
also continue to check for the development of any complications associated with your diabetes
(eg eye , foot , or kidney problems) as we do on a routine basis at the clinic. If you do have a
severe hypo it would be most helpful if a relative , friend or other observer who is with you at
the time would also complete the questionnaire, as witnesses are often able to give a more
detailed account of what has happened during a hypo.
I will review patients personally in the clinic on regular basis to collect blood glucose data and
any reports of hypos which have occurred.
If at any time you wish to withdraw from the study you are free to do so. All information
provided will be treated as confidential.
Dr. Ann E. Gold , Research Registrar.
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SYMPTOM ASSESSMENT FOR STUDY 7 (1)
13. When you started on treatment with insulin , which of the following symptoms did you
have during a hypo ? :
Please tick which affect you and in addition indicate with a cross which of these
symptoms are the most important warning to you that a hypo is occurring.
Not at all A great deal





















SYMPTOM ASSESSMENT FOR STUDY 7 (2)
14. At the present which of the following symptoms do you have during a hypo :
Please tick which symptoms apply to you and in addition indicate with a cross which of
these symptoms are the most important to you as warning of a hypo.
Not at all A great deal
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P125. The effect of altered awareness of
hypoglycaemia on cognitive function during
acute hypoglycaemia in patients with insulin-
dependent diabetes.
Gold A. E.,a MacLeod K. M.,a Deary I. J.,b Frier B. Ma
department of Diabetes, Royal Infirmary, Edinburgh
and "department of Psychology, University of
Edinburgh.
Cognitive function was examined in 20 IDD patients: 10 had
normal awareness of hypoglycaemia (group 1) and 10 had
altered awareness of hypoglycaemia (group 2). The groups
were matched for age, intelligence, glycaemic control, age
of onset and duration of diabetes. The following cognitive
function tests: Rapid Visual Information Processing (RVIP),
Trail Making B (TMB), Paced Auditory Serial Addition Test
(PASAT) and Digit Symbol Substitution Test (DSST) were
measured during: a) euglycaemia (4.5 mmol M), b) hypo¬
glycaemia (2.5 mmol I"1) and c) restoration of euglycaemia
(4.5 mmol I"1) achieved with a hyperinsulinaemic glucose
clamp. A normoglycaemic control study (4.5 mmol I"1) was
performed on another day. Multivariate analysis of variance
demonstrated a significant difference in performance in all
the tests in the hypoglycaemic study compared with the
normoglycaemic control study (p < 0.01). A trend towards
an overall effect of awareness on performance was observed
(p = 0.08). Although performance at baseline did not differ
between the groups, group 2 showed a tendency to
perform more poorly during hypoglycaemia (RVIP correct
responses p = 0.08) and their performance remained signifi¬
cantly impaired following recovery from hypoglycaemia
compared to group 1 (TMB p = 0.04 and RVIP correct
responses p = 0.02). Thus, IDD patients with altered awareness
of hypoglycaemia exhibited more profound and protracted
cognitive dysfunction during and after acute hypoglycaemia.
Diabetic Medicine 1993; 10 suppl 1: S45.
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P126. Prospective assessment of the frequency
of severe hypoglycaemia in insulin-dependent
diabetic patients (IDDM) with altered
awareness of hypoglycaemia.
Gold A. E., MacLeod K. M., Frier B. M. Department of
Diabetes, Royal Infirmary, Edinburgh.
Diabetic patients with altered awareness of hypoglycaemia
are reported to have an increased frequency of severe
hypogiycaemia, when assessed retrospectively. 57 IDDM
patients were studied prospectively for 12 months: 29 having
altered awareness of hypoglycaemia (group A) and 28
retaining normal awareness of hypoglycaemia (group B). The
groups were matched for age, age of onset of diabetes,
duration of diabetes and glycaemic control. Episodes of
severe hypoglycaemia were recorded within 24 hours of the
event. Nineteen (66%) of patients in group A had one or
more episodes of severe hypoglycaemia in 12 months with
an overall incidence of 2.8 episodes per patient per year.
Group B had significantly fewer episodes of severe hypo¬
glycaemia with 7 (25%) of the patients experiencing one or
more episodes and an incidence of 0.4 episodes per
patient per year (p<0.001). The time of day of severe
hypoglycaemia differed between the two groups: group A
patients experienced a greater proportion of episodes in the
evening (p = 0.05) and tended to have a smaller proportion of
episodes overnight (p = 0.09) than group B. This prospective
evaluation confirmed that altered awareness of hypogly¬
caemia predisposes to more episodes of severe hypogly¬
caemia, many of which occur at home during waking hours.
Diabetic Medicine 1993; 10 suppl 1: S45.
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A32. Preservation of the regional cerebral
blood flow responses to hypoglycaemia in
patients with Type 1 diabetes who have
diminished awareness of hypoglycaemia.
MacLeod K. M.a, Cold A. E.a, Ebmeier K.c,
Hepburn D. A.a, Deary I. j.b, Dougall N.c, Murray C.c,
Goodwin G.c, Frier B. Ma. department of Diabetes,
Edinburgh Royal Infirmary, department of Psychology,
University of Edinburgh and cMRC Brain Metabolism
Unit, Royal Edinburgh Hospital.
Regional cerebral blood flow (rCBF) was examined in 20
Type 1 diabetic patients, 10 of whom had normal awareness
of hypoglycaemia (group 1) while 10 had diminished
hypoglycaemia awareness (group 2). rCBF was determined
sequentially during 1. normoglycaemia (blood glucose con¬
centration 4.5 mmol I"1) and 2. hypoglycaemia (2.5 mmol I"1)
induced with a hyperinsulinaemic glucose clamp technique.
The distribution of the isotope 99mTechnetium-Exametazime
was detected using a single slice multi-detector head
scanner, employing a split-dose technique, with 250 MBq
injected during steady-state normoglycaemia and 250 MBq
during hypoglycaemia. rCBF was estimated in 30 regions of
interest, derived from a standard neuroanatomical atlas, on
two parallel slices at 35 and 55 mm above the orbito-meatal
line. In comparison with the rCBF during euglycaemia, both
patient groups demonstrated a significant alteration in the
pattern of rCBF during hypoglycaemia with an increase in
regional blood flow to both frontal cortices (weighted mean
average blood flow 1.01 vs 1.07 and 1.00 vs 1.05 for the right
and left cortex respectively; both p<0.01); an increased flow
to the right thalamus (1.02 vs 1.11; p<0.01) and reduced flow
to the right posterior cingulate cortex (1.03 vs 0.95; p = 0.05)
and the right putamen (1.06 vs 0.98; p = 0.03). No between
group differences in the pattern of regional cerebral blood
flow were demonstrated during hypoglycaemia. In conclusion
the pattern of changes in regional blood flow during
hypoglycaemia is preserved in those with diminished
hypoglycaemia awareness.
Diabetic Medicine 1993; 10 suppl 1: S9.
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Cognitive Function During Acute
Hypoglycemia in Patients with Insulin-
Dependent Diabetes and Altered Awareness of
Hypoglycemia, ANN E GOLD, KENNETH M
MACLEOD, IAN J DEARY and BRIAN M FRIER",
EDINBURGH, UK.
Cognitive function was examined in 20 Type 1 diabetic
patients, 10 of whom had normal awareness of the onset
of hypoglycemia (group 1) while 10 had altered
awareness of hypoglycemia (group 2). A
hyperinsulinemic glucose clamp was used to produce the
following conditions: (a) euglycemia (blood glucose
concentration 4.5 mmol/1), (b) hypoglycemia (2.5mmol/l)
and (c) restoration of euglycemia (4.5mmol/l). On
another day a normoglycemic control study was
performed (4.5mmol/l). Cognitive function was
assessed using Rapid Visual Information Processing
(RVIP), Trail Making B (TMB), Paced Auditory Serial
Addition Test (PASAT) and Digit Symbol Substitution
Test (DSST). Multivariate analysis demonstrated a
significant difference in performance in the hypoglycemic
study compared with the normoglycemic control study
(p<0.01). There was a trend towards an overall effect
of awareness on performance (p=0.08). Further analysis
of the individual tests demonstrated a significant effect of
awareness on RVIP correct responses across time
(p=0.05) and an interaction of awareness by study by
TMB (p=0.03). Analysis of the simple effects revealed
that on recovery from hypoglycemia, cognitive function
remained impaired in group 2 compared to group 1 (TMB
p = 0.04 and RVIP correct responses p= 0.02). In
conclusion patients with altered awareness of
hypoglycemia exhibited more profound cognitive
dysfunction during acute hypoglycemia which persisted
for longer following blood glucose recovery.
Diabetes 1993; 42 suppl 1: 104A.
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Frequency of Severe Hypoglycemia in
Insulin-Dependent Diabetic Patients with
Altered Awareness of Hypoglycemia, KENNETH M
MACLEOD, ANN E GOLD and BRIAN M FRIER*,
Edinburgh, UK.
The frequency of severe hypoglycemia has been shown
to be increased in patients with altered awareness of
hypoglycemia, when measured retrospectively. 57 IDD
patients, 29 of whom had altered awareness of
hypoglycemia and 28 with normal awareness of
hypoglycemia, were studied prospectively for one year.
The groups were matched for age, age of onset of
diabetes, duration of diabetes and glycemic control. The
patients were asked to document all episodes of severe
hypoglycemia within 24 hours of the event. Possible
precipitating factors, activity, time of day, location, form
of treatment and any resulting morbidity were
documented. Nineteen (66%) of patients with altered
awareness of hypoglycemia experienced one or more
episodes of severe hypoglycemia in 12 months with a
frequency of 2.8 episodes per patient per year. By
comparison 7 (25%) of the patients with normal awareness
of hypoglycaemia experienced an episode of severe
hypoglycemia with a frequency of 0.4 episodes per patient
per year (p< 0.001). One unaware patient sustained
significant injuries. The timing of hypoglycemia differed
between the two groups: the patients with altered
awareness experienced a greater proportion of episodes of
severe hypoglycemia in the evening (p=0.05) and tended
to have a smaller proportion of episodes overnight
(p=0.09) compared with those with normal awareness of
hypoglycemia. This prospective evaluation confirmed
that patients with altered awareness experience more
episodes of severe hypoglycemia, which may have a
greater morbidity, and many of these occur during waking
hours in the home environment.
Diabetes 1993; 42 suppl 1: 26A.
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SHORT-TERM CEREBRAL ADAPTATION TO ACUTE
HYPOGLYCEMIA DOES NOT OCCUR IN NON-DIABETIC HUMANS
A.E. Gold", K.M. MacLeod", I.J. Deary1" and B.M. Frier".
"
- Department of Diabetes, Royal Infirmary, Edinburgh; b - Department of
Psychology, University of Edinburgh.
Acute hypoglycaemia causes cognitive dysfunction both in diabetic and non-
diabetic humans. Previous studies have suggested that cerebral adaptation
may occur during acute hypoglycaemia. The aim of the present study was to
examine changes in cognitive function and symptoms during hypoglycaemia.
Hypoglycaemia was induced with a hypennsulinaemic glucose clamp on 3
separate occasions in 12 non-diabetic subjects and cognitive function was
assessed using a cognitive test battery : Paced Auditory Serial Addition Test
(PASAT), Rapid Visual Information Processing (RVIP), Trail-Making B
(TMB), Digit Symbol Substitution Test (DSST) and Four Choice Reaction
Times (CRT). In Study A the blood glucose was maintained at 4.5mmol/l
throughout. On two occasions (Study B and Study C) the blood glucose was
stabilisd at 4.5mmol/l for 30 minutes, lowered to 2.5mmol/l for 60 minutes
and restored to 4.5mmol/l for 30 minutes. In each study the first cognitive
test battery was performed immediately after stabilisation of blood glucose at
4.5 mmol/1, then was repeated as follows: Study A - after a further 40
minutes of normoglycaemia; Study B - after 40 minutes of hypoglycaemia;
Study C - after 5 minutes of hypoglycaemia. Acute hypoglycaemia induced a
significant deterioration in cognitive function in DSST (p<0.01), PASAT
(p<0.05), Choice Reaction Time (p<0.03) and RVIP (p<0.005). No
differences in performance were identified between Studies B and C.
Symptoms assessed by a scaled symptom questionnaire increased significantly
during hypoglycaemia (p= 0.002) but the symptom scores after 30 minutes and
after 60 minutes of hypoglycaemia did not differ. This study suggests that
after exposure to 40 minutes of hypoglycaemia (2.5 mmol/1) neither cognitive
function nor symptom score improve, thus excluding an adaptation effect.
Diabetologia 1993; 36 suppl 1: A151.
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